data_1nbj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nbj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 32.1 m . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -150.77 132.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.073 0.463 . . . . 0.0 111.177 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.425 ' HB2' HG21 ' A' ' 6' ' ' VAL . 1.6 p -105.88 128.41 53.75 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.74 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -88.9 3.04 52.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 23' ' ' ARG . 7.1 t -36.47 -44.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.039 0.837 . . . . 0.0 113.162 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.573 ' O ' HG21 ' A' ' 8' ' ' ILE . 9.7 m-85 -120.58 -8.68 9.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.74 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.6 pt -158.04 141.48 11.07 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.549 0.214 . . . . 0.0 111.559 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 29.6 Cg_exo -60.96 152.52 70.27 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.926 2.418 . . . . 0.0 112.425 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 6.9 m -51.53 135.82 27.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.5 m -114.61 -73.81 0.64 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.98 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 t -64.48 -48.48 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 109.55 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.869 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 56.2 p -66.57 -14.75 62.77 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.252 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.19 82.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mp -68.63 -25.34 64.79 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -83.66 -8.87 59.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.532 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.53 24.27 36.81 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.353 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.869 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.4 m -77.32 129.94 36.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.959 0.409 . . . . 0.0 111.153 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.6 t -105.27 144.61 31.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 t -72.59 122.99 22.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.539 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -150.58 126.28 10.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.24 36.33 25.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.082 0.944 . . . . 0.0 110.438 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.561 ' O ' HG22 ' A' ' 6' ' ' VAL . 29.5 mtm-85 67.68 16.47 9.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.757 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.15 141.11 34.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.949 0.404 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 56.2 m -78.47 127.03 31.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.962 0.411 . . . . 0.0 110.898 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.91 150.49 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.611 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 45.6 t30 -160.02 68.41 0.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 -46.44 3.61 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 27' ' ' ASN . 34.2 pt -121.99 156.98 58.98 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.461 -0.411 0 C-N-CA 122.25 1.967 . . . . 0.0 111.579 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.556 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 17.0 m . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 120.731 0.3 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.87 42.07 0.95 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -149.19 139.51 22.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.512 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -110.47 126.32 54.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.3 p -87.0 4.64 41.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 23' ' ' ARG . 15.9 t -34.59 -46.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.188 0.93 . . . . 0.0 113.175 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' HG22 ' A' ' 8' ' ' ILE . 6.1 m-85 -126.47 -2.09 6.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.762 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.03 137.84 9.84 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 34.6 Cg_exo -60.76 150.0 85.01 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.827 2.351 . . . . 0.0 112.279 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -51.55 131.56 29.53 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.487 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.4 m -113.36 -70.26 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.564 0.221 . . . . 0.0 111.433 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.26 -50.16 80.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.93 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 68.9 p -67.62 -11.22 57.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.484 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.58 78.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.31 -25.85 65.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.358 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.25 -6.9 59.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.718 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.49 29.05 33.96 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.399 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.93 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 81.0 m -77.67 136.18 38.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.943 0.401 . . . . 0.0 111.375 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -110.01 145.96 36.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.304 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.84 123.02 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.748 0.309 . . . . 0.0 110.535 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.0 m -144.07 120.19 10.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.73 33.85 23.74 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.524 ' O ' HG21 ' A' ' 6' ' ' VAL . 78.9 mtm180 73.31 13.59 4.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.769 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.7 137.87 54.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 65.3 m -75.25 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -147.26 143.01 27.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 24.1 p-10 -156.49 59.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.18 0.99 . . . . 0.0 109.603 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.68 -44.04 2.88 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -116.52 149.96 44.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.461 -0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 111.254 -179.459 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 31.0 m . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.667 0.27 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.44 42.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -151.59 138.07 18.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.018 0.437 . . . . 0.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.433 ' HB2' HG22 ' A' ' 6' ' ' VAL . 1.6 p -110.28 127.52 55.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.738 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 5.9 p -88.79 7.05 35.99 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 4' ' ' SER . 20.4 t -33.01 -48.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.344 1.028 . . . . 0.0 113.208 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' O ' HG23 ' A' ' 8' ' ' ILE . 5.4 m-85 -128.99 1.59 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.37 137.93 10.26 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 26.0 Cg_exo -61.91 150.17 87.26 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.82 2.347 . . . . 0.0 112.351 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -52.51 133.2 35.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 32.4 m -114.79 -68.65 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.41 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.9 t -63.05 -54.28 35.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.756 0.788 . . . . 0.0 109.886 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.883 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 58.2 p -66.43 -7.68 21.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.513 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 11' ' ' THR . . . -67.02 -36.04 81.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -71.45 -19.88 62.17 Favored 'General case' 0 N--CA 1.46 0.058 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -85.42 -10.21 56.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.191 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.72 24.14 36.74 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.317 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.883 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 85.7 m -74.96 128.4 35.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.031 0.443 . . . . 0.0 111.392 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -104.49 144.39 31.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.506 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.0 t -71.64 125.97 28.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -148.07 120.51 8.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 56.21 40.54 29.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.521 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 68.56 13.62 8.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.143 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -133.73 138.44 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 62.0 m -77.07 128.09 33.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -136.76 144.25 43.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.913 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.627 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 42.5 t30 -160.03 70.58 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.51 -47.48 3.64 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 27' ' ' ASN . 34.1 pt -122.59 156.8 60.85 Favored Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.461 -0.405 0 C-N-CA 122.353 2.036 . . . . 0.0 111.084 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.43 46.5 1.34 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.493 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -147.18 139.63 24.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.435 ' HB2' HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -114.49 122.64 47.2 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -85.45 8.05 20.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 4' ' ' SER . 25.4 t -32.74 -48.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.385 1.053 . . . . 0.0 113.119 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.469 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.6 m-85 -129.49 1.17 5.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.18 138.24 10.6 Favored Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.84 149.87 90.06 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.733 2.288 . . . . 0.0 112.807 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.6 m -57.15 133.9 55.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -110.15 -70.77 0.79 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.37 -51.03 75.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.16 0.981 . . . . 0.0 109.833 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.531 ' CG2' ' HB3' ' A' ' 1' ' ' CYS . 71.3 p -65.98 -11.85 50.74 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.833 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.74 -34.81 77.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.93 -26.76 66.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.36 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.72 -19.41 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.991 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 4.49 51.22 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.29 119.64 11.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.491 0.662 . . . . 0.0 111.322 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.1 m -98.06 154.36 17.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.17 120.16 16.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.7 m -144.86 118.4 9.12 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 59.54 35.8 22.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.335 0.588 . . . . 0.0 110.262 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 67.15 16.94 10.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.833 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 25' ' ' CYS . 53.4 t -131.68 140.0 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 59.8 m -78.81 121.16 24.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.837 0.351 . . . . 0.0 110.279 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -139.68 142.57 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.554 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 20.6 t30 -160.94 72.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.96 -50.56 4.42 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -118.22 152.49 50.68 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 122.586 2.191 . . . . 0.0 111.043 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.696 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 13.2 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.09 45.76 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.668 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -148.06 139.0 23.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 110.656 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -113.63 130.72 56.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 25.0 p -90.92 0.01 57.62 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.359 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.532 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 17.6 t -37.15 -48.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.929 0.768 . . . . 0.0 112.832 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.591 ' O ' HG22 ' A' ' 8' ' ' ILE . 16.1 m-85 -100.99 -23.23 14.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -159.1 149.48 15.58 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 120.412 0.149 . . . . 0.0 111.38 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.48 150.0 71.3 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.019 2.479 . . . . 0.0 112.75 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -54.11 137.12 41.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.069 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 32.2 m -116.22 -70.27 0.8 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.21 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.65 -53.39 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.678 0.751 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.696 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 33.0 p -69.15 -7.19 33.92 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.778 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -68.55 -33.98 75.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 15' ' ' LEU . 9.6 mp -68.14 -26.14 65.63 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.552 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.58 -20.61 42.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.84 35.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.699 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.95 128.29 35.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.308 0.575 . . . . 0.0 111.353 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 26.2 p -97.64 158.17 15.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.82 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.8 t -76.58 67.36 2.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' HG11 ' A' ' 24' ' ' VAL . 51.5 m -94.91 123.0 38.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.796 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m120 57.27 36.33 27.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.417 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.73 17.68 9.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.497 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 21' ' ' SER . 10.9 p -140.96 141.15 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.218 0.533 . . . . 0.0 109.895 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 35.3 m -74.71 113.67 12.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.268 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' A' ' 24' ' ' VAL . 3.3 m-85 -131.93 147.62 52.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.11 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.699 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 41.7 t30 -160.89 68.56 0.34 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.64 3.71 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 27' ' ' ASN . 33.8 pt -117.95 153.44 51.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.672 2.248 . . . . 0.0 111.925 -179.588 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 24.5 m . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.47 45.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.26 140.49 22.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.369 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.95 122.18 47.06 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.715 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -83.87 3.17 34.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.46 ' CG2' ' HB3' ' A' ' 23' ' ' ARG . 6.6 t -38.38 -43.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.038 0.836 . . . . 0.0 112.964 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -114.98 -14.61 11.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.715 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.6 pt -160.48 143.63 9.97 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-O 120.547 0.213 . . . . 0.0 111.348 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.26 151.38 74.08 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.649 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 m -50.89 130.77 25.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.757 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 27.2 m -109.22 -69.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.84 -53.6 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 122.118 0.961 . . . . 0.0 109.792 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.888 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 26.0 p -64.69 -8.26 13.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.88 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -69.01 -30.08 68.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.62 -23.19 61.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.923 0.868 . . . . 0.0 108.908 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 16' ' ' LEU . 3.1 mm? -86.49 -12.3 49.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.001 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.47 22.39 37.45 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.395 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.888 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 69.6 m -70.57 124.39 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.934 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -102.67 147.4 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.613 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -74.49 122.64 23.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.574 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.3 m -144.09 121.07 11.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 3.1 m120 57.77 33.4 23.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.779 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.39 13.72 6.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.716 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.38 138.34 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 84.4 m -76.51 127.37 32.69 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.157 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -138.83 143.76 38.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.785 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.9 t30 -160.34 70.43 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.26 -47.77 3.66 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 27' ' ' ASN . 34.9 pt -121.26 155.63 58.39 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.463 -0.298 0 C-N-CA 122.455 2.104 . . . . 0.0 111.324 -179.644 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.544 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 18.4 m . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.39 43.43 1.07 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.67 135.99 19.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 p -106.05 128.93 54.19 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.0 p -86.27 -1.09 57.17 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.543 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 18.8 t -37.56 -46.31 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.598 ' O ' HG23 ' A' ' 8' ' ' ILE . 29.6 m-85 -105.46 -21.52 13.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.7 pt -161.69 150.05 12.61 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 120.529 0.204 . . . . 0.0 111.195 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.85 155.17 39.53 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.068 2.512 . . . . 0.0 112.702 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -52.16 135.34 31.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.038 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -115.12 -71.03 0.76 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.875 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.31 -50.67 77.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.769 0.795 . . . . 0.0 109.823 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.918 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.1 p -67.55 -11.4 57.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.486 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.18 79.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -68.65 -25.84 65.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.382 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.22 -8.02 59.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.773 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.24 30.51 25.03 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.413 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.918 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 88.9 m -81.4 138.86 35.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.5 t -113.09 147.55 37.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.348 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.1 t -75.97 116.4 16.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.497 ' O ' HG13 ' A' ' 24' ' ' VAL . 51.1 m -144.91 127.18 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.49 33.43 20.57 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.211 0.529 . . . . 0.0 110.343 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.665 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 2.6 mmp_? 68.53 11.83 8.49 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.636 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 21' ' ' SER . 10.1 p -134.58 145.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 63.6 m -78.84 124.31 28.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.038 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CD1' HG12 ' A' ' 24' ' ' VAL . 4.3 m-85 -141.09 150.05 42.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.111 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 26.1 p-10 -160.11 58.67 0.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.347 1.07 . . . . 0.0 109.455 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.67 -42.49 2.9 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -118.24 153.52 51.57 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.458 -0.571 0 C-N-CA 122.381 2.054 . . . . 0.0 111.581 -179.455 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 24.0 m . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.28 45.6 1.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -150.41 136.59 18.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.53 124.89 50.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.3 p -86.21 -2.27 58.21 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 23' ' ' ARG . 21.6 t -36.53 -44.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.551 ' O ' HG22 ' A' ' 8' ' ' ILE . 52.8 m-85 -113.29 -16.52 12.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.0 pt -158.03 145.45 13.51 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.666 0.27 . . . . 0.0 111.475 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.3 153.2 71.87 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.305 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 m -53.67 131.92 39.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.796 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 26.9 m -109.42 -69.92 0.84 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.09 -53.41 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 122.057 0.932 . . . . 0.0 109.834 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.882 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 28.6 p -64.44 -8.9 15.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.904 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 11' ' ' THR . . . -68.76 -31.15 69.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.37 -23.79 61.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.841 0.829 . . . . 0.0 108.893 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.564 HD21 ' N ' ' A' ' 16' ' ' LEU . 3.2 mm? -84.68 -14.4 48.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.978 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 24.37 26.49 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.426 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.882 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.0 m -74.12 127.34 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 111.048 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.0 t -107.64 147.4 30.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.049 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -71.39 121.62 18.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.272 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' HG11 ' A' ' 24' ' ' VAL . 49.5 m -150.15 124.38 9.48 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.98 37.68 21.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.855 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.431 ' O ' HG21 ' A' ' 6' ' ' VAL . 35.2 mtp85 71.5 1.56 3.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.677 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 21' ' ' SER . 11.5 p -128.03 147.33 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 72.8 m -75.23 128.34 35.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.75 147.06 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 111.145 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.592 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 44.8 t30 -160.67 68.16 0.34 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.79 -49.88 4.0 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 27' ' ' ASN . 35.2 pt -116.56 155.92 48.18 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.459 -0.509 0 C-N-CA 122.191 1.927 . . . . 0.0 111.64 -179.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.511 ' HB3' HG22 ' A' ' 13' ' ' THR . 11.3 m . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.589 0.233 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 44.2 1.1 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -148.18 140.62 24.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.99 125.46 53.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -87.49 12.86 11.27 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.629 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 30.8 t -33.34 -50.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.396 1.06 . . . . 0.0 113.138 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.54 ' O ' HG21 ' A' ' 8' ' ' ILE . 4.9 m-85 -125.68 -0.09 7.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -157.09 142.78 12.7 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 21.8 Cg_exo -64.43 152.83 80.01 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.911 2.407 . . . . 0.0 112.319 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -51.64 130.32 27.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.49 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 24.8 m -106.83 -69.18 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 t -63.69 -53.67 41.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.172 0.986 . . . . 0.0 109.77 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.947 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 31.1 p -65.58 -3.17 4.17 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.98 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 11' ' ' THR . . . -68.19 -32.33 72.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.14 -26.17 63.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.806 0.812 . . . . 0.0 108.915 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.493 ' CD1' ' HA ' ' A' ' 13' ' ' THR . 7.1 mp -81.7 -10.83 59.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.375 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.63 26.21 39.56 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.032 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.947 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 64.0 m -72.89 131.73 42.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.843 0.354 . . . . 0.0 111.241 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -109.74 148.15 31.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.591 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.5 123.2 24.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -146.17 121.02 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 m120 58.02 35.52 25.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.941 0.4 . . . . 0.0 110.911 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.629 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 69.11 15.01 8.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.044 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.45 140.87 46.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 71.6 m -78.14 126.49 30.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.974 0.416 . . . . 0.0 110.155 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -148.67 142.51 25.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 21.3 p-10 -156.37 58.83 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.184 0.992 . . . . 0.0 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 -44.07 2.85 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 29' ' ' ILE . 33.0 pt -115.75 150.04 44.17 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.416 2.077 . . . . 0.0 111.611 -179.203 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.692 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 12.9 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.45 44.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.689 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.02 143.08 26.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.981 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.436 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -120.57 129.6 53.85 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.5 p -88.97 8.52 29.14 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.615 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 30.7 t -33.14 -49.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.319 1.012 . . . . 0.0 112.825 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.571 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.9 m-85 -125.83 -1.28 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.746 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.67 142.03 12.52 Favored Pre-proline 0 N--CA 1.473 0.69 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 26.3 Cg_exo -62.04 148.24 93.55 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.915 2.41 . . . . 0.0 112.512 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -56.31 137.94 51.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.9 m -117.79 -67.95 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.335 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.584 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.5 t -61.44 -56.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.79 0.805 . . . . 0.0 110.556 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.692 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 30.2 p -67.47 -5.66 15.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.75 78.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -70.27 -21.3 62.98 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 13' ' ' THR . 79.3 mt -80.89 -20.63 41.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.886 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.86 4.15 48.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.475 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.657 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.87 120.49 13.65 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.549 0.69 . . . . 0.0 111.466 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -97.95 153.72 18.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.815 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.05 118.12 16.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.524 ' O ' HG21 ' A' ' 24' ' ' VAL . 22.7 t -150.67 131.4 14.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.65 28.54 17.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.73 0.776 . . . . 0.0 109.639 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.615 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 36.4 mmt180 68.06 16.95 9.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.214 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 21' ' ' SER . 30.2 m -134.43 151.83 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 39.7 m -82.6 121.24 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -138.74 140.83 38.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.459 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.1 t30 -160.56 74.36 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.15 -51.84 4.64 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -119.74 155.12 55.07 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 122.52 2.146 . . . . 0.0 110.877 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.526 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 18.5 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.626 0.251 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.71 42.46 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.21 135.65 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.493 . . . . 0.0 110.826 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 p -105.94 128.62 53.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.717 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -91.62 10.25 28.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.852 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.543 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 15.1 t -33.85 -45.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.291 0.994 . . . . 0.0 113.217 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.553 ' O ' HG21 ' A' ' 8' ' ' ILE . 11.7 m-85 -131.77 1.2 3.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.0 pt -154.82 139.39 11.68 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.94 151.87 78.6 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.957 2.438 . . . . 0.0 112.648 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 m -52.55 132.92 36.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 28.8 m -114.26 -70.71 0.79 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.28 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.91 -51.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.644 0.735 . . . . 0.0 110.04 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.91 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.4 p -67.08 -7.6 24.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.692 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -68.64 -30.99 69.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 15' ' ' LEU . 3.6 mm? -71.94 -23.56 61.48 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.903 0.858 . . . . 0.0 108.903 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 13' ' ' THR . 3.5 mm? -84.8 -9.82 57.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.066 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.78 32.37 27.17 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.057 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.91 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 90.0 m -80.8 134.4 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.908 0.385 . . . . 0.0 111.589 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 p -107.82 144.72 34.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.92 124.51 27.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.509 ' O ' HG11 ' A' ' 24' ' ' VAL . 51.1 m -150.17 127.04 11.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.7 m120 58.15 35.84 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.258 0.552 . . . . 0.0 110.762 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 24.5 mmt85 65.39 20.03 11.71 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.593 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.509 HG11 ' O ' ' A' ' 21' ' ' SER . 10.4 p -141.34 143.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 61.9 m -78.93 123.7 27.52 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.009 0.433 . . . . 0.0 111.295 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.97 149.31 39.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.6 p-10 -159.8 59.09 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.274 1.035 . . . . 0.0 109.317 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.83 -42.02 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.99 153.44 52.77 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.05 -1.075 . . . . 0.0 108.121 177.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.598 0 C-N-CA 122.329 2.019 . . . . 0.0 111.416 -179.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.685 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 8.4 m . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.09 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 111.237 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.504 ' HB2' HG23 ' A' ' 13' ' ' THR . 77.8 mt-10 -145.22 138.44 26.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.132 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.423 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -114.67 128.1 56.12 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.744 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -88.71 8.53 28.27 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.844 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.9 t -30.82 -50.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 124.541 1.15 . . . . 0.0 113.15 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.508 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.9 m-85 -132.83 4.68 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.5 pt -154.42 137.64 10.43 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 120.595 0.236 . . . . 0.0 111.454 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.77 150.59 85.25 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.763 2.309 . . . . 0.0 112.903 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.0 m -58.17 138.5 56.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.348 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.0 m -117.09 -71.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.234 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.39 -49.08 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.728 0.775 . . . . 0.0 109.883 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.685 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 30.9 p -68.33 -13.55 62.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.625 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.27 78.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.84 -27.07 66.39 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.46 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.96 -20.11 46.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.124 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.82 10.38 40.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.466 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -72.62 121.8 20.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.37 0.605 . . . . 0.0 111.217 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -96.61 155.38 16.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.035 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.4 t -72.49 118.8 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.498 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 m -142.85 120.0 11.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.53 35.73 26.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 110.558 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 67.35 19.66 10.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.929 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.35 139.05 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 47.6 m -78.22 119.93 22.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.955 0.407 . . . . 0.0 109.961 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.33 142.67 43.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.708 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.659 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.9 t30 -160.38 73.74 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.59 -49.56 3.89 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 27' ' ' ASN . 37.8 pt -118.57 152.62 51.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.456 -0.73 0 C-N-CA 122.183 1.922 . . . . 0.0 111.519 -179.493 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.729 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 12.3 m . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.21 45.96 1.31 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.726 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -147.21 140.74 25.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.264 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 p -117.28 126.17 52.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.742 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -87.31 5.39 38.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.479 ' H ' HG22 ' A' ' 6' ' ' VAL . 12.2 t -35.49 -44.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.157 0.91 . . . . 0.0 113.229 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 8' ' ' ILE . 8.5 m-85 -124.68 -5.83 7.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.3 pt -158.37 141.05 10.53 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.24 148.61 89.28 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.89 2.393 . . . . 0.0 112.548 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 m -55.2 138.58 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.827 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 28.3 m -120.33 -66.02 1.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.321 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.35 -54.56 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.634 0.73 . . . . 0.0 110.508 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.729 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 32.4 p -70.1 -5.41 26.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.679 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -70.93 -28.54 64.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.87 -25.3 62.74 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.953 0.882 . . . . 0.0 108.839 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.685 HD22 ' N ' ' A' ' 16' ' ' LEU . 3.0 mm? -82.05 -21.02 37.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.64 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.48 12.91 39.96 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.668 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -71.9 123.52 22.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 111.252 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 p -98.37 153.98 18.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.695 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.19 121.68 21.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.552 ' O ' HG22 ' A' ' 24' ' ' VAL . 21.7 t -150.0 124.08 9.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 58.03 36.33 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.178 0.513 . . . . 0.0 111.011 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 69.59 9.37 7.19 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.742 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 21' ' ' SER . 30.0 m -130.91 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 43.3 m -82.67 124.4 30.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -137.98 142.2 40.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.587 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.658 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.7 t30 -160.85 73.07 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.896 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -50.4 4.4 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.51 155.13 59.69 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.459 -0.508 0 C-N-CA 122.584 2.189 . . . . 0.0 111.004 -179.716 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.69 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 4.3 m . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.63 0.252 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.24 44.0 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.034 0.445 . . . . 0.0 111.131 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 13' ' ' THR . 72.5 mt-10 -147.18 137.03 23.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.846 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -114.27 128.02 56.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -86.71 2.86 47.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.465 HG13 ' HD3' ' A' ' 23' ' ' ARG . 12.6 t -36.94 -44.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.96 0.788 . . . . 0.0 113.079 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.601 ' O ' HG22 ' A' ' 8' ' ' ILE . 32.7 m-85 -115.14 -15.05 11.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.4 pt -159.47 145.71 12.2 Favored Pre-proline 0 N--CA 1.47 0.558 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.48 150.07 77.83 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.085 2.523 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 m -53.69 138.51 34.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -118.39 -71.13 0.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.1 t -63.12 -49.9 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.439 0.638 . . . . 0.0 110.201 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.69 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 34.8 p -67.79 -9.39 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.808 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.27 68.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.92 -24.89 62.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.784 0.802 . . . . 0.0 108.872 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.656 HD21 ' N ' ' A' ' 16' ' ' LEU . 2.9 mm? -81.49 -21.13 38.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.594 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.12 13.92 37.84 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.17 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.98 122.93 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 0.0 111.112 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -98.88 154.35 18.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.18 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 t -74.27 120.77 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.384 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 24' ' ' VAL . 45.5 m -148.82 124.73 10.61 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.4 34.08 23.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 110.562 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HD3' HG13 ' A' ' 6' ' ' VAL . 84.3 mtt-85 68.4 15.33 9.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.639 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 21' ' ' SER . 12.2 p -136.48 143.9 34.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.4 m -81.94 119.01 23.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.971 0.415 . . . . 0.0 111.343 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.75 149.35 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.395 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.701 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.9 t30 -160.75 69.03 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.72 -47.44 3.66 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 27' ' ' ASN . 32.0 pt -120.11 154.57 55.87 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.461 -0.42 0 C-N-CA 122.612 2.208 . . . . 0.0 111.741 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.679 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 17.5 m . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.1 42.59 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.512 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -148.66 150.07 32.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.994 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.489 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.8 p -130.07 130.21 44.59 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -82.79 -3.09 56.18 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.814 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.6 t -37.51 -45.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 124.104 0.877 . . . . 0.0 112.475 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.583 ' O ' HG21 ' A' ' 8' ' ' ILE . 33.7 m-85 -105.9 -22.77 12.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.798 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.0 pt -162.6 143.64 7.75 Favored Pre-proline 0 N--CA 1.471 0.585 0 O-C-N 123.162 0.289 . . . . 0.0 110.738 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.87 147.98 39.61 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 123.258 2.639 . . . . 0.0 113.192 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.0 m -53.62 135.15 41.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.017 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.1 m -117.07 -70.65 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.208 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.86 -51.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.83 0.824 . . . . 0.0 110.293 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.679 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 43.7 p -68.64 -9.54 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.846 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.64 79.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.41 -25.63 65.13 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.659 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.07 -20.06 46.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.221 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.24 12.78 35.19 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.8 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.6 m -75.28 128.35 35.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 0.0 111.466 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 m -98.2 162.3 13.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.797 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.16 66.26 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.695 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.2 m -89.82 121.99 32.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.72 32.31 20.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.22 0.533 . . . . 0.0 110.756 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 69.2 mtp180 67.44 18.72 10.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.244 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 21' ' ' SER . 8.3 p -131.36 142.61 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 49.4 m -72.8 113.15 9.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -142.75 145.56 33.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.452 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.7 p-10 -156.33 55.64 0.57 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.254 1.026 . . . . 0.0 109.265 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 -46.22 2.77 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.4 pt -110.37 150.81 42.12 Favored Pre-proline 0 N--CA 1.442 -0.846 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 C-N-CA 122.488 2.125 . . . . 0.0 112.317 -178.741 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.533 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 7.3 m . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.765 0.317 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.01 45.42 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.9 0.381 . . . . 0.0 111.414 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -146.39 134.12 21.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 p -109.48 126.35 53.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.1 p -89.24 8.04 32.36 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.8 t -31.78 -48.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 124.422 1.076 . . . . 0.0 113.122 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.73 7.19 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.539 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.716 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 7.9 pt -152.51 136.41 10.09 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.75 149.18 87.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.503 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.3 132.83 55.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.247 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.443 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 23.7 m -111.21 -72.52 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.24 -50.09 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 122.018 0.913 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.11 -15.97 62.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.724 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 11' ' ' THR . . . -66.7 -36.86 83.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.26 -25.89 65.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.614 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.2 mt -80.24 -18.37 49.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.071 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.65 3.11 49.93 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.52 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -67.97 120.47 14.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.507 0.67 . . . . 0.0 111.256 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.4 m -98.14 149.16 22.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.552 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.84 120.8 16.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.388 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 24' ' ' VAL . 48.2 m -150.13 125.7 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.34 36.62 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.927 0.394 . . . . 0.0 111.204 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 68.76 17.55 8.81 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.707 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 21' ' ' SER . 11.8 p -143.57 145.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.226 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 24.3 m -82.59 119.37 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.943 0.402 . . . . 0.0 111.363 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.439 ' CE1' HG12 ' A' ' 24' ' ' VAL . 3.7 m-85 -131.09 149.41 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.451 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.697 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.5 t30 -161.0 69.29 0.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.2 -48.68 3.84 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 27' ' ' ASN . 34.1 pt -116.28 153.41 48.64 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.459 -0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 111.72 -179.544 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.712 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 7.8 m . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.21 45.6 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.779 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -146.8 133.61 20.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.066 0.46 . . . . 0.0 110.504 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -109.89 127.71 54.89 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.743 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -90.38 4.94 49.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 23' ' ' ARG . 15.9 t -34.5 -45.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.325 1.016 . . . . 0.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.507 ' O ' HG23 ' A' ' 8' ' ' ILE . 6.6 m-85 -130.77 2.27 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.8 pt -153.82 138.85 11.63 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.35 146.32 89.7 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 m -56.5 136.28 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.554 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 32.7 m -124.07 -66.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.488 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.85 -55.48 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.573 0.702 . . . . 0.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.712 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 32.0 p -70.19 -5.93 30.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.629 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -70.73 -28.72 64.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.8 -25.29 62.8 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.873 0.844 . . . . 0.0 108.733 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 16' ' ' LEU . 2.9 mm? -82.42 -21.56 35.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.567 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.18 33.44 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.635 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -74.42 122.33 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.363 0.601 . . . . 0.0 111.202 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 t -98.44 153.21 18.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.269 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.3 t -71.95 122.88 21.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -150.39 126.79 10.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 56.9 32.83 22.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 111.094 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 6' ' ' VAL . 81.2 mtm180 71.46 18.62 5.43 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.491 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 25' ' ' CYS . 9.1 p -143.24 142.74 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.868 0.366 . . . . 0.0 110.06 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.5 m -78.67 121.11 24.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.14 147.94 51.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.398 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.701 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.7 t30 -160.96 70.29 0.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.463 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.07 -46.47 3.51 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 27' ' ' ASN . 32.6 pt -122.89 156.15 62.65 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.46 -0.489 0 C-N-CA 122.653 2.235 . . . . 0.0 111.717 -179.74 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 17.8 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.852 0.358 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.7 47.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.595 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -146.24 137.14 24.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.001 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 p -109.78 123.32 49.34 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.6 p -86.71 3.01 46.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.273 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 23' ' ' ARG . 10.2 t -34.54 -45.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 124.224 0.952 . . . . 0.0 113.163 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.476 ' O ' HG23 ' A' ' 8' ' ' ILE . 8.0 m-85 -125.77 -3.92 7.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.15 138.32 10.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 120.664 0.269 . . . . 0.0 111.615 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 150.7 86.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.637 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 m -56.95 133.22 54.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.437 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -111.52 -69.83 0.85 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 t -62.68 -53.08 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 122.05 0.929 . . . . 0.0 110.042 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 67.9 p -65.91 -8.42 22.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.995 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -29.74 66.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.74 -24.89 62.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.82 0.819 . . . . 0.0 108.823 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -80.79 -21.2 41.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.678 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.55 7.93 50.31 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.431 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.662 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -67.22 120.19 13.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.471 0.653 . . . . 0.0 111.192 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 m -98.45 152.31 19.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.462 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.49 121.56 18.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.456 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 m -149.51 122.41 8.75 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.55 35.92 22.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 110.918 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 8.9 mpt_? 69.08 11.55 8.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -133.01 147.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.88 0.371 . . . . 0.0 110.151 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 60.4 m -80.6 122.36 26.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.33 . . . . 0.0 110.356 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -137.93 142.95 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 111.503 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.662 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 16.9 t30 -160.96 72.44 0.44 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.34 -48.97 3.72 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 27' ' ' ASN . 35.7 pt -118.57 151.58 49.99 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.27 1.98 . . . . 0.0 111.805 -179.503 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.709 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 14.2 m . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.55 46.06 1.27 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.737 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -145.95 139.49 26.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.415 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -115.67 123.71 49.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 3.3 p -84.38 0.85 47.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.259 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 23' ' ' ARG . 6.7 t -38.12 -43.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 124.09 0.869 . . . . 0.0 113.046 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.604 ' O ' HG21 ' A' ' 8' ' ' ILE . 10.5 m-85 -115.78 -13.59 11.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.3 pt -160.93 142.33 8.89 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.446 0.165 . . . . 0.0 111.062 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.45 150.02 62.3 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.903 2.402 . . . . 0.0 112.65 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.3 m -54.39 138.03 40.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.778 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 m -118.56 -68.13 0.94 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.159 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.58 -53.33 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.72 0.771 . . . . 0.0 110.376 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.709 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 29.9 p -70.04 -8.35 48.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.686 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.19 73.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.01 -27.53 66.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.228 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.43 -19.94 45.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.088 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.68 8.07 46.7 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.693 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.665 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -69.04 120.81 15.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.545 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 m -97.56 149.67 21.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.462 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.57 104.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.603 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 m -121.67 110.73 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 23.7 m-20 56.96 43.78 24.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.412 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.448 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.19 6.59 5.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.337 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.2 135.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m -72.17 120.89 18.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -137.78 142.08 40.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 111.612 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.665 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 19.0 t30 -160.59 74.18 0.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.78 -48.28 3.84 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' H ' ' C ' ' A' ' 27' ' ' ASN . 2.4 pp -122.37 153.87 62.21 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.554 0 C-N-CA 122.595 2.196 . . . . 0.0 111.247 -179.431 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 8.5 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.42 45.62 1.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.536 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -147.59 136.41 22.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.886 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -109.79 125.77 53.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.7 p -88.95 6.56 38.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.551 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 20.6 t -32.38 -48.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 124.446 1.091 . . . . 0.0 113.039 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.507 ' O ' HG23 ' A' ' 8' ' ' ILE . 6.3 m-85 -133.66 6.76 3.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.716 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.7 pt -151.85 139.76 12.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 12.7 Cg_exo -68.59 144.05 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.777 2.318 . . . . 0.0 111.947 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 m -56.65 132.83 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -112.24 -70.51 0.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.3 -52.93 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.953 0.882 . . . . 0.0 110.18 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.562 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 76.2 p -65.4 -10.56 34.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.953 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.66 -30.38 68.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.8 -24.8 62.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.808 0.814 . . . . 0.0 108.953 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -80.76 -21.12 41.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.599 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.86 49.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.472 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.671 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -68.13 119.55 12.89 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.474 0.654 . . . . 0.0 111.115 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -97.8 151.16 20.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.485 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.5 t -71.03 120.86 17.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.482 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.422 ' O ' HG12 ' A' ' 24' ' ' VAL . 46.5 m -150.21 126.45 10.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 56.86 34.79 25.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 0.0 111.034 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 1.6 mpt_? 68.74 16.55 8.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.693 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 21' ' ' SER . 12.4 p -137.19 143.95 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.946 0.403 . . . . 0.0 109.94 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 55.2 m -77.72 118.35 20.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -131.69 144.39 50.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 0.0 111.785 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.671 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 18.8 t30 -161.22 71.66 0.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.778 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.17 -52.68 4.67 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.56 HD11 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -117.44 156.02 49.56 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.456 -0.733 0 C-N-CA 122.195 1.93 . . . . 0.0 111.738 -179.478 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 32.1 m . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -150.77 132.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.073 0.463 . . . . 0.0 111.177 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.425 ' HB2' HG21 ' A' ' 6' ' ' VAL . 1.6 p -105.88 128.41 53.75 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.74 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -88.9 3.04 52.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 23' ' ' ARG . 7.1 t -36.47 -44.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.039 0.837 . . . . 0.0 113.162 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.573 ' O ' HG21 ' A' ' 8' ' ' ILE . 9.7 m-85 -120.58 -8.68 9.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.74 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.6 pt -158.04 141.48 11.07 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.549 0.214 . . . . 0.0 111.559 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 29.6 Cg_exo -60.96 152.52 70.27 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.926 2.418 . . . . 0.0 112.425 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.4 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 6.9 m -51.53 135.82 27.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.5 m -114.61 -73.81 0.64 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.98 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 t -64.48 -48.48 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 109.55 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.869 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 56.2 p -66.57 -14.75 62.77 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.252 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.19 82.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mp -68.63 -25.34 64.79 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -83.66 -8.87 59.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.532 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.53 24.27 36.81 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.353 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.869 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.4 m -77.32 129.94 36.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.959 0.409 . . . . 0.0 111.153 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.6 t -105.27 144.61 31.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 t -72.59 122.99 22.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.539 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -150.58 126.28 10.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.24 36.33 25.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.082 0.944 . . . . 0.0 110.438 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.561 ' O ' HG22 ' A' ' 6' ' ' VAL . 29.5 mtm-85 67.68 16.47 9.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.757 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.15 141.11 34.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.949 0.404 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.545 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 56.2 m -78.47 127.03 31.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.962 0.411 . . . . 0.0 110.898 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.91 150.49 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.611 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 45.6 t30 -160.02 68.41 0.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 -46.44 3.61 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 27' ' ' ASN . 34.2 pt -121.99 156.98 58.98 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.461 -0.411 0 C-N-CA 122.25 1.967 . . . . 0.0 111.579 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.556 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 17.0 m . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 120.731 0.3 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.87 42.07 0.95 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -149.19 139.51 22.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.512 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.5 p -110.47 126.32 54.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.762 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.3 p -87.0 4.64 41.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 23' ' ' ARG . 15.9 t -34.59 -46.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.188 0.93 . . . . 0.0 113.175 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.415 ' O ' HG22 ' A' ' 8' ' ' ILE . 6.1 m-85 -126.47 -2.09 6.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.762 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.03 137.84 9.84 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 34.6 Cg_exo -60.76 150.0 85.01 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.827 2.351 . . . . 0.0 112.279 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -51.55 131.56 29.53 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.487 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.4 m -113.36 -70.26 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.564 0.221 . . . . 0.0 111.433 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.26 -50.16 80.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.93 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 68.9 p -67.62 -11.22 57.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.484 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.58 78.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.31 -25.85 65.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.358 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.25 -6.9 59.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.718 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.49 29.05 33.96 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.399 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.93 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 81.0 m -77.67 136.18 38.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.943 0.401 . . . . 0.0 111.375 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -110.01 145.96 36.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.304 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.84 123.02 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.748 0.309 . . . . 0.0 110.535 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.0 m -144.07 120.19 10.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.73 33.85 23.74 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.524 ' O ' HG21 ' A' ' 6' ' ' VAL . 78.9 mtm180 73.31 13.59 4.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.769 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.7 137.87 54.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 65.3 m -75.25 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -147.26 143.01 27.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 24.1 p-10 -156.49 59.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.18 0.99 . . . . 0.0 109.603 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.68 -44.04 2.88 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -116.52 149.96 44.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.461 -0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 111.254 -179.459 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.494 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 31.0 m . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.667 0.27 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.44 42.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -151.59 138.07 18.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.018 0.437 . . . . 0.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.433 ' HB2' HG22 ' A' ' 6' ' ' VAL . 1.6 p -110.28 127.52 55.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.738 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 5.9 p -88.79 7.05 35.99 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 4' ' ' SER . 20.4 t -33.01 -48.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.344 1.028 . . . . 0.0 113.208 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' O ' HG23 ' A' ' 8' ' ' ILE . 5.4 m-85 -128.99 1.59 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.738 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.37 137.93 10.26 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 26.0 Cg_exo -61.91 150.17 87.26 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.82 2.347 . . . . 0.0 112.351 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -52.51 133.2 35.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 32.4 m -114.79 -68.65 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.41 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.9 t -63.05 -54.28 35.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.756 0.788 . . . . 0.0 109.886 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.883 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 58.2 p -66.43 -7.68 21.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.513 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 11' ' ' THR . . . -67.02 -36.04 81.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -71.45 -19.88 62.17 Favored 'General case' 0 N--CA 1.46 0.058 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -85.42 -10.21 56.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.191 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.72 24.14 36.74 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.317 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.883 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 85.7 m -74.96 128.4 35.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.031 0.443 . . . . 0.0 111.392 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -104.49 144.39 31.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.506 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.0 t -71.64 125.97 28.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -148.07 120.51 8.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 56.21 40.54 29.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.521 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 68.56 13.62 8.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.143 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -133.73 138.44 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 62.0 m -77.07 128.09 33.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -136.76 144.25 43.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.913 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.627 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 42.5 t30 -160.03 70.58 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.51 -47.48 3.64 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.42 ' H ' ' C ' ' A' ' 27' ' ' ASN . 34.1 pt -122.59 156.8 60.85 Favored Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.461 -0.405 0 C-N-CA 122.353 2.036 . . . . 0.0 111.084 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.531 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.43 46.5 1.34 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.493 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -147.18 139.63 24.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.435 ' HB2' HG21 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -114.49 122.64 47.2 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -85.45 8.05 20.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 4' ' ' SER . 25.4 t -32.74 -48.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.385 1.053 . . . . 0.0 113.119 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.469 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.6 m-85 -129.49 1.17 5.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.18 138.24 10.6 Favored Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.84 149.87 90.06 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.733 2.288 . . . . 0.0 112.807 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.6 m -57.15 133.9 55.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -110.15 -70.77 0.79 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.37 -51.03 75.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.16 0.981 . . . . 0.0 109.833 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.531 ' CG2' ' HB3' ' A' ' 1' ' ' CYS . 71.3 p -65.98 -11.85 50.74 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.833 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.74 -34.81 77.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.93 -26.76 66.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.36 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.72 -19.41 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.991 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 4.49 51.22 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.655 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.29 119.64 11.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.491 0.662 . . . . 0.0 111.322 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.1 m -98.06 154.36 17.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.17 120.16 16.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.7 m -144.86 118.4 9.12 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 59.54 35.8 22.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.335 0.588 . . . . 0.0 110.262 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 67.15 16.94 10.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.833 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 25' ' ' CYS . 53.4 t -131.68 140.0 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 59.8 m -78.81 121.16 24.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.837 0.351 . . . . 0.0 110.279 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -139.68 142.57 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.554 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.655 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 20.6 t30 -160.94 72.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.96 -50.56 4.42 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.551 ' H ' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -118.22 152.49 50.68 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 122.586 2.191 . . . . 0.0 111.043 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.696 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 13.2 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.09 45.76 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.668 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -148.06 139.0 23.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 110.656 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 p -113.63 130.72 56.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.666 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 25.0 p -90.92 0.01 57.62 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.359 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.532 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 17.6 t -37.15 -48.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.929 0.768 . . . . 0.0 112.832 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.591 ' O ' HG22 ' A' ' 8' ' ' ILE . 16.1 m-85 -100.99 -23.23 14.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.666 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -159.1 149.48 15.58 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 120.412 0.149 . . . . 0.0 111.38 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.48 150.0 71.3 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.019 2.479 . . . . 0.0 112.75 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -54.11 137.12 41.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.069 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.48 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 32.2 m -116.22 -70.27 0.8 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.21 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.65 -53.39 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.678 0.751 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.696 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 33.0 p -69.15 -7.19 33.92 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.778 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -68.55 -33.98 75.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 15' ' ' LEU . 9.6 mp -68.14 -26.14 65.63 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.552 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.58 -20.61 42.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.84 35.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.699 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.95 128.29 35.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.308 0.575 . . . . 0.0 111.353 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 26.2 p -97.64 158.17 15.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.82 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.8 t -76.58 67.36 2.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.502 ' O ' HG11 ' A' ' 24' ' ' VAL . 51.5 m -94.91 123.0 38.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.796 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m120 57.27 36.33 27.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.417 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.73 17.68 9.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.497 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 21' ' ' SER . 10.9 p -140.96 141.15 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.218 0.533 . . . . 0.0 109.895 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 35.3 m -74.71 113.67 12.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.268 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' A' ' 24' ' ' VAL . 3.3 m-85 -131.93 147.62 52.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.11 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.699 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 41.7 t30 -160.89 68.56 0.34 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.64 3.71 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 27' ' ' ASN . 33.8 pt -117.95 153.44 51.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.672 2.248 . . . . 0.0 111.925 -179.588 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.477 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 24.5 m . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.47 45.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.26 140.49 22.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.369 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.95 122.18 47.06 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.715 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -83.87 3.17 34.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.46 ' CG2' ' HB3' ' A' ' 23' ' ' ARG . 6.6 t -38.38 -43.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.038 0.836 . . . . 0.0 112.964 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -114.98 -14.61 11.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.715 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.6 pt -160.48 143.63 9.97 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-O 120.547 0.213 . . . . 0.0 111.348 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.26 151.38 74.08 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.649 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 m -50.89 130.77 25.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.757 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 27.2 m -109.22 -69.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.84 -53.6 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 122.118 0.961 . . . . 0.0 109.792 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.888 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 26.0 p -64.69 -8.26 13.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.88 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -69.01 -30.08 68.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.62 -23.19 61.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.923 0.868 . . . . 0.0 108.908 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.674 HD23 ' N ' ' A' ' 16' ' ' LEU . 3.1 mm? -86.49 -12.3 49.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.001 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.47 22.39 37.45 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.395 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.888 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 69.6 m -70.57 124.39 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.934 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -102.67 147.4 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.613 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -74.49 122.64 23.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.574 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.3 m -144.09 121.07 11.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 3.1 m120 57.77 33.4 23.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.779 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.39 13.72 6.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.716 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.38 138.34 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 84.4 m -76.51 127.37 32.69 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.157 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -138.83 143.76 38.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.785 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.9 t30 -160.34 70.43 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.26 -47.77 3.66 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.417 ' H ' ' C ' ' A' ' 27' ' ' ASN . 34.9 pt -121.26 155.63 58.39 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.463 -0.298 0 C-N-CA 122.455 2.104 . . . . 0.0 111.324 -179.644 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.544 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 18.4 m . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.39 43.43 1.07 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.67 135.99 19.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 p -106.05 128.93 54.19 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.708 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.0 p -86.27 -1.09 57.17 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.543 ' HA ' ' HD3' ' A' ' 23' ' ' ARG . 18.8 t -37.56 -46.31 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.598 ' O ' HG23 ' A' ' 8' ' ' ILE . 29.6 m-85 -105.46 -21.52 13.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.708 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.7 pt -161.69 150.05 12.61 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 120.529 0.204 . . . . 0.0 111.195 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.85 155.17 39.53 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.068 2.512 . . . . 0.0 112.702 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -52.16 135.34 31.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.038 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -115.12 -71.03 0.76 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.875 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.31 -50.67 77.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.769 0.795 . . . . 0.0 109.823 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.918 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.1 p -67.55 -11.4 57.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.486 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.18 79.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -68.65 -25.84 65.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.382 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.22 -8.02 59.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.773 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.24 30.51 25.03 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.413 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.918 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 88.9 m -81.4 138.86 35.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.5 t -113.09 147.55 37.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.348 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.1 t -75.97 116.4 16.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.497 ' O ' HG13 ' A' ' 24' ' ' VAL . 51.1 m -144.91 127.18 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.49 33.43 20.57 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.211 0.529 . . . . 0.0 110.343 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.665 ' HE ' ' HA ' ' A' ' 23' ' ' ARG . 2.6 mmp_? 68.53 11.83 8.49 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.636 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 21' ' ' SER . 10.1 p -134.58 145.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 63.6 m -78.84 124.31 28.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.038 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.419 ' CD1' HG12 ' A' ' 24' ' ' VAL . 4.3 m-85 -141.09 150.05 42.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.111 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 26.1 p-10 -160.11 58.67 0.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.347 1.07 . . . . 0.0 109.455 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.67 -42.49 2.9 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -118.24 153.52 51.57 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.458 -0.571 0 C-N-CA 122.381 2.054 . . . . 0.0 111.581 -179.455 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 25' ' ' CYS . 24.0 m . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.28 45.6 1.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -150.41 136.59 18.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.53 124.89 50.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.685 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.3 p -86.21 -2.27 58.21 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 23' ' ' ARG . 21.6 t -36.53 -44.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.551 ' O ' HG22 ' A' ' 8' ' ' ILE . 52.8 m-85 -113.29 -16.52 12.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.0 pt -158.03 145.45 13.51 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.666 0.27 . . . . 0.0 111.475 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.3 153.2 71.87 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.305 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 m -53.67 131.92 39.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.796 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.56 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 26.9 m -109.42 -69.92 0.84 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.09 -53.41 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 122.057 0.932 . . . . 0.0 109.834 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.882 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 28.6 p -64.44 -8.9 15.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.904 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 11' ' ' THR . . . -68.76 -31.15 69.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.37 -23.79 61.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.841 0.829 . . . . 0.0 108.893 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.564 HD21 ' N ' ' A' ' 16' ' ' LEU . 3.2 mm? -84.68 -14.4 48.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.978 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 24.37 26.49 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.426 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.882 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.0 m -74.12 127.34 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 111.048 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.0 t -107.64 147.4 30.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.049 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -71.39 121.62 18.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.272 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.411 ' O ' HG11 ' A' ' 24' ' ' VAL . 49.5 m -150.15 124.38 9.48 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.98 37.68 21.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.855 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.431 ' O ' HG21 ' A' ' 6' ' ' VAL . 35.2 mtp85 71.5 1.56 3.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.677 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 21' ' ' SER . 11.5 p -128.03 147.33 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 72.8 m -75.23 128.34 35.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.75 147.06 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 111.145 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.592 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 44.8 t30 -160.67 68.16 0.34 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.79 -49.88 4.0 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.41 ' H ' ' C ' ' A' ' 27' ' ' ASN . 35.2 pt -116.56 155.92 48.18 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.459 -0.509 0 C-N-CA 122.191 1.927 . . . . 0.0 111.64 -179.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.511 ' HB3' HG22 ' A' ' 13' ' ' THR . 11.3 m . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.589 0.233 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 44.2 1.1 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -148.18 140.62 24.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.99 125.46 53.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -87.49 12.86 11.27 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.629 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 30.8 t -33.34 -50.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.396 1.06 . . . . 0.0 113.138 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.54 ' O ' HG21 ' A' ' 8' ' ' ILE . 4.9 m-85 -125.68 -0.09 7.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.684 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -157.09 142.78 12.7 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 21.8 Cg_exo -64.43 152.83 80.01 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.911 2.407 . . . . 0.0 112.319 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -51.64 130.32 27.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.49 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 24.8 m -106.83 -69.18 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 t -63.69 -53.67 41.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.172 0.986 . . . . 0.0 109.77 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.947 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 31.1 p -65.58 -3.17 4.17 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.98 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 11' ' ' THR . . . -68.19 -32.33 72.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.14 -26.17 63.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.806 0.812 . . . . 0.0 108.915 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.493 ' CD1' ' HA ' ' A' ' 13' ' ' THR . 7.1 mp -81.7 -10.83 59.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.375 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.63 26.21 39.56 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.032 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.947 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 64.0 m -72.89 131.73 42.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.843 0.354 . . . . 0.0 111.241 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -109.74 148.15 31.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.591 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.5 123.2 24.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -146.17 121.02 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 m120 58.02 35.52 25.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.941 0.4 . . . . 0.0 110.911 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.629 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 69.11 15.01 8.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.044 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.45 140.87 46.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 71.6 m -78.14 126.49 30.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.974 0.416 . . . . 0.0 110.155 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -148.67 142.51 25.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 21.3 p-10 -156.37 58.83 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.184 0.992 . . . . 0.0 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 -44.07 2.85 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.403 HG21 HD11 ' A' ' 29' ' ' ILE . 33.0 pt -115.75 150.04 44.17 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.416 2.077 . . . . 0.0 111.611 -179.203 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.692 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 12.9 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.45 44.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.689 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.02 143.08 26.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.981 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.436 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -120.57 129.6 53.85 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.746 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.5 p -88.97 8.52 29.14 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.615 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 30.7 t -33.14 -49.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.319 1.012 . . . . 0.0 112.825 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.571 ' O ' HG22 ' A' ' 8' ' ' ILE . 4.9 m-85 -125.83 -1.28 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.746 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.67 142.03 12.52 Favored Pre-proline 0 N--CA 1.473 0.69 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 26.3 Cg_exo -62.04 148.24 93.55 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.915 2.41 . . . . 0.0 112.512 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -56.31 137.94 51.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.9 m -117.79 -67.95 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.335 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.584 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.5 t -61.44 -56.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.79 0.805 . . . . 0.0 110.556 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.692 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 30.2 p -67.47 -5.66 15.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.02 -35.75 78.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -70.27 -21.3 62.98 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 13' ' ' THR . 79.3 mt -80.89 -20.63 41.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.886 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.86 4.15 48.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.475 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.657 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.87 120.49 13.65 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.549 0.69 . . . . 0.0 111.466 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -97.95 153.72 18.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.815 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.05 118.12 16.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.524 ' O ' HG21 ' A' ' 24' ' ' VAL . 22.7 t -150.67 131.4 14.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.65 28.54 17.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.73 0.776 . . . . 0.0 109.639 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.615 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 36.4 mmt180 68.06 16.95 9.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.214 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 21' ' ' SER . 30.2 m -134.43 151.83 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 39.7 m -82.6 121.24 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -138.74 140.83 38.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.459 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.657 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.1 t30 -160.56 74.36 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.15 -51.84 4.64 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -119.74 155.12 55.07 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 122.52 2.146 . . . . 0.0 110.877 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.526 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 18.5 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.626 0.251 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.71 42.46 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.21 135.65 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.493 . . . . 0.0 110.826 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 p -105.94 128.62 53.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.717 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -91.62 10.25 28.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.852 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.543 ' HA ' ' HB3' ' A' ' 23' ' ' ARG . 15.1 t -33.85 -45.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.291 0.994 . . . . 0.0 113.217 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.553 ' O ' HG21 ' A' ' 8' ' ' ILE . 11.7 m-85 -131.77 1.2 3.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.717 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.0 pt -154.82 139.39 11.68 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.94 151.87 78.6 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.957 2.438 . . . . 0.0 112.648 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 m -52.55 132.92 36.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 28.8 m -114.26 -70.71 0.79 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.28 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.91 -51.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.644 0.735 . . . . 0.0 110.04 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.91 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.4 p -67.08 -7.6 24.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.692 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -68.64 -30.99 69.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 15' ' ' LEU . 3.6 mm? -71.94 -23.56 61.48 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.903 0.858 . . . . 0.0 108.903 178.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 13' ' ' THR . 3.5 mm? -84.8 -9.82 57.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.066 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.78 32.37 27.17 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.057 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.91 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 90.0 m -80.8 134.4 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.908 0.385 . . . . 0.0 111.589 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 p -107.82 144.72 34.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.92 124.51 27.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.509 ' O ' HG11 ' A' ' 24' ' ' VAL . 51.1 m -150.17 127.04 11.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.7 m120 58.15 35.84 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.258 0.552 . . . . 0.0 110.762 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HB3' ' HA ' ' A' ' 6' ' ' VAL . 24.5 mmt85 65.39 20.03 11.71 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.593 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.509 HG11 ' O ' ' A' ' 21' ' ' SER . 10.4 p -141.34 143.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 61.9 m -78.93 123.7 27.52 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.009 0.433 . . . . 0.0 111.295 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.97 149.31 39.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.6 p-10 -159.8 59.09 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.274 1.035 . . . . 0.0 109.317 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.83 -42.02 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.99 153.44 52.77 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.05 -1.075 . . . . 0.0 108.121 177.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.598 0 C-N-CA 122.329 2.019 . . . . 0.0 111.416 -179.477 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.685 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 8.4 m . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.09 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 111.237 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.504 ' HB2' HG23 ' A' ' 13' ' ' THR . 77.8 mt-10 -145.22 138.44 26.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.132 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.423 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -114.67 128.1 56.12 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.744 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -88.71 8.53 28.27 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.844 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.9 t -30.82 -50.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 124.541 1.15 . . . . 0.0 113.15 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' O ' HG22 ' A' ' 8' ' ' ILE . 5.9 m-85 -132.83 4.68 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.744 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.5 pt -154.42 137.64 10.43 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 120.595 0.236 . . . . 0.0 111.454 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.77 150.59 85.25 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.763 2.309 . . . . 0.0 112.903 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.0 m -58.17 138.5 56.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.348 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.0 m -117.09 -71.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.234 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.39 -49.08 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.728 0.775 . . . . 0.0 109.883 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.685 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 30.9 p -68.33 -13.55 62.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.625 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.27 78.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.84 -27.07 66.39 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.46 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.96 -20.11 46.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.124 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.82 10.38 40.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.466 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.659 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -72.62 121.8 20.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.37 0.605 . . . . 0.0 111.217 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -96.61 155.38 16.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.035 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.4 t -72.49 118.8 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.498 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 m -142.85 120.0 11.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.53 35.73 26.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 110.558 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 67.35 19.66 10.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.929 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.35 139.05 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.586 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 47.6 m -78.22 119.93 22.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.955 0.407 . . . . 0.0 109.961 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.33 142.67 43.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.708 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.659 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.9 t30 -160.38 73.74 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.59 -49.56 3.89 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.408 ' H ' ' C ' ' A' ' 27' ' ' ASN . 37.8 pt -118.57 152.62 51.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.456 -0.73 0 C-N-CA 122.183 1.922 . . . . 0.0 111.519 -179.493 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.729 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 12.3 m . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.21 45.96 1.31 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.726 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -147.21 140.74 25.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.264 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 p -117.28 126.17 52.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.742 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -87.31 5.39 38.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.479 ' H ' HG22 ' A' ' 6' ' ' VAL . 12.2 t -35.49 -44.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.157 0.91 . . . . 0.0 113.229 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.593 ' O ' HG23 ' A' ' 8' ' ' ILE . 8.5 m-85 -124.68 -5.83 7.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.742 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.3 pt -158.37 141.05 10.53 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.24 148.61 89.28 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.89 2.393 . . . . 0.0 112.548 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 m -55.2 138.58 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.827 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.539 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 28.3 m -120.33 -66.02 1.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.321 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.35 -54.56 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.634 0.73 . . . . 0.0 110.508 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.729 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 32.4 p -70.1 -5.41 26.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.679 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -70.93 -28.54 64.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.87 -25.3 62.74 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.953 0.882 . . . . 0.0 108.839 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.685 HD22 ' N ' ' A' ' 16' ' ' LEU . 3.0 mm? -82.05 -21.02 37.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.64 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.48 12.91 39.96 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.668 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -71.9 123.52 22.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 111.252 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 p -98.37 153.98 18.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.695 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.19 121.68 21.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.552 ' O ' HG22 ' A' ' 24' ' ' VAL . 21.7 t -150.0 124.08 9.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 58.03 36.33 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.178 0.513 . . . . 0.0 111.011 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.3 mpt_? 69.59 9.37 7.19 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.742 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 21' ' ' SER . 30.0 m -130.91 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 178.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 43.3 m -82.67 124.4 30.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -137.98 142.2 40.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.587 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.658 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.7 t30 -160.85 73.07 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.896 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -50.4 4.4 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.548 ' H ' HD12 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.51 155.13 59.69 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.459 -0.508 0 C-N-CA 122.584 2.189 . . . . 0.0 111.004 -179.716 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.69 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 4.3 m . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.63 0.252 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.24 44.0 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.034 0.445 . . . . 0.0 111.131 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' HB2' HG23 ' A' ' 13' ' ' THR . 72.5 mt-10 -147.18 137.03 23.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.846 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -114.27 128.02 56.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -86.71 2.86 47.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG13 ' HD3' ' A' ' 23' ' ' ARG . 12.6 t -36.94 -44.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.96 0.788 . . . . 0.0 113.079 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.601 ' O ' HG22 ' A' ' 8' ' ' ILE . 32.7 m-85 -115.14 -15.05 11.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.725 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.4 pt -159.47 145.71 12.2 Favored Pre-proline 0 N--CA 1.47 0.558 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.48 150.07 77.83 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.085 2.523 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 m -53.69 138.51 34.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -118.39 -71.13 0.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.1 t -63.12 -49.9 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.439 0.638 . . . . 0.0 110.201 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.69 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 34.8 p -67.79 -9.39 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.808 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.27 68.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.92 -24.89 62.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.784 0.802 . . . . 0.0 108.872 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.656 HD21 ' N ' ' A' ' 16' ' ' LEU . 2.9 mm? -81.49 -21.13 38.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.594 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.12 13.92 37.84 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.17 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.98 122.93 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 0.0 111.112 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -98.88 154.35 18.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.18 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 t -74.27 120.77 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.384 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.529 ' O ' HG12 ' A' ' 24' ' ' VAL . 45.5 m -148.82 124.73 10.61 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.4 34.08 23.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 110.562 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.465 ' HD3' HG13 ' A' ' 6' ' ' VAL . 84.3 mtt-85 68.4 15.33 9.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.639 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 21' ' ' SER . 12.2 p -136.48 143.9 34.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.4 m -81.94 119.01 23.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.971 0.415 . . . . 0.0 111.343 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.75 149.35 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.395 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.701 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.9 t30 -160.75 69.03 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.72 -47.44 3.66 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.421 ' H ' ' C ' ' A' ' 27' ' ' ASN . 32.0 pt -120.11 154.57 55.87 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.461 -0.42 0 C-N-CA 122.612 2.208 . . . . 0.0 111.741 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.679 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 17.5 m . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.1 42.59 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.512 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -148.66 150.07 32.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.994 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.489 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.8 p -130.07 130.21 44.59 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -82.79 -3.09 56.18 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.814 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.6 t -37.51 -45.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 124.104 0.877 . . . . 0.0 112.475 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.583 ' O ' HG21 ' A' ' 8' ' ' ILE . 33.7 m-85 -105.9 -22.77 12.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.798 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.0 pt -162.6 143.64 7.75 Favored Pre-proline 0 N--CA 1.471 0.585 0 O-C-N 123.162 0.289 . . . . 0.0 110.738 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.87 147.98 39.61 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 123.258 2.639 . . . . 0.0 113.192 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.0 m -53.62 135.15 41.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.017 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.1 m -117.07 -70.65 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.208 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.86 -51.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.83 0.824 . . . . 0.0 110.293 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.679 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 43.7 p -68.64 -9.54 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.846 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.64 79.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.41 -25.63 65.13 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.659 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.07 -20.06 46.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.221 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.24 12.78 35.19 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.8 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.6 m -75.28 128.35 35.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 0.0 111.466 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 m -98.2 162.3 13.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.797 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.16 66.26 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.695 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.453 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.2 m -89.82 121.99 32.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.72 32.31 20.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.22 0.533 . . . . 0.0 110.756 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.476 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 69.2 mtp180 67.44 18.72 10.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.244 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 21' ' ' SER . 8.3 p -131.36 142.61 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 49.4 m -72.8 113.15 9.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -142.75 145.56 33.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.452 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.571 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.7 p-10 -156.33 55.64 0.57 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.254 1.026 . . . . 0.0 109.265 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 -46.22 2.77 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.4 pt -110.37 150.81 42.12 Favored Pre-proline 0 N--CA 1.442 -0.846 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 C-N-CA 122.488 2.125 . . . . 0.0 112.317 -178.741 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.533 ' HB3' ' CG2' ' A' ' 13' ' ' THR . 7.3 m . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.765 0.317 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.01 45.42 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.9 0.381 . . . . 0.0 111.414 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -146.39 134.12 21.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.4 p -109.48 126.35 53.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.1 p -89.24 8.04 32.36 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.8 t -31.78 -48.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 124.422 1.076 . . . . 0.0 113.122 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -134.73 7.19 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.539 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.716 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 7.9 pt -152.51 136.41 10.09 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.75 149.18 87.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.503 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.3 132.83 55.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.247 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.443 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 23.7 m -111.21 -72.52 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.24 -50.09 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 122.018 0.913 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.11 -15.97 62.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.724 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 11' ' ' THR . . . -66.7 -36.86 83.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.26 -25.89 65.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.614 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.2 mt -80.24 -18.37 49.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.071 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.65 3.11 49.93 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.52 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -67.97 120.47 14.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.507 0.67 . . . . 0.0 111.256 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.4 m -98.14 149.16 22.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.552 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.84 120.8 16.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.388 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.518 ' O ' HG13 ' A' ' 24' ' ' VAL . 48.2 m -150.13 125.7 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.34 36.62 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.927 0.394 . . . . 0.0 111.204 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 68.76 17.55 8.81 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.707 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 21' ' ' SER . 11.8 p -143.57 145.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.226 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 24.3 m -82.59 119.37 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.943 0.402 . . . . 0.0 111.363 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.439 ' CE1' HG12 ' A' ' 24' ' ' VAL . 3.7 m-85 -131.09 149.41 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.451 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.697 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.5 t30 -161.0 69.29 0.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.2 -48.68 3.84 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.418 ' H ' ' C ' ' A' ' 27' ' ' ASN . 34.1 pt -116.28 153.41 48.64 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.459 -0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 111.72 -179.544 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.712 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 7.8 m . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.21 45.6 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.779 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -146.8 133.61 20.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.066 0.46 . . . . 0.0 110.504 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.7 p -109.89 127.71 54.89 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.743 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -90.38 4.94 49.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 23' ' ' ARG . 15.9 t -34.5 -45.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.325 1.016 . . . . 0.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' O ' HG23 ' A' ' 8' ' ' ILE . 6.6 m-85 -130.77 2.27 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.8 pt -153.82 138.85 11.63 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.35 146.32 89.7 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 m -56.5 136.28 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.554 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 32.7 m -124.07 -66.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.488 -179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.85 -55.48 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.573 0.702 . . . . 0.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.712 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 32.0 p -70.19 -5.93 30.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.629 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -70.73 -28.72 64.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.8 -25.29 62.8 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.873 0.844 . . . . 0.0 108.733 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.69 HD22 ' N ' ' A' ' 16' ' ' LEU . 2.9 mm? -82.42 -21.56 35.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.567 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.18 33.44 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.635 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.701 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -74.42 122.33 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.363 0.601 . . . . 0.0 111.202 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 t -98.44 153.21 18.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.269 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.3 t -71.95 122.88 21.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -150.39 126.79 10.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 56.9 32.83 22.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 111.094 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 6' ' ' VAL . 81.2 mtm180 71.46 18.62 5.43 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.491 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 25' ' ' CYS . 9.1 p -143.24 142.74 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.868 0.366 . . . . 0.0 110.06 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.5 m -78.67 121.11 24.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.14 147.94 51.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.398 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.701 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.7 t30 -160.96 70.29 0.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.463 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.07 -46.47 3.51 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.422 ' H ' ' C ' ' A' ' 27' ' ' ASN . 32.6 pt -122.89 156.15 62.65 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.46 -0.489 0 C-N-CA 122.653 2.235 . . . . 0.0 111.717 -179.74 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.597 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 17.8 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.852 0.358 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.7 47.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.595 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -146.24 137.14 24.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.001 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 p -109.78 123.32 49.34 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.758 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.6 p -86.71 3.01 46.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.273 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 23' ' ' ARG . 10.2 t -34.54 -45.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 124.224 0.952 . . . . 0.0 113.163 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.476 ' O ' HG23 ' A' ' 8' ' ' ILE . 8.0 m-85 -125.77 -3.92 7.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.758 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.15 138.32 10.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 120.664 0.269 . . . . 0.0 111.615 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 150.7 86.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.637 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 m -56.95 133.22 54.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.437 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -111.52 -69.83 0.85 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 t -62.68 -53.08 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 122.05 0.929 . . . . 0.0 110.042 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.597 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 67.9 p -65.91 -8.42 22.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.995 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -29.74 66.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.74 -24.89 62.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.82 0.819 . . . . 0.0 108.823 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.491 HD22 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -80.79 -21.2 41.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.678 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.55 7.93 50.31 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.431 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.662 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -67.22 120.19 13.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.471 0.653 . . . . 0.0 111.192 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 m -98.45 152.31 19.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.462 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.49 121.56 18.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.456 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 m -149.51 122.41 8.75 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.55 35.92 22.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 110.918 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 8.9 mpt_? 69.08 11.55 8.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -133.01 147.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.88 0.371 . . . . 0.0 110.151 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 60.4 m -80.6 122.36 26.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.33 . . . . 0.0 110.356 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -137.93 142.95 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 111.503 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.662 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 16.9 t30 -160.96 72.44 0.44 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.34 -48.97 3.72 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.425 ' H ' ' C ' ' A' ' 27' ' ' ASN . 35.7 pt -118.57 151.58 49.99 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.27 1.98 . . . . 0.0 111.805 -179.503 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.709 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 14.2 m . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.55 46.06 1.27 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.737 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -145.95 139.49 26.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.415 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.3 p -115.67 123.71 49.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 3.3 p -84.38 0.85 47.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.259 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.448 ' CG2' ' HB3' ' A' ' 23' ' ' ARG . 6.7 t -38.12 -43.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 124.09 0.869 . . . . 0.0 113.046 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.604 ' O ' HG21 ' A' ' 8' ' ' ILE . 10.5 m-85 -115.78 -13.59 11.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.766 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.3 pt -160.93 142.33 8.89 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.446 0.165 . . . . 0.0 111.062 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.45 150.02 62.3 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.903 2.402 . . . . 0.0 112.65 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.3 m -54.39 138.03 40.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.778 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 m -118.56 -68.13 0.94 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.159 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.58 -53.33 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.72 0.771 . . . . 0.0 110.376 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.709 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 29.9 p -70.04 -8.35 48.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.686 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.19 73.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.01 -27.53 66.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.228 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.43 -19.94 45.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.088 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.68 8.07 46.7 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.693 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.665 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -69.04 120.81 15.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.545 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 m -97.56 149.67 21.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.462 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.57 104.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.603 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 m -121.67 110.73 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 23.7 m-20 56.96 43.78 24.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.412 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.448 ' HB3' ' CG2' ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.19 6.59 5.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.337 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.2 135.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m -72.17 120.89 18.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -137.78 142.08 40.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 111.612 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.665 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 19.0 t30 -160.59 74.18 0.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.78 -48.28 3.84 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' H ' ' C ' ' A' ' 27' ' ' ASN . 2.4 pp -122.37 153.87 62.21 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.554 0 C-N-CA 122.595 2.196 . . . . 0.0 111.247 -179.431 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.562 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 8.5 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.42 45.62 1.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.536 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -147.59 136.41 22.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.886 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 p -109.79 125.77 53.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.716 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.7 p -88.95 6.56 38.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.551 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . 20.6 t -32.38 -48.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 124.446 1.091 . . . . 0.0 113.039 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' O ' HG23 ' A' ' 8' ' ' ILE . 6.3 m-85 -133.66 6.76 3.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.716 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.7 pt -151.85 139.76 12.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 12.7 Cg_exo -68.59 144.05 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.777 2.318 . . . . 0.0 111.947 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 m -56.65 132.83 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -112.24 -70.51 0.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.3 -52.93 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.953 0.882 . . . . 0.0 110.18 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.562 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 76.2 p -65.4 -10.56 34.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.953 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.66 -30.38 68.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.8 -24.8 62.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.808 0.814 . . . . 0.0 108.953 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.513 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -80.76 -21.12 41.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.599 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.86 49.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.472 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.671 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -68.13 119.55 12.89 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.474 0.654 . . . . 0.0 111.115 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -97.8 151.16 20.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.485 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.5 t -71.03 120.86 17.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.482 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.422 ' O ' HG12 ' A' ' 24' ' ' VAL . 46.5 m -150.21 126.45 10.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 56.86 34.79 25.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 0.0 111.034 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 1.6 mpt_? 68.74 16.55 8.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.693 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 21' ' ' SER . 12.4 p -137.19 143.95 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.946 0.403 . . . . 0.0 109.94 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 55.2 m -77.72 118.35 20.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -131.69 144.39 50.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 0.0 111.785 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.671 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 18.8 t30 -161.22 71.66 0.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.778 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.17 -52.68 4.67 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.56 HD11 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -117.44 156.02 49.56 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.761 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 N--CA 1.456 -0.733 0 C-N-CA 122.195 1.93 . . . . 0.0 111.738 -179.478 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.64 ' HB3' HG21 ' A' ' 13' ' ' THR . 32.1 m . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -150.77 132.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.073 0.463 . . . . 0.0 111.177 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.697 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -105.88 128.41 53.75 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -88.9 3.04 52.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 23' ' ' ARG . 7.1 t -36.47 -44.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.039 0.837 . . . . 0.0 113.162 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.58 -8.68 9.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.753 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.6 pt -158.04 141.48 11.07 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.549 0.214 . . . . 0.0 111.559 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 29.6 Cg_exo -60.96 152.52 70.27 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.926 2.418 . . . . 0.0 112.425 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 6.9 m -51.53 135.82 27.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.5 m -114.61 -73.81 0.64 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.98 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 t -64.48 -48.48 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 109.55 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.881 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 56.2 p -66.57 -14.75 62.77 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.252 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.19 82.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mp -68.63 -25.34 64.79 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -83.66 -8.87 59.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.532 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.53 24.27 36.81 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.353 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.881 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.4 m -77.32 129.94 36.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.959 0.409 . . . . 0.0 111.153 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.6 t -105.27 144.61 31.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 t -72.59 122.99 22.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.539 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -150.58 126.28 10.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.24 36.33 25.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.082 0.944 . . . . 0.0 110.438 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 6' ' ' VAL . 29.5 mtm-85 67.68 16.47 9.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.757 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.15 141.11 34.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.949 0.404 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 56.2 m -78.47 127.03 31.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.962 0.411 . . . . 0.0 110.898 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.91 150.49 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.611 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.632 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 45.6 t30 -160.02 68.41 0.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 -46.44 3.61 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.99 156.98 58.98 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.461 -0.411 0 C-N-CA 122.25 1.967 . . . . 0.0 111.579 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.739 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.0 m . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 120.731 0.3 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.87 42.07 0.95 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -149.19 139.51 22.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.512 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.744 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.5 p -110.47 126.32 54.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.3 p -87.0 4.64 41.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.744 HG23 ' HB2' ' A' ' 4' ' ' SER . 15.9 t -34.59 -46.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.188 0.93 . . . . 0.0 113.175 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.516 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.1 m-85 -126.47 -2.09 6.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.03 137.84 9.84 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 34.6 Cg_exo -60.76 150.0 85.01 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.827 2.351 . . . . 0.0 112.279 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -51.55 131.56 29.53 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.487 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.4 m -113.36 -70.26 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.564 0.221 . . . . 0.0 111.433 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.26 -50.16 80.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.944 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 68.9 p -67.62 -11.22 57.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.484 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.58 78.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.31 -25.85 65.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.358 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.25 -6.9 59.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.718 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.49 29.05 33.96 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.399 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.944 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 81.0 m -77.67 136.18 38.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.943 0.401 . . . . 0.0 111.375 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -110.01 145.96 36.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.304 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.84 123.02 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.748 0.309 . . . . 0.0 110.535 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.0 m -144.07 120.19 10.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 57.73 33.85 23.74 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HB3' HG22 ' A' ' 6' ' ' VAL . 78.9 mtm180 73.31 13.59 4.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.769 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.7 137.87 54.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 65.3 m -75.25 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -147.26 143.01 27.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 24.1 p-10 -156.49 59.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.18 0.99 . . . . 0.0 109.603 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.68 -44.04 2.88 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -116.52 149.96 44.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.461 -0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 111.254 -179.459 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.751 ' HB3' HG21 ' A' ' 13' ' ' THR . 31.0 m . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.667 0.27 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.44 42.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -151.59 138.07 18.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.018 0.437 . . . . 0.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.776 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -110.28 127.52 55.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.754 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 5.9 p -88.79 7.05 35.99 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.776 HG23 ' HB2' ' A' ' 4' ' ' SER . 20.4 t -33.01 -48.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.344 1.028 . . . . 0.0 113.208 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.613 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.4 m-85 -128.99 1.59 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.37 137.93 10.26 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 26.0 Cg_exo -61.91 150.17 87.26 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.82 2.347 . . . . 0.0 112.351 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -52.51 133.2 35.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 32.4 m -114.79 -68.65 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.41 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.9 t -63.05 -54.28 35.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.756 0.788 . . . . 0.0 109.886 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.891 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 58.2 p -66.43 -7.68 21.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.513 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -67.02 -36.04 81.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -71.45 -19.88 62.17 Favored 'General case' 0 N--CA 1.46 0.058 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -85.42 -10.21 56.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.191 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.72 24.14 36.74 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.317 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.891 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 85.7 m -74.96 128.4 35.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.031 0.443 . . . . 0.0 111.392 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -104.49 144.39 31.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.506 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.0 t -71.64 125.97 28.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -148.07 120.51 8.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 56.21 40.54 29.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.521 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.727 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 68.56 13.62 8.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.143 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -133.73 138.44 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 62.0 m -77.07 128.09 33.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -136.76 144.25 43.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.913 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.667 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 42.5 t30 -160.03 70.58 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.51 -47.48 3.64 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 pt -122.59 156.8 60.85 Favored Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.461 -0.405 0 C-N-CA 122.353 2.036 . . . . 0.0 111.084 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.86 ' HB3' HG21 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.43 46.5 1.34 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.493 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -147.18 139.63 24.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.763 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -114.49 122.64 47.2 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -85.45 8.05 20.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.763 HG23 ' HB2' ' A' ' 4' ' ' SER . 25.4 t -32.74 -48.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.385 1.053 . . . . 0.0 113.119 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.651 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.6 m-85 -129.49 1.17 5.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.18 138.24 10.6 Favored Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.84 149.87 90.06 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.733 2.288 . . . . 0.0 112.807 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 6.6 m -57.15 133.9 55.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -110.15 -70.77 0.79 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.37 -51.03 75.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.16 0.981 . . . . 0.0 109.833 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.86 HG21 ' HB3' ' A' ' 1' ' ' CYS . 71.3 p -65.98 -11.85 50.74 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.833 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -67.74 -34.81 77.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.93 -26.76 66.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.36 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.72 -19.41 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.991 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 4.49 51.22 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.29 119.64 11.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.491 0.662 . . . . 0.0 111.322 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.1 m -98.06 154.36 17.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.17 120.16 16.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.7 m -144.86 118.4 9.12 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 59.54 35.8 22.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.335 0.588 . . . . 0.0 110.262 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.637 ' HD3' HG13 ' A' ' 6' ' ' VAL . 87.1 mtt-85 67.15 16.94 10.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -131.68 140.0 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 59.8 m -78.81 121.16 24.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.837 0.351 . . . . 0.0 110.279 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -139.68 142.57 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.554 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 20.6 t30 -160.94 72.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.96 -50.56 4.42 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -118.22 152.49 50.68 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 122.586 2.191 . . . . 0.0 111.043 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.919 ' HB3' HG21 ' A' ' 13' ' ' THR . 13.2 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.09 45.76 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.668 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -148.06 139.0 23.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 110.656 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.473 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.0 p -113.63 130.72 56.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 25.0 p -90.92 0.01 57.62 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.359 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.764 HG22 ' HB3' ' A' ' 23' ' ' ARG . 17.6 t -37.15 -48.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.929 0.768 . . . . 0.0 112.832 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -100.99 -23.23 14.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -159.1 149.48 15.58 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 120.412 0.149 . . . . 0.0 111.38 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.48 150.0 71.3 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.019 2.479 . . . . 0.0 112.75 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -54.11 137.12 41.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.069 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.2 m -116.22 -70.27 0.8 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.21 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.65 -53.39 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.678 0.751 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.919 HG21 ' HB3' ' A' ' 1' ' ' CYS . 33.0 p -69.15 -7.19 33.92 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.778 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.55 -33.98 75.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.14 -26.14 65.63 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.552 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.58 -20.61 42.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.84 35.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.737 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.95 128.29 35.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.308 0.575 . . . . 0.0 111.353 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 26.2 p -97.64 158.17 15.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.82 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.8 t -76.58 67.36 2.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 m -94.91 123.0 38.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.796 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 57.27 36.33 27.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.417 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.764 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.73 17.68 9.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.497 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.96 141.15 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.218 0.533 . . . . 0.0 109.895 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 35.3 m -74.71 113.67 12.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.268 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.93 147.62 52.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.11 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.737 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 41.7 t30 -160.89 68.56 0.34 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.64 3.71 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.8 pt -117.95 153.44 51.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.672 2.248 . . . . 0.0 111.925 -179.588 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.712 ' HB3' HG21 ' A' ' 13' ' ' THR . 24.5 m . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.47 45.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.26 140.49 22.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.369 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.672 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -111.95 122.18 47.06 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.726 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -83.87 3.17 34.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.915 HG22 ' HB3' ' A' ' 23' ' ' ARG . 6.6 t -38.38 -43.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.038 0.836 . . . . 0.0 112.964 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 8' ' ' ILE . 16.4 m-85 -114.98 -14.61 11.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.6 pt -160.48 143.63 9.97 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-O 120.547 0.213 . . . . 0.0 111.348 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.26 151.38 74.08 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.649 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 6.4 m -50.89 130.77 25.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.757 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -109.22 -69.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.84 -53.6 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 122.118 0.961 . . . . 0.0 109.792 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.895 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 26.0 p -64.69 -8.26 13.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.88 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -69.01 -30.08 68.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.62 -23.19 61.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.923 0.868 . . . . 0.0 108.908 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.1 mm? -86.49 -12.3 49.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.001 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.47 22.39 37.45 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.395 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.895 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 69.6 m -70.57 124.39 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.934 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -102.67 147.4 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.613 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -74.49 122.64 23.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.574 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.3 m -144.09 121.07 11.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 3.1 m120 57.77 33.4 23.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.779 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.915 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.39 13.72 6.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.716 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.38 138.34 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 84.4 m -76.51 127.37 32.69 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.157 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -138.83 143.76 38.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.785 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.66 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.9 t30 -160.34 70.43 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.26 -47.77 3.66 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.9 pt -121.26 155.63 58.39 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.463 -0.298 0 C-N-CA 122.455 2.104 . . . . 0.0 111.324 -179.644 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HB3' HG21 ' A' ' 13' ' ' THR . 18.4 m . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.39 43.43 1.07 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.67 135.99 19.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.61 ' HB2' HG23 ' A' ' 6' ' ' VAL . 5.6 p -106.05 128.93 54.19 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.0 p -86.27 -1.09 57.17 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 23' ' ' ARG . 18.8 t -37.56 -46.31 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 8' ' ' ILE . 29.6 m-85 -105.46 -21.52 13.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.7 pt -161.69 150.05 12.61 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 120.529 0.204 . . . . 0.0 111.195 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.85 155.17 39.53 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.068 2.512 . . . . 0.0 112.702 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -52.16 135.34 31.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.038 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -115.12 -71.03 0.76 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.875 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.31 -50.67 77.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.769 0.795 . . . . 0.0 109.823 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.928 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.1 p -67.55 -11.4 57.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.486 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.18 79.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -68.65 -25.84 65.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.382 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.22 -8.02 59.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.773 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.24 30.51 25.03 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.413 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.928 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 88.9 m -81.4 138.86 35.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.5 t -113.09 147.55 37.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.348 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.1 t -75.97 116.4 16.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.1 m -144.91 127.18 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 60.49 33.43 20.57 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.211 0.529 . . . . 0.0 110.343 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.839 ' HB3' HG22 ' A' ' 6' ' ' VAL . 2.6 mmp_? 68.53 11.83 8.49 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.636 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.58 145.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 63.6 m -78.84 124.31 28.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.038 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.09 150.05 42.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 26.1 p-10 -160.11 58.67 0.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.347 1.07 . . . . 0.0 109.455 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.67 -42.49 2.9 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -118.24 153.52 51.57 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.458 -0.571 0 C-N-CA 122.381 2.054 . . . . 0.0 111.581 -179.455 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.739 ' HB3' HG21 ' A' ' 13' ' ' THR . 24.0 m . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.28 45.6 1.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -150.41 136.59 18.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.53 124.89 50.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.3 p -86.21 -2.27 58.21 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' A' ' 23' ' ' ARG . 21.6 t -36.53 -44.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -113.29 -16.52 12.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.7 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.0 pt -158.03 145.45 13.51 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.666 0.27 . . . . 0.0 111.475 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.3 153.2 71.87 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.305 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 4.8 m -53.67 131.92 39.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.796 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.9 m -109.42 -69.92 0.84 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.09 -53.41 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 122.057 0.932 . . . . 0.0 109.834 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.89 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 28.6 p -64.44 -8.9 15.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.904 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -68.76 -31.15 69.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.37 -23.79 61.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.841 0.829 . . . . 0.0 108.893 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.2 mm? -84.68 -14.4 48.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.978 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 24.37 26.49 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.426 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.89 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.0 m -74.12 127.34 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 111.048 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.0 t -107.64 147.4 30.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.049 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -71.39 121.62 18.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.272 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -150.15 124.38 9.48 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.98 37.68 21.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.855 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.943 ' HB3' HG22 ' A' ' 6' ' ' VAL . 35.2 mtp85 71.5 1.56 3.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.677 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.03 147.33 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 72.8 m -75.23 128.34 35.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.75 147.06 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 111.145 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.626 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 44.8 t30 -160.67 68.16 0.34 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.79 -49.88 4.0 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.56 155.92 48.18 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.459 -0.509 0 C-N-CA 122.191 1.927 . . . . 0.0 111.64 -179.45 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.696 ' HB3' HG21 ' A' ' 13' ' ' THR . 11.3 m . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.589 0.233 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 44.2 1.1 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -148.18 140.62 24.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.785 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -110.99 125.46 53.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.292 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -87.49 12.86 11.27 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 4' ' ' SER . 30.8 t -33.34 -50.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.396 1.06 . . . . 0.0 113.138 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.674 ' HD1' HG12 ' A' ' 6' ' ' VAL . 4.9 m-85 -125.68 -0.09 7.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -157.09 142.78 12.7 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 21.8 Cg_exo -64.43 152.83 80.01 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.911 2.407 . . . . 0.0 112.319 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -51.64 130.32 27.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.49 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -106.83 -69.18 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 t -63.69 -53.67 41.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.172 0.986 . . . . 0.0 109.77 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 1.021 ' HA ' HD13 ' A' ' 16' ' ' LEU . 31.1 p -65.58 -3.17 4.17 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.98 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -32.33 72.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.14 -26.17 63.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.806 0.812 . . . . 0.0 108.915 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.021 HD13 ' HA ' ' A' ' 13' ' ' THR . 7.1 mp -81.7 -10.83 59.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.375 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.63 26.21 39.56 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.032 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.955 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 64.0 m -72.89 131.73 42.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.843 0.354 . . . . 0.0 111.241 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -109.74 148.15 31.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.591 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.5 123.2 24.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -146.17 121.02 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 58.02 35.52 25.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.941 0.4 . . . . 0.0 110.911 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.676 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 69.11 15.01 8.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.044 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.45 140.87 46.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 71.6 m -78.14 126.49 30.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.974 0.416 . . . . 0.0 110.155 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -148.67 142.51 25.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 21.3 p-10 -156.37 58.83 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.184 0.992 . . . . 0.0 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 -44.07 2.85 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.0 pt -115.75 150.04 44.17 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.416 2.077 . . . . 0.0 111.611 -179.203 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.937 ' HB3' HG21 ' A' ' 13' ' ' THR . 12.9 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.45 44.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.689 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.02 143.08 26.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.981 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.79 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -120.57 129.6 53.85 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.5 p -88.97 8.52 29.14 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' ' 4' ' ' SER . 30.7 t -33.14 -49.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.319 1.012 . . . . 0.0 112.825 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.629 ' HD1' HG12 ' A' ' 6' ' ' VAL . 4.9 m-85 -125.83 -1.28 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.759 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.67 142.03 12.52 Favored Pre-proline 0 N--CA 1.473 0.69 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.04 148.24 93.55 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.915 2.41 . . . . 0.0 112.512 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -56.31 137.94 51.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 29.9 m -117.79 -67.95 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.335 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.5 t -61.44 -56.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.79 0.805 . . . . 0.0 110.556 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.937 HG21 ' HB3' ' A' ' 1' ' ' CYS . 30.2 p -67.47 -5.66 15.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -68.02 -35.75 78.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -70.27 -21.3 62.98 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.89 -20.63 41.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.886 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.86 4.15 48.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.475 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.87 120.49 13.65 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.549 0.69 . . . . 0.0 111.466 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -97.95 153.72 18.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.815 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.05 118.12 16.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -150.67 131.4 14.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 59.65 28.54 17.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.73 0.776 . . . . 0.0 109.639 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.655 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 36.4 mmt180 68.06 16.95 9.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.214 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.43 151.83 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 39.7 m -82.6 121.24 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -138.74 140.83 38.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.459 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.1 t30 -160.56 74.36 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.15 -51.84 4.64 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -119.74 155.12 55.07 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 122.52 2.146 . . . . 0.0 110.877 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.735 ' HB3' HG21 ' A' ' 13' ' ' THR . 18.5 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.626 0.251 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.71 42.46 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.21 135.65 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.493 . . . . 0.0 110.826 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.805 ' HB2' HG23 ' A' ' 6' ' ' VAL . 3.6 p -105.94 128.62 53.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -91.62 10.25 28.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.852 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.805 HG23 ' HB2' ' A' ' 4' ' ' SER . 15.1 t -33.85 -45.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.291 0.994 . . . . 0.0 113.217 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.471 ' HD1' HG12 ' A' ' 6' ' ' VAL . 11.7 m-85 -131.77 1.2 3.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.0 pt -154.82 139.39 11.68 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.94 151.87 78.6 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.957 2.438 . . . . 0.0 112.648 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 m -52.55 132.92 36.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -114.26 -70.71 0.79 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.28 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.91 -51.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.644 0.735 . . . . 0.0 110.04 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.919 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.4 p -67.08 -7.6 24.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.692 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -30.99 69.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.94 -23.56 61.48 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.903 0.858 . . . . 0.0 108.903 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.5 mm? -84.8 -9.82 57.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.066 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.78 32.37 27.17 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.057 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.919 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 90.0 m -80.8 134.4 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.908 0.385 . . . . 0.0 111.589 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 p -107.82 144.72 34.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.92 124.51 27.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.1 m -150.17 127.04 11.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.7 m120 58.15 35.84 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.258 0.552 . . . . 0.0 110.762 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 24.5 mmt85 65.39 20.03 11.71 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.593 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 10.4 p -141.34 143.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 61.9 m -78.93 123.7 27.52 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.009 0.433 . . . . 0.0 111.295 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.97 149.31 39.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.6 p-10 -159.8 59.09 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.274 1.035 . . . . 0.0 109.317 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.83 -42.02 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.99 153.44 52.77 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.05 -1.075 . . . . 0.0 108.121 177.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.598 0 C-N-CA 122.329 2.019 . . . . 0.0 111.416 -179.477 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.851 ' HB3' HG21 ' A' ' 13' ' ' THR . 8.4 m . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.09 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 111.237 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -145.22 138.44 26.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.132 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.815 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -114.67 128.1 56.12 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.761 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -88.71 8.53 28.27 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.844 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.9 t -30.82 -50.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 124.541 1.15 . . . . 0.0 113.15 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.776 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.9 m-85 -132.83 4.68 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.5 pt -154.42 137.64 10.43 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 120.595 0.236 . . . . 0.0 111.454 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.77 150.59 85.25 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.763 2.309 . . . . 0.0 112.903 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.0 m -58.17 138.5 56.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.348 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.0 m -117.09 -71.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.234 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.39 -49.08 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.728 0.775 . . . . 0.0 109.883 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.851 HG21 ' HB3' ' A' ' 1' ' ' CYS . 30.9 p -68.33 -13.55 62.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.625 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.27 78.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.84 -27.07 66.39 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.46 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.96 -20.11 46.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.124 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.82 10.38 40.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.466 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -72.62 121.8 20.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.37 0.605 . . . . 0.0 111.217 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -96.61 155.38 16.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.035 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.4 t -72.49 118.8 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.498 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 m -142.85 120.0 11.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.53 35.73 26.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 110.558 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.698 ' HD3' HG13 ' A' ' 6' ' ' VAL . 89.8 mtt180 67.35 19.66 10.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.929 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.35 139.05 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 47.6 m -78.22 119.93 22.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.955 0.407 . . . . 0.0 109.961 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.33 142.67 43.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.708 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.9 t30 -160.38 73.74 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.59 -49.56 3.89 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.8 pt -118.57 152.62 51.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.456 -0.73 0 C-N-CA 122.183 1.922 . . . . 0.0 111.519 -179.493 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.893 ' HB3' HG21 ' A' ' 13' ' ' THR . 12.3 m . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.21 45.96 1.31 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.726 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -147.21 140.74 25.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.264 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.759 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -117.28 126.17 52.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -87.31 5.39 38.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.854 HG22 ' HB3' ' A' ' 23' ' ' ARG . 12.2 t -35.49 -44.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.157 0.91 . . . . 0.0 113.229 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.68 -5.83 7.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.3 pt -158.37 141.05 10.53 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.24 148.61 89.28 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.89 2.393 . . . . 0.0 112.548 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 m -55.2 138.58 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.827 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -120.33 -66.02 1.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.321 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.35 -54.56 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.634 0.73 . . . . 0.0 110.508 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.893 HG21 ' HB3' ' A' ' 1' ' ' CYS . 32.4 p -70.1 -5.41 26.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.679 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -28.54 64.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.87 -25.3 62.74 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.953 0.882 . . . . 0.0 108.839 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.807 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -82.05 -21.02 37.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.64 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.48 12.91 39.96 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.668 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -71.9 123.52 22.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 111.252 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 p -98.37 153.98 18.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.695 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.19 121.68 21.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -150.0 124.08 9.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 58.03 36.33 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.178 0.513 . . . . 0.0 111.011 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.854 ' HB3' HG22 ' A' ' 6' ' ' VAL . 8.3 mpt_? 69.59 9.37 7.19 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.742 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.91 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.661 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 43.3 m -82.67 124.4 30.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -137.98 142.2 40.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.587 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.7 t30 -160.85 73.07 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.896 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -50.4 4.4 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.51 155.13 59.69 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.459 -0.508 0 C-N-CA 122.584 2.189 . . . . 0.0 111.004 -179.716 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.873 ' HB3' HG21 ' A' ' 13' ' ' THR . 4.3 m . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.63 0.252 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.24 44.0 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.034 0.445 . . . . 0.0 111.131 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -147.18 137.03 23.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.707 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.8 p -114.27 128.02 56.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -86.71 2.86 47.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.826 HG22 ' HB3' ' A' ' 23' ' ' ARG . 12.6 t -36.94 -44.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.96 0.788 . . . . 0.0 113.079 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' ILE . 32.7 m-85 -115.14 -15.05 11.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.4 pt -159.47 145.71 12.2 Favored Pre-proline 0 N--CA 1.47 0.558 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.48 150.07 77.83 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.085 2.523 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 m -53.69 138.51 34.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -118.39 -71.13 0.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.1 t -63.12 -49.9 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.439 0.638 . . . . 0.0 110.201 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.873 HG21 ' HB3' ' A' ' 1' ' ' CYS . 34.8 p -67.79 -9.39 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.808 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.27 68.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.92 -24.89 62.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.784 0.802 . . . . 0.0 108.872 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.621 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -81.49 -21.13 38.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.594 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.12 13.92 37.84 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.17 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.744 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.98 122.93 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 0.0 111.112 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -98.88 154.35 18.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.18 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 t -74.27 120.77 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.384 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.5 m -148.82 124.73 10.61 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.4 34.08 23.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 110.562 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.826 ' HB3' HG22 ' A' ' 6' ' ' VAL . 84.3 mtt-85 68.4 15.33 9.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.639 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.48 143.9 34.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.4 m -81.94 119.01 23.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.971 0.415 . . . . 0.0 111.343 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.75 149.35 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.395 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.744 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.9 t30 -160.75 69.03 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.72 -47.44 3.66 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.0 pt -120.11 154.57 55.87 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.461 -0.42 0 C-N-CA 122.612 2.208 . . . . 0.0 111.741 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.891 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.5 m . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.1 42.59 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.512 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -148.66 150.07 32.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.994 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.542 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.8 p -130.07 130.21 44.59 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.816 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -82.79 -3.09 56.18 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.814 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.6 t -37.51 -45.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 124.104 0.877 . . . . 0.0 112.475 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' ILE . 33.7 m-85 -105.9 -22.77 12.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.0 pt -162.6 143.64 7.75 Favored Pre-proline 0 N--CA 1.471 0.585 0 O-C-N 123.162 0.289 . . . . 0.0 110.738 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.87 147.98 39.61 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 123.258 2.639 . . . . 0.0 113.192 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.0 m -53.62 135.15 41.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.017 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.1 m -117.07 -70.65 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.208 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.86 -51.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.83 0.824 . . . . 0.0 110.293 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 1' ' ' CYS . 43.7 p -68.64 -9.54 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.846 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.64 79.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.41 -25.63 65.13 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.659 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.07 -20.06 46.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.221 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.24 12.78 35.19 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.8 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.6 m -75.28 128.35 35.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 0.0 111.466 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 m -98.2 162.3 13.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.797 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.16 66.26 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.695 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.2 m -89.82 121.99 32.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.72 32.31 20.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.22 0.533 . . . . 0.0 110.756 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 69.2 mtp180 67.44 18.72 10.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.244 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' SER . 8.3 p -131.36 142.61 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 49.4 m -72.8 113.15 9.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -142.75 145.56 33.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.452 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.7 p-10 -156.33 55.64 0.57 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.254 1.026 . . . . 0.0 109.265 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 -46.22 2.77 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.4 pt -110.37 150.81 42.12 Favored Pre-proline 0 N--CA 1.442 -0.846 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 C-N-CA 122.488 2.125 . . . . 0.0 112.317 -178.741 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.804 ' HB3' HG21 ' A' ' 13' ' ' THR . 7.3 m . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.765 0.317 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.01 45.42 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.9 0.381 . . . . 0.0 111.414 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -146.39 134.12 21.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.724 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.4 p -109.48 126.35 53.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.1 p -89.24 8.04 32.36 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.727 HG12 ' HD1' ' A' ' 7' ' ' TYR . 38.8 t -31.78 -48.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 124.422 1.076 . . . . 0.0 113.122 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.727 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.5 m-85 -134.73 7.19 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.539 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 7.9 pt -152.51 136.41 10.09 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.75 149.18 87.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.503 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.3 132.83 55.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.247 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -111.21 -72.52 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.24 -50.09 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 122.018 0.913 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.804 HG21 ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.11 -15.97 62.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.724 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.86 83.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.26 -25.89 65.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.614 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.2 mt -80.24 -18.37 49.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.071 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.65 3.11 49.93 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.52 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -67.97 120.47 14.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.507 0.67 . . . . 0.0 111.256 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.4 m -98.14 149.16 22.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.552 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.84 120.8 16.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.388 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 m -150.13 125.7 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.34 36.62 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.927 0.394 . . . . 0.0 111.204 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HB3' HG22 ' A' ' 6' ' ' VAL . 61.3 mtp180 68.76 17.55 8.81 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.707 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 11.8 p -143.57 145.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.226 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 24.3 m -82.59 119.37 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.943 0.402 . . . . 0.0 111.363 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.09 149.41 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.451 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.5 t30 -161.0 69.29 0.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.2 -48.68 3.84 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 pt -116.28 153.41 48.64 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.459 -0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 111.72 -179.544 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.896 ' HB3' HG21 ' A' ' 13' ' ' THR . 7.8 m . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.21 45.6 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.779 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -146.8 133.61 20.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.066 0.46 . . . . 0.0 110.504 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.68 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.7 p -109.89 127.71 54.89 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -90.38 4.94 49.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 23' ' ' ARG . 15.9 t -34.5 -45.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.325 1.016 . . . . 0.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.529 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.6 m-85 -130.77 2.27 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.756 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.8 pt -153.82 138.85 11.63 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.35 146.32 89.7 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 m -56.5 136.28 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.554 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.7 m -124.07 -66.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.488 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.85 -55.48 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.573 0.702 . . . . 0.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.896 HG21 ' HB3' ' A' ' 1' ' ' CYS . 32.0 p -70.19 -5.93 30.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.629 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -28.72 64.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.8 -25.29 62.8 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.873 0.844 . . . . 0.0 108.733 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.759 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -82.42 -21.56 35.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.567 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.18 33.44 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.635 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.749 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -74.42 122.33 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.363 0.601 . . . . 0.0 111.202 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 t -98.44 153.21 18.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.269 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.3 t -71.95 122.88 21.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -150.39 126.79 10.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 56.9 32.83 22.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 111.094 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 6' ' ' VAL . 81.2 mtm180 71.46 18.62 5.43 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.491 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 9.1 p -143.24 142.74 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.868 0.366 . . . . 0.0 110.06 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.5 m -78.67 121.11 24.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.14 147.94 51.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.398 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.749 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.7 t30 -160.96 70.29 0.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.463 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.07 -46.47 3.51 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.89 156.15 62.65 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.46 -0.489 0 C-N-CA 122.653 2.235 . . . . 0.0 111.717 -179.74 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.835 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.8 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.852 0.358 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.7 47.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.595 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -146.24 137.14 24.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.001 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.719 ' HB2' HG23 ' A' ' 6' ' ' VAL . 4.3 p -109.78 123.32 49.34 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.769 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.6 p -86.71 3.01 46.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.273 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' A' ' 23' ' ' ARG . 10.2 t -34.54 -45.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 124.224 0.952 . . . . 0.0 113.163 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -125.77 -3.92 7.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.15 138.32 10.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 120.664 0.269 . . . . 0.0 111.615 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 150.7 86.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.637 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 m -56.95 133.22 54.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.437 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -111.52 -69.83 0.85 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 t -62.68 -53.08 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 122.05 0.929 . . . . 0.0 110.042 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.835 HG21 ' HB3' ' A' ' 1' ' ' CYS . 67.9 p -65.91 -8.42 22.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.995 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -29.74 66.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.74 -24.89 62.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.82 0.819 . . . . 0.0 108.823 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -80.79 -21.2 41.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.678 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.55 7.93 50.31 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.431 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -67.22 120.19 13.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.471 0.653 . . . . 0.0 111.192 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 m -98.45 152.31 19.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.462 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.49 121.56 18.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.456 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 m -149.51 122.41 8.75 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.55 35.92 22.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 110.918 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.908 ' HB3' HG22 ' A' ' 6' ' ' VAL . 8.9 mpt_? 69.08 11.55 8.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -133.01 147.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.88 0.371 . . . . 0.0 110.151 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 60.4 m -80.6 122.36 26.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.33 . . . . 0.0 110.356 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -137.93 142.95 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 111.503 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 16.9 t30 -160.96 72.44 0.44 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.34 -48.97 3.72 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 pt -118.57 151.58 49.99 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.27 1.98 . . . . 0.0 111.805 -179.503 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.929 ' HB3' HG21 ' A' ' 13' ' ' THR . 14.2 m . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.55 46.06 1.27 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.737 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -145.95 139.49 26.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.415 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.679 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.3 p -115.67 123.71 49.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 3.3 p -84.38 0.85 47.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.259 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 23' ' ' ARG . 6.7 t -38.12 -43.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 124.09 0.869 . . . . 0.0 113.046 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 8' ' ' ILE . 10.5 m-85 -115.78 -13.59 11.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.777 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.3 pt -160.93 142.33 8.89 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.446 0.165 . . . . 0.0 111.062 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.45 150.02 62.3 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.903 2.402 . . . . 0.0 112.65 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.3 m -54.39 138.03 40.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.778 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 m -118.56 -68.13 0.94 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.159 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.58 -53.33 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.72 0.771 . . . . 0.0 110.376 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.929 HG21 ' HB3' ' A' ' 1' ' ' CYS . 29.9 p -70.04 -8.35 48.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.686 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.19 73.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.01 -27.53 66.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.228 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.43 -19.94 45.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.088 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.68 8.07 46.7 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.693 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -69.04 120.81 15.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.545 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 m -97.56 149.67 21.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.462 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.57 104.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.603 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 m -121.67 110.73 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 23.7 m-20 56.96 43.78 24.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.412 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.937 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.19 6.59 5.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.337 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.2 135.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m -72.17 120.89 18.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -137.78 142.08 40.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 111.612 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 19.0 t30 -160.59 74.18 0.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.78 -48.28 3.84 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.37 153.87 62.21 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.554 0 C-N-CA 122.595 2.196 . . . . 0.0 111.247 -179.431 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.845 ' HB3' HG21 ' A' ' 13' ' ' THR . 8.5 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.42 45.62 1.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.536 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -147.59 136.41 22.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.886 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.72 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.2 p -109.79 125.77 53.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.7 p -88.95 6.56 38.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 23' ' ' ARG . 20.6 t -32.38 -48.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 124.446 1.091 . . . . 0.0 113.039 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.63 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.3 m-85 -133.66 6.76 3.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.7 pt -151.85 139.76 12.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 12.7 Cg_exo -68.59 144.05 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.777 2.318 . . . . 0.0 111.947 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 m -56.65 132.83 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -112.24 -70.51 0.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.3 -52.93 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.953 0.882 . . . . 0.0 110.18 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.845 HG21 ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.4 -10.56 34.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.953 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.66 -30.38 68.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.8 -24.8 62.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.808 0.814 . . . . 0.0 108.953 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -80.76 -21.12 41.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.599 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.86 49.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.472 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.721 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -68.13 119.55 12.89 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.474 0.654 . . . . 0.0 111.115 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -97.8 151.16 20.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.485 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.5 t -71.03 120.86 17.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.482 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.5 m -150.21 126.45 10.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 56.86 34.79 25.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 0.0 111.034 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.75 ' HB3' HG22 ' A' ' 6' ' ' VAL . 1.6 mpt_? 68.74 16.55 8.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.693 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.19 143.95 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.946 0.403 . . . . 0.0 109.94 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.624 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 55.2 m -77.72 118.35 20.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -131.69 144.39 50.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 0.0 111.785 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.721 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 18.8 t30 -161.22 71.66 0.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.778 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.17 -52.68 4.67 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -117.44 156.02 49.56 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.761 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 61.5 Cg_endo . . . . . 0 N--CA 1.456 -0.733 0 C-N-CA 122.195 1.93 . . . . 0.0 111.738 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.64 ' HB3' HG21 ' A' ' 13' ' ' THR . 32.1 m . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -150.77 132.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.073 0.463 . . . . 0.0 111.177 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.697 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -105.88 128.41 53.75 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -88.9 3.04 52.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 23' ' ' ARG . 7.1 t -36.47 -44.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.039 0.837 . . . . 0.0 113.162 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.58 -8.68 9.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.753 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.6 pt -158.04 141.48 11.07 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.549 0.214 . . . . 0.0 111.559 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 29.6 Cg_exo -60.96 152.52 70.27 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.926 2.418 . . . . 0.0 112.425 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 6.9 m -51.53 135.82 27.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.5 m -114.61 -73.81 0.64 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.98 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 t -64.48 -48.48 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 109.55 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.881 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 56.2 p -66.57 -14.75 62.77 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.252 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.19 82.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mp -68.63 -25.34 64.79 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -83.66 -8.87 59.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.532 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.53 24.27 36.81 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.353 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.881 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.4 m -77.32 129.94 36.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.959 0.409 . . . . 0.0 111.153 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.6 t -105.27 144.61 31.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 t -72.59 122.99 22.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.539 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -150.58 126.28 10.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.24 36.33 25.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.082 0.944 . . . . 0.0 110.438 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 6' ' ' VAL . 29.5 mtm-85 67.68 16.47 9.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.757 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.15 141.11 34.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.949 0.404 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 56.2 m -78.47 127.03 31.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.962 0.411 . . . . 0.0 110.898 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.91 150.49 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.611 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.632 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 45.6 t30 -160.02 68.41 0.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 -46.44 3.61 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.99 156.98 58.98 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.461 -0.411 0 C-N-CA 122.25 1.967 . . . . 0.0 111.579 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.739 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.0 m . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 120.731 0.3 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.87 42.07 0.95 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -149.19 139.51 22.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.512 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.744 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.5 p -110.47 126.32 54.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.3 p -87.0 4.64 41.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.744 HG23 ' HB2' ' A' ' 4' ' ' SER . 15.9 t -34.59 -46.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.188 0.93 . . . . 0.0 113.175 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.516 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.1 m-85 -126.47 -2.09 6.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.03 137.84 9.84 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 34.6 Cg_exo -60.76 150.0 85.01 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.827 2.351 . . . . 0.0 112.279 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -51.55 131.56 29.53 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.487 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.4 m -113.36 -70.26 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.564 0.221 . . . . 0.0 111.433 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.26 -50.16 80.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.944 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 68.9 p -67.62 -11.22 57.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.484 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.58 78.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.31 -25.85 65.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.358 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.25 -6.9 59.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.718 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.49 29.05 33.96 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.399 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.944 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 81.0 m -77.67 136.18 38.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.943 0.401 . . . . 0.0 111.375 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -110.01 145.96 36.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.304 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.84 123.02 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.748 0.309 . . . . 0.0 110.535 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.0 m -144.07 120.19 10.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 57.73 33.85 23.74 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HB3' HG22 ' A' ' 6' ' ' VAL . 78.9 mtm180 73.31 13.59 4.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.769 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.7 137.87 54.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 65.3 m -75.25 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -147.26 143.01 27.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 24.1 p-10 -156.49 59.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.18 0.99 . . . . 0.0 109.603 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.68 -44.04 2.88 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -116.52 149.96 44.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.461 -0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 111.254 -179.459 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.751 ' HB3' HG21 ' A' ' 13' ' ' THR . 31.0 m . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.667 0.27 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.44 42.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -151.59 138.07 18.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.018 0.437 . . . . 0.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.776 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -110.28 127.52 55.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.754 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 5.9 p -88.79 7.05 35.99 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.776 HG23 ' HB2' ' A' ' 4' ' ' SER . 20.4 t -33.01 -48.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.344 1.028 . . . . 0.0 113.208 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.613 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.4 m-85 -128.99 1.59 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.37 137.93 10.26 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 26.0 Cg_exo -61.91 150.17 87.26 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.82 2.347 . . . . 0.0 112.351 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -52.51 133.2 35.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 32.4 m -114.79 -68.65 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.41 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.9 t -63.05 -54.28 35.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.756 0.788 . . . . 0.0 109.886 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.891 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 58.2 p -66.43 -7.68 21.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.513 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -67.02 -36.04 81.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -71.45 -19.88 62.17 Favored 'General case' 0 N--CA 1.46 0.058 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -85.42 -10.21 56.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.191 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.72 24.14 36.74 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.317 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.891 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 85.7 m -74.96 128.4 35.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.031 0.443 . . . . 0.0 111.392 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -104.49 144.39 31.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.506 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.0 t -71.64 125.97 28.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -148.07 120.51 8.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 56.21 40.54 29.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.521 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.727 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 68.56 13.62 8.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.143 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -133.73 138.44 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 62.0 m -77.07 128.09 33.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -136.76 144.25 43.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.913 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.667 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 42.5 t30 -160.03 70.58 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.51 -47.48 3.64 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 pt -122.59 156.8 60.85 Favored Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.461 -0.405 0 C-N-CA 122.353 2.036 . . . . 0.0 111.084 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.86 ' HB3' HG21 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.43 46.5 1.34 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.493 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -147.18 139.63 24.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.763 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -114.49 122.64 47.2 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -85.45 8.05 20.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.763 HG23 ' HB2' ' A' ' 4' ' ' SER . 25.4 t -32.74 -48.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.385 1.053 . . . . 0.0 113.119 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.651 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.6 m-85 -129.49 1.17 5.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.18 138.24 10.6 Favored Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.84 149.87 90.06 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.733 2.288 . . . . 0.0 112.807 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 6.6 m -57.15 133.9 55.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -110.15 -70.77 0.79 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.37 -51.03 75.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.16 0.981 . . . . 0.0 109.833 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.86 HG21 ' HB3' ' A' ' 1' ' ' CYS . 71.3 p -65.98 -11.85 50.74 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.833 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -67.74 -34.81 77.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.93 -26.76 66.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.36 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.72 -19.41 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.991 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 4.49 51.22 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.29 119.64 11.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.491 0.662 . . . . 0.0 111.322 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.1 m -98.06 154.36 17.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.17 120.16 16.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.7 m -144.86 118.4 9.12 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 59.54 35.8 22.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.335 0.588 . . . . 0.0 110.262 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.637 ' HD3' HG13 ' A' ' 6' ' ' VAL . 87.1 mtt-85 67.15 16.94 10.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -131.68 140.0 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 59.8 m -78.81 121.16 24.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.837 0.351 . . . . 0.0 110.279 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -139.68 142.57 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.554 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 20.6 t30 -160.94 72.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.96 -50.56 4.42 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -118.22 152.49 50.68 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 122.586 2.191 . . . . 0.0 111.043 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.919 ' HB3' HG21 ' A' ' 13' ' ' THR . 13.2 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.09 45.76 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.668 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -148.06 139.0 23.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 110.656 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.473 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.0 p -113.63 130.72 56.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 25.0 p -90.92 0.01 57.62 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.359 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.764 HG22 ' HB3' ' A' ' 23' ' ' ARG . 17.6 t -37.15 -48.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.929 0.768 . . . . 0.0 112.832 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -100.99 -23.23 14.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -159.1 149.48 15.58 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 120.412 0.149 . . . . 0.0 111.38 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.48 150.0 71.3 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.019 2.479 . . . . 0.0 112.75 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -54.11 137.12 41.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.069 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.2 m -116.22 -70.27 0.8 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.21 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.65 -53.39 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.678 0.751 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.919 HG21 ' HB3' ' A' ' 1' ' ' CYS . 33.0 p -69.15 -7.19 33.92 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.778 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.55 -33.98 75.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.14 -26.14 65.63 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.552 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.58 -20.61 42.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.84 35.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.737 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.95 128.29 35.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.308 0.575 . . . . 0.0 111.353 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 26.2 p -97.64 158.17 15.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.82 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.8 t -76.58 67.36 2.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 m -94.91 123.0 38.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.796 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 57.27 36.33 27.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.417 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.764 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.73 17.68 9.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.497 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.96 141.15 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.218 0.533 . . . . 0.0 109.895 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 35.3 m -74.71 113.67 12.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.268 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.93 147.62 52.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.11 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.737 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 41.7 t30 -160.89 68.56 0.34 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.64 3.71 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.8 pt -117.95 153.44 51.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.672 2.248 . . . . 0.0 111.925 -179.588 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.712 ' HB3' HG21 ' A' ' 13' ' ' THR . 24.5 m . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.47 45.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.26 140.49 22.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.369 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.672 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -111.95 122.18 47.06 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.726 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -83.87 3.17 34.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.915 HG22 ' HB3' ' A' ' 23' ' ' ARG . 6.6 t -38.38 -43.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.038 0.836 . . . . 0.0 112.964 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 8' ' ' ILE . 16.4 m-85 -114.98 -14.61 11.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.6 pt -160.48 143.63 9.97 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-O 120.547 0.213 . . . . 0.0 111.348 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.26 151.38 74.08 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.649 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 6.4 m -50.89 130.77 25.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.757 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -109.22 -69.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.84 -53.6 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 122.118 0.961 . . . . 0.0 109.792 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.895 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 26.0 p -64.69 -8.26 13.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.88 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -69.01 -30.08 68.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.62 -23.19 61.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.923 0.868 . . . . 0.0 108.908 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.1 mm? -86.49 -12.3 49.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.001 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.47 22.39 37.45 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.395 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.895 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 69.6 m -70.57 124.39 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.934 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -102.67 147.4 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.613 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -74.49 122.64 23.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.574 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.3 m -144.09 121.07 11.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 3.1 m120 57.77 33.4 23.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.779 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.915 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.39 13.72 6.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.716 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.38 138.34 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 84.4 m -76.51 127.37 32.69 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.157 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -138.83 143.76 38.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.785 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.66 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.9 t30 -160.34 70.43 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.26 -47.77 3.66 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.9 pt -121.26 155.63 58.39 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.463 -0.298 0 C-N-CA 122.455 2.104 . . . . 0.0 111.324 -179.644 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HB3' HG21 ' A' ' 13' ' ' THR . 18.4 m . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.39 43.43 1.07 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.67 135.99 19.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.61 ' HB2' HG23 ' A' ' 6' ' ' VAL . 5.6 p -106.05 128.93 54.19 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.0 p -86.27 -1.09 57.17 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 23' ' ' ARG . 18.8 t -37.56 -46.31 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 8' ' ' ILE . 29.6 m-85 -105.46 -21.52 13.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.7 pt -161.69 150.05 12.61 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 120.529 0.204 . . . . 0.0 111.195 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.85 155.17 39.53 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.068 2.512 . . . . 0.0 112.702 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -52.16 135.34 31.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.038 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -115.12 -71.03 0.76 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.875 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.31 -50.67 77.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.769 0.795 . . . . 0.0 109.823 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.928 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.1 p -67.55 -11.4 57.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.486 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.18 79.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -68.65 -25.84 65.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.382 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.22 -8.02 59.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.773 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.24 30.51 25.03 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.413 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.928 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 88.9 m -81.4 138.86 35.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.5 t -113.09 147.55 37.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.348 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.1 t -75.97 116.4 16.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.1 m -144.91 127.18 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 60.49 33.43 20.57 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.211 0.529 . . . . 0.0 110.343 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.839 ' HB3' HG22 ' A' ' 6' ' ' VAL . 2.6 mmp_? 68.53 11.83 8.49 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.636 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.58 145.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 63.6 m -78.84 124.31 28.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.038 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.09 150.05 42.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 26.1 p-10 -160.11 58.67 0.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.347 1.07 . . . . 0.0 109.455 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.67 -42.49 2.9 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -118.24 153.52 51.57 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.458 -0.571 0 C-N-CA 122.381 2.054 . . . . 0.0 111.581 -179.455 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.739 ' HB3' HG21 ' A' ' 13' ' ' THR . 24.0 m . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.28 45.6 1.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -150.41 136.59 18.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.53 124.89 50.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.3 p -86.21 -2.27 58.21 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' A' ' 23' ' ' ARG . 21.6 t -36.53 -44.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -113.29 -16.52 12.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.7 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.0 pt -158.03 145.45 13.51 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.666 0.27 . . . . 0.0 111.475 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.3 153.2 71.87 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.305 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 4.8 m -53.67 131.92 39.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.796 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.9 m -109.42 -69.92 0.84 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.09 -53.41 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 122.057 0.932 . . . . 0.0 109.834 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.89 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 28.6 p -64.44 -8.9 15.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.904 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -68.76 -31.15 69.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.37 -23.79 61.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.841 0.829 . . . . 0.0 108.893 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.2 mm? -84.68 -14.4 48.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.978 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 24.37 26.49 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.426 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.89 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.0 m -74.12 127.34 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 111.048 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.0 t -107.64 147.4 30.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.049 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -71.39 121.62 18.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.272 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -150.15 124.38 9.48 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.98 37.68 21.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.855 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.943 ' HB3' HG22 ' A' ' 6' ' ' VAL . 35.2 mtp85 71.5 1.56 3.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.677 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.03 147.33 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 72.8 m -75.23 128.34 35.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.75 147.06 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 111.145 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.626 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 44.8 t30 -160.67 68.16 0.34 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.79 -49.88 4.0 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.56 155.92 48.18 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.459 -0.509 0 C-N-CA 122.191 1.927 . . . . 0.0 111.64 -179.45 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.696 ' HB3' HG21 ' A' ' 13' ' ' THR . 11.3 m . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.589 0.233 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 44.2 1.1 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -148.18 140.62 24.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.785 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -110.99 125.46 53.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.292 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -87.49 12.86 11.27 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 4' ' ' SER . 30.8 t -33.34 -50.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.396 1.06 . . . . 0.0 113.138 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.674 ' HD1' HG12 ' A' ' 6' ' ' VAL . 4.9 m-85 -125.68 -0.09 7.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -157.09 142.78 12.7 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 21.8 Cg_exo -64.43 152.83 80.01 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.911 2.407 . . . . 0.0 112.319 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -51.64 130.32 27.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.49 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -106.83 -69.18 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 t -63.69 -53.67 41.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.172 0.986 . . . . 0.0 109.77 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 1.021 ' HA ' HD13 ' A' ' 16' ' ' LEU . 31.1 p -65.58 -3.17 4.17 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.98 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -32.33 72.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.14 -26.17 63.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.806 0.812 . . . . 0.0 108.915 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.021 HD13 ' HA ' ' A' ' 13' ' ' THR . 7.1 mp -81.7 -10.83 59.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.375 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.63 26.21 39.56 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.032 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.955 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 64.0 m -72.89 131.73 42.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.843 0.354 . . . . 0.0 111.241 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -109.74 148.15 31.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.591 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.5 123.2 24.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -146.17 121.02 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 58.02 35.52 25.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.941 0.4 . . . . 0.0 110.911 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.676 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 69.11 15.01 8.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.044 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.45 140.87 46.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 71.6 m -78.14 126.49 30.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.974 0.416 . . . . 0.0 110.155 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -148.67 142.51 25.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 21.3 p-10 -156.37 58.83 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.184 0.992 . . . . 0.0 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 -44.07 2.85 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.0 pt -115.75 150.04 44.17 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.416 2.077 . . . . 0.0 111.611 -179.203 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.937 ' HB3' HG21 ' A' ' 13' ' ' THR . 12.9 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.45 44.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.689 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.02 143.08 26.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.981 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.79 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -120.57 129.6 53.85 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.5 p -88.97 8.52 29.14 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' ' 4' ' ' SER . 30.7 t -33.14 -49.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.319 1.012 . . . . 0.0 112.825 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.629 ' HD1' HG12 ' A' ' 6' ' ' VAL . 4.9 m-85 -125.83 -1.28 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.759 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.67 142.03 12.52 Favored Pre-proline 0 N--CA 1.473 0.69 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.04 148.24 93.55 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.915 2.41 . . . . 0.0 112.512 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -56.31 137.94 51.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 29.9 m -117.79 -67.95 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.335 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.5 t -61.44 -56.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.79 0.805 . . . . 0.0 110.556 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.937 HG21 ' HB3' ' A' ' 1' ' ' CYS . 30.2 p -67.47 -5.66 15.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -68.02 -35.75 78.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -70.27 -21.3 62.98 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.89 -20.63 41.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.886 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.86 4.15 48.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.475 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.87 120.49 13.65 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.549 0.69 . . . . 0.0 111.466 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -97.95 153.72 18.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.815 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.05 118.12 16.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -150.67 131.4 14.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 59.65 28.54 17.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.73 0.776 . . . . 0.0 109.639 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.655 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 36.4 mmt180 68.06 16.95 9.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.214 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.43 151.83 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 39.7 m -82.6 121.24 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -138.74 140.83 38.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.459 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.1 t30 -160.56 74.36 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.15 -51.84 4.64 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -119.74 155.12 55.07 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 122.52 2.146 . . . . 0.0 110.877 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.735 ' HB3' HG21 ' A' ' 13' ' ' THR . 18.5 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.626 0.251 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.71 42.46 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.21 135.65 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.493 . . . . 0.0 110.826 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.805 ' HB2' HG23 ' A' ' 6' ' ' VAL . 3.6 p -105.94 128.62 53.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -91.62 10.25 28.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.852 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.805 HG23 ' HB2' ' A' ' 4' ' ' SER . 15.1 t -33.85 -45.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.291 0.994 . . . . 0.0 113.217 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.471 ' HD1' HG12 ' A' ' 6' ' ' VAL . 11.7 m-85 -131.77 1.2 3.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.0 pt -154.82 139.39 11.68 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.94 151.87 78.6 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.957 2.438 . . . . 0.0 112.648 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 m -52.55 132.92 36.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -114.26 -70.71 0.79 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.28 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.91 -51.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.644 0.735 . . . . 0.0 110.04 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.919 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.4 p -67.08 -7.6 24.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.692 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -30.99 69.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.94 -23.56 61.48 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.903 0.858 . . . . 0.0 108.903 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.5 mm? -84.8 -9.82 57.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.066 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.78 32.37 27.17 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.057 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.919 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 90.0 m -80.8 134.4 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.908 0.385 . . . . 0.0 111.589 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 p -107.82 144.72 34.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.92 124.51 27.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.1 m -150.17 127.04 11.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.7 m120 58.15 35.84 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.258 0.552 . . . . 0.0 110.762 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 24.5 mmt85 65.39 20.03 11.71 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.593 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 10.4 p -141.34 143.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 61.9 m -78.93 123.7 27.52 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.009 0.433 . . . . 0.0 111.295 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.97 149.31 39.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.6 p-10 -159.8 59.09 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.274 1.035 . . . . 0.0 109.317 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.83 -42.02 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.99 153.44 52.77 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.05 -1.075 . . . . 0.0 108.121 177.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.598 0 C-N-CA 122.329 2.019 . . . . 0.0 111.416 -179.477 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.851 ' HB3' HG21 ' A' ' 13' ' ' THR . 8.4 m . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.09 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 111.237 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -145.22 138.44 26.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.132 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.815 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -114.67 128.1 56.12 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.761 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -88.71 8.53 28.27 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.844 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.9 t -30.82 -50.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 124.541 1.15 . . . . 0.0 113.15 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.776 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.9 m-85 -132.83 4.68 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.5 pt -154.42 137.64 10.43 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 120.595 0.236 . . . . 0.0 111.454 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.77 150.59 85.25 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.763 2.309 . . . . 0.0 112.903 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.0 m -58.17 138.5 56.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.348 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.0 m -117.09 -71.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.234 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.39 -49.08 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.728 0.775 . . . . 0.0 109.883 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.851 HG21 ' HB3' ' A' ' 1' ' ' CYS . 30.9 p -68.33 -13.55 62.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.625 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.27 78.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.84 -27.07 66.39 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.46 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.96 -20.11 46.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.124 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.82 10.38 40.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.466 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -72.62 121.8 20.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.37 0.605 . . . . 0.0 111.217 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -96.61 155.38 16.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.035 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.4 t -72.49 118.8 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.498 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 m -142.85 120.0 11.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.53 35.73 26.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 110.558 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.698 ' HD3' HG13 ' A' ' 6' ' ' VAL . 89.8 mtt180 67.35 19.66 10.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.929 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.35 139.05 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 47.6 m -78.22 119.93 22.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.955 0.407 . . . . 0.0 109.961 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.33 142.67 43.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.708 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.9 t30 -160.38 73.74 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.59 -49.56 3.89 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.8 pt -118.57 152.62 51.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.456 -0.73 0 C-N-CA 122.183 1.922 . . . . 0.0 111.519 -179.493 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.893 ' HB3' HG21 ' A' ' 13' ' ' THR . 12.3 m . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.21 45.96 1.31 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.726 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -147.21 140.74 25.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.264 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.759 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -117.28 126.17 52.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -87.31 5.39 38.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.854 HG22 ' HB3' ' A' ' 23' ' ' ARG . 12.2 t -35.49 -44.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.157 0.91 . . . . 0.0 113.229 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.68 -5.83 7.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.3 pt -158.37 141.05 10.53 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.24 148.61 89.28 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.89 2.393 . . . . 0.0 112.548 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 m -55.2 138.58 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.827 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -120.33 -66.02 1.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.321 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.35 -54.56 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.634 0.73 . . . . 0.0 110.508 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.893 HG21 ' HB3' ' A' ' 1' ' ' CYS . 32.4 p -70.1 -5.41 26.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.679 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -28.54 64.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.87 -25.3 62.74 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.953 0.882 . . . . 0.0 108.839 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.807 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -82.05 -21.02 37.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.64 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.48 12.91 39.96 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.668 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -71.9 123.52 22.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 111.252 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 p -98.37 153.98 18.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.695 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.19 121.68 21.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -150.0 124.08 9.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 58.03 36.33 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.178 0.513 . . . . 0.0 111.011 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.854 ' HB3' HG22 ' A' ' 6' ' ' VAL . 8.3 mpt_? 69.59 9.37 7.19 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.742 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.91 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.661 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 43.3 m -82.67 124.4 30.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -137.98 142.2 40.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.587 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.7 t30 -160.85 73.07 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.896 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -50.4 4.4 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.51 155.13 59.69 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.459 -0.508 0 C-N-CA 122.584 2.189 . . . . 0.0 111.004 -179.716 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.873 ' HB3' HG21 ' A' ' 13' ' ' THR . 4.3 m . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.63 0.252 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.24 44.0 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.034 0.445 . . . . 0.0 111.131 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -147.18 137.03 23.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.707 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.8 p -114.27 128.02 56.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -86.71 2.86 47.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.826 HG22 ' HB3' ' A' ' 23' ' ' ARG . 12.6 t -36.94 -44.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.96 0.788 . . . . 0.0 113.079 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' ILE . 32.7 m-85 -115.14 -15.05 11.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.4 pt -159.47 145.71 12.2 Favored Pre-proline 0 N--CA 1.47 0.558 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.48 150.07 77.83 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.085 2.523 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 m -53.69 138.51 34.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -118.39 -71.13 0.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.1 t -63.12 -49.9 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.439 0.638 . . . . 0.0 110.201 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.873 HG21 ' HB3' ' A' ' 1' ' ' CYS . 34.8 p -67.79 -9.39 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.808 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.27 68.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.92 -24.89 62.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.784 0.802 . . . . 0.0 108.872 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.621 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -81.49 -21.13 38.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.594 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.12 13.92 37.84 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.17 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.744 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.98 122.93 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 0.0 111.112 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -98.88 154.35 18.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.18 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 t -74.27 120.77 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.384 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.5 m -148.82 124.73 10.61 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.4 34.08 23.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 110.562 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.826 ' HB3' HG22 ' A' ' 6' ' ' VAL . 84.3 mtt-85 68.4 15.33 9.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.639 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.48 143.9 34.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.4 m -81.94 119.01 23.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.971 0.415 . . . . 0.0 111.343 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.75 149.35 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.395 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.744 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.9 t30 -160.75 69.03 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.72 -47.44 3.66 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.0 pt -120.11 154.57 55.87 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.461 -0.42 0 C-N-CA 122.612 2.208 . . . . 0.0 111.741 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.891 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.5 m . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.1 42.59 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.512 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -148.66 150.07 32.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.994 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.542 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.8 p -130.07 130.21 44.59 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.816 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -82.79 -3.09 56.18 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.814 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.6 t -37.51 -45.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 124.104 0.877 . . . . 0.0 112.475 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' ILE . 33.7 m-85 -105.9 -22.77 12.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.0 pt -162.6 143.64 7.75 Favored Pre-proline 0 N--CA 1.471 0.585 0 O-C-N 123.162 0.289 . . . . 0.0 110.738 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.87 147.98 39.61 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 123.258 2.639 . . . . 0.0 113.192 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.0 m -53.62 135.15 41.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.017 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.1 m -117.07 -70.65 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.208 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.86 -51.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.83 0.824 . . . . 0.0 110.293 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 1' ' ' CYS . 43.7 p -68.64 -9.54 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.846 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.64 79.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.41 -25.63 65.13 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.659 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.07 -20.06 46.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.221 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.24 12.78 35.19 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.8 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.6 m -75.28 128.35 35.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 0.0 111.466 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 m -98.2 162.3 13.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.797 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.16 66.26 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.695 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.2 m -89.82 121.99 32.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.72 32.31 20.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.22 0.533 . . . . 0.0 110.756 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 69.2 mtp180 67.44 18.72 10.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.244 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' SER . 8.3 p -131.36 142.61 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 49.4 m -72.8 113.15 9.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -142.75 145.56 33.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.452 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.7 p-10 -156.33 55.64 0.57 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.254 1.026 . . . . 0.0 109.265 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 -46.22 2.77 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.4 pt -110.37 150.81 42.12 Favored Pre-proline 0 N--CA 1.442 -0.846 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 C-N-CA 122.488 2.125 . . . . 0.0 112.317 -178.741 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.804 ' HB3' HG21 ' A' ' 13' ' ' THR . 7.3 m . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.765 0.317 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.01 45.42 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.9 0.381 . . . . 0.0 111.414 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -146.39 134.12 21.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.724 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.4 p -109.48 126.35 53.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.1 p -89.24 8.04 32.36 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.727 HG12 ' HD1' ' A' ' 7' ' ' TYR . 38.8 t -31.78 -48.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 124.422 1.076 . . . . 0.0 113.122 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.727 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.5 m-85 -134.73 7.19 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.539 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 7.9 pt -152.51 136.41 10.09 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.75 149.18 87.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.503 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.3 132.83 55.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.247 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -111.21 -72.52 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.24 -50.09 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 122.018 0.913 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.804 HG21 ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.11 -15.97 62.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.724 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.86 83.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.26 -25.89 65.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.614 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.2 mt -80.24 -18.37 49.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.071 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.65 3.11 49.93 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.52 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -67.97 120.47 14.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.507 0.67 . . . . 0.0 111.256 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.4 m -98.14 149.16 22.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.552 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.84 120.8 16.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.388 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 m -150.13 125.7 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.34 36.62 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.927 0.394 . . . . 0.0 111.204 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HB3' HG22 ' A' ' 6' ' ' VAL . 61.3 mtp180 68.76 17.55 8.81 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.707 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 11.8 p -143.57 145.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.226 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 24.3 m -82.59 119.37 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.943 0.402 . . . . 0.0 111.363 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.09 149.41 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.451 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.5 t30 -161.0 69.29 0.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.2 -48.68 3.84 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 pt -116.28 153.41 48.64 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.459 -0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 111.72 -179.544 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.896 ' HB3' HG21 ' A' ' 13' ' ' THR . 7.8 m . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.21 45.6 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.779 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -146.8 133.61 20.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.066 0.46 . . . . 0.0 110.504 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.68 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.7 p -109.89 127.71 54.89 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -90.38 4.94 49.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 23' ' ' ARG . 15.9 t -34.5 -45.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.325 1.016 . . . . 0.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.529 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.6 m-85 -130.77 2.27 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.756 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.8 pt -153.82 138.85 11.63 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.35 146.32 89.7 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 m -56.5 136.28 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.554 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.7 m -124.07 -66.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.488 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.85 -55.48 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.573 0.702 . . . . 0.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.896 HG21 ' HB3' ' A' ' 1' ' ' CYS . 32.0 p -70.19 -5.93 30.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.629 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -28.72 64.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.8 -25.29 62.8 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.873 0.844 . . . . 0.0 108.733 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.759 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -82.42 -21.56 35.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.567 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.18 33.44 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.635 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.749 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -74.42 122.33 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.363 0.601 . . . . 0.0 111.202 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 t -98.44 153.21 18.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.269 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.3 t -71.95 122.88 21.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -150.39 126.79 10.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 56.9 32.83 22.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 111.094 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 6' ' ' VAL . 81.2 mtm180 71.46 18.62 5.43 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.491 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 9.1 p -143.24 142.74 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.868 0.366 . . . . 0.0 110.06 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.5 m -78.67 121.11 24.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.14 147.94 51.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.398 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.749 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.7 t30 -160.96 70.29 0.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.463 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.07 -46.47 3.51 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.89 156.15 62.65 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.46 -0.489 0 C-N-CA 122.653 2.235 . . . . 0.0 111.717 -179.74 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.835 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.8 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.852 0.358 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.7 47.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.595 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -146.24 137.14 24.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.001 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.719 ' HB2' HG23 ' A' ' 6' ' ' VAL . 4.3 p -109.78 123.32 49.34 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.769 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.6 p -86.71 3.01 46.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.273 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' A' ' 23' ' ' ARG . 10.2 t -34.54 -45.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 124.224 0.952 . . . . 0.0 113.163 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -125.77 -3.92 7.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.15 138.32 10.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 120.664 0.269 . . . . 0.0 111.615 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 150.7 86.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.637 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 m -56.95 133.22 54.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.437 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -111.52 -69.83 0.85 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 t -62.68 -53.08 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 122.05 0.929 . . . . 0.0 110.042 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.835 HG21 ' HB3' ' A' ' 1' ' ' CYS . 67.9 p -65.91 -8.42 22.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.995 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -29.74 66.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.74 -24.89 62.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.82 0.819 . . . . 0.0 108.823 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -80.79 -21.2 41.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.678 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.55 7.93 50.31 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.431 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -67.22 120.19 13.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.471 0.653 . . . . 0.0 111.192 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 m -98.45 152.31 19.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.462 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.49 121.56 18.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.456 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 m -149.51 122.41 8.75 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.55 35.92 22.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 110.918 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.908 ' HB3' HG22 ' A' ' 6' ' ' VAL . 8.9 mpt_? 69.08 11.55 8.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -133.01 147.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.88 0.371 . . . . 0.0 110.151 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 60.4 m -80.6 122.36 26.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.33 . . . . 0.0 110.356 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -137.93 142.95 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 111.503 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 16.9 t30 -160.96 72.44 0.44 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.34 -48.97 3.72 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 pt -118.57 151.58 49.99 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.27 1.98 . . . . 0.0 111.805 -179.503 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.929 ' HB3' HG21 ' A' ' 13' ' ' THR . 14.2 m . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.55 46.06 1.27 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.737 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -145.95 139.49 26.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.415 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.679 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.3 p -115.67 123.71 49.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 3.3 p -84.38 0.85 47.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.259 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 23' ' ' ARG . 6.7 t -38.12 -43.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 124.09 0.869 . . . . 0.0 113.046 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 8' ' ' ILE . 10.5 m-85 -115.78 -13.59 11.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.777 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.3 pt -160.93 142.33 8.89 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.446 0.165 . . . . 0.0 111.062 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.45 150.02 62.3 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.903 2.402 . . . . 0.0 112.65 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.3 m -54.39 138.03 40.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.778 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 m -118.56 -68.13 0.94 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.159 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.58 -53.33 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.72 0.771 . . . . 0.0 110.376 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.929 HG21 ' HB3' ' A' ' 1' ' ' CYS . 29.9 p -70.04 -8.35 48.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.686 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.19 73.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.01 -27.53 66.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.228 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.43 -19.94 45.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.088 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.68 8.07 46.7 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.693 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -69.04 120.81 15.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.545 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 m -97.56 149.67 21.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.462 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.57 104.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.603 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 m -121.67 110.73 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 23.7 m-20 56.96 43.78 24.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.412 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.937 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.19 6.59 5.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.337 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.2 135.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m -72.17 120.89 18.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -137.78 142.08 40.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 111.612 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 19.0 t30 -160.59 74.18 0.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.78 -48.28 3.84 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.37 153.87 62.21 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.554 0 C-N-CA 122.595 2.196 . . . . 0.0 111.247 -179.431 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.845 ' HB3' HG21 ' A' ' 13' ' ' THR . 8.5 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.42 45.62 1.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.536 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -147.59 136.41 22.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.886 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.72 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.2 p -109.79 125.77 53.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.7 p -88.95 6.56 38.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 23' ' ' ARG . 20.6 t -32.38 -48.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 124.446 1.091 . . . . 0.0 113.039 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.63 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.3 m-85 -133.66 6.76 3.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.7 pt -151.85 139.76 12.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 12.7 Cg_exo -68.59 144.05 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.777 2.318 . . . . 0.0 111.947 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 m -56.65 132.83 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -112.24 -70.51 0.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.3 -52.93 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.953 0.882 . . . . 0.0 110.18 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.845 HG21 ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.4 -10.56 34.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.953 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.66 -30.38 68.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.8 -24.8 62.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.808 0.814 . . . . 0.0 108.953 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -80.76 -21.12 41.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.599 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.86 49.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.472 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.721 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -68.13 119.55 12.89 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.474 0.654 . . . . 0.0 111.115 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -97.8 151.16 20.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.485 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.5 t -71.03 120.86 17.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.482 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.5 m -150.21 126.45 10.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 56.86 34.79 25.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 0.0 111.034 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.75 ' HB3' HG22 ' A' ' 6' ' ' VAL . 1.6 mpt_? 68.74 16.55 8.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.693 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.19 143.95 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.946 0.403 . . . . 0.0 109.94 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.624 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 55.2 m -77.72 118.35 20.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -131.69 144.39 50.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 0.0 111.785 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.721 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 18.8 t30 -161.22 71.66 0.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.778 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.17 -52.68 4.67 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -117.44 156.02 49.56 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.761 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 61.5 Cg_endo . . . . . 0 N--CA 1.456 -0.733 0 C-N-CA 122.195 1.93 . . . . 0.0 111.738 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.64 ' HB3' HG21 ' A' ' 13' ' ' THR . 32.1 m . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -150.77 132.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.073 0.463 . . . . 0.0 111.177 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.697 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -105.88 128.41 53.75 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -88.9 3.04 52.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 23' ' ' ARG . 7.1 t -36.47 -44.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.039 0.837 . . . . 0.0 113.162 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.58 -8.68 9.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.753 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.6 pt -158.04 141.48 11.07 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.549 0.214 . . . . 0.0 111.559 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 29.6 Cg_exo -60.96 152.52 70.27 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.926 2.418 . . . . 0.0 112.425 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 6.9 m -51.53 135.82 27.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.5 m -114.61 -73.81 0.64 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.98 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 t -64.48 -48.48 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 109.55 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.881 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 56.2 p -66.57 -14.75 62.77 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.252 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.19 82.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mp -68.63 -25.34 64.79 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -83.66 -8.87 59.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.532 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.53 24.27 36.81 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.353 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.881 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.4 m -77.32 129.94 36.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.959 0.409 . . . . 0.0 111.153 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.6 t -105.27 144.61 31.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 t -72.59 122.99 22.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.539 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -150.58 126.28 10.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.24 36.33 25.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.082 0.944 . . . . 0.0 110.438 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 6' ' ' VAL . 29.5 mtm-85 67.68 16.47 9.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.757 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.15 141.11 34.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.949 0.404 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 56.2 m -78.47 127.03 31.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.962 0.411 . . . . 0.0 110.898 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.91 150.49 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.611 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.632 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 45.6 t30 -160.02 68.41 0.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 -46.44 3.61 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.99 156.98 58.98 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.461 -0.411 0 C-N-CA 122.25 1.967 . . . . 0.0 111.579 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.739 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.0 m . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 120.731 0.3 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.87 42.07 0.95 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -149.19 139.51 22.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.512 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.744 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.5 p -110.47 126.32 54.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.3 p -87.0 4.64 41.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.744 HG23 ' HB2' ' A' ' 4' ' ' SER . 15.9 t -34.59 -46.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.188 0.93 . . . . 0.0 113.175 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.516 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.1 m-85 -126.47 -2.09 6.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.03 137.84 9.84 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 34.6 Cg_exo -60.76 150.0 85.01 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.827 2.351 . . . . 0.0 112.279 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -51.55 131.56 29.53 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.487 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.4 m -113.36 -70.26 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.564 0.221 . . . . 0.0 111.433 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.26 -50.16 80.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.944 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 68.9 p -67.62 -11.22 57.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.484 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.58 78.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.31 -25.85 65.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.358 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.25 -6.9 59.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.718 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.49 29.05 33.96 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.399 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.944 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 81.0 m -77.67 136.18 38.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.943 0.401 . . . . 0.0 111.375 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -110.01 145.96 36.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.304 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.84 123.02 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.748 0.309 . . . . 0.0 110.535 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.0 m -144.07 120.19 10.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.73 33.85 23.74 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HB3' HG22 ' A' ' 6' ' ' VAL . 78.9 mtm180 73.31 13.59 4.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.769 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.7 137.87 54.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 65.3 m -75.25 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -147.26 143.01 27.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 24.1 p-10 -156.49 59.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.18 0.99 . . . . 0.0 109.603 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.68 -44.04 2.88 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -116.52 149.96 44.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.461 -0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 111.254 -179.459 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.751 ' HB3' HG21 ' A' ' 13' ' ' THR . 31.0 m . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.667 0.27 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.44 42.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -151.59 138.07 18.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.018 0.437 . . . . 0.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.776 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -110.28 127.52 55.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.754 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 5.9 p -88.79 7.05 35.99 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.776 HG23 ' HB2' ' A' ' 4' ' ' SER . 20.4 t -33.01 -48.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.344 1.028 . . . . 0.0 113.208 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.613 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.4 m-85 -128.99 1.59 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.37 137.93 10.26 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 26.0 Cg_exo -61.91 150.17 87.26 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.82 2.347 . . . . 0.0 112.351 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -52.51 133.2 35.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 32.4 m -114.79 -68.65 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.41 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.9 t -63.05 -54.28 35.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.756 0.788 . . . . 0.0 109.886 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.891 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 58.2 p -66.43 -7.68 21.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.513 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -67.02 -36.04 81.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -71.45 -19.88 62.17 Favored 'General case' 0 N--CA 1.46 0.058 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -85.42 -10.21 56.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.191 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.72 24.14 36.74 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.317 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.891 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 85.7 m -74.96 128.4 35.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.031 0.443 . . . . 0.0 111.392 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -104.49 144.39 31.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.506 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.0 t -71.64 125.97 28.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -148.07 120.51 8.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 56.21 40.54 29.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.521 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.727 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 68.56 13.62 8.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.143 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -133.73 138.44 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 62.0 m -77.07 128.09 33.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -136.76 144.25 43.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.913 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.667 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 42.5 t30 -160.03 70.58 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.51 -47.48 3.64 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 pt -122.59 156.8 60.85 Favored Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.461 -0.405 0 C-N-CA 122.353 2.036 . . . . 0.0 111.084 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.86 ' HB3' HG21 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.43 46.5 1.34 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.493 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -147.18 139.63 24.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.763 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -114.49 122.64 47.2 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -85.45 8.05 20.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.763 HG23 ' HB2' ' A' ' 4' ' ' SER . 25.4 t -32.74 -48.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.385 1.053 . . . . 0.0 113.119 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.651 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.6 m-85 -129.49 1.17 5.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.18 138.24 10.6 Favored Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.84 149.87 90.06 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.733 2.288 . . . . 0.0 112.807 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 6.6 m -57.15 133.9 55.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -110.15 -70.77 0.79 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.37 -51.03 75.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.16 0.981 . . . . 0.0 109.833 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.86 HG21 ' HB3' ' A' ' 1' ' ' CYS . 71.3 p -65.98 -11.85 50.74 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.833 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -67.74 -34.81 77.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.93 -26.76 66.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.36 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.72 -19.41 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.991 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 4.49 51.22 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.29 119.64 11.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.491 0.662 . . . . 0.0 111.322 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.1 m -98.06 154.36 17.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.17 120.16 16.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.7 m -144.86 118.4 9.12 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 59.54 35.8 22.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.335 0.588 . . . . 0.0 110.262 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.637 ' HD3' HG13 ' A' ' 6' ' ' VAL . 87.1 mtt-85 67.15 16.94 10.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -131.68 140.0 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 59.8 m -78.81 121.16 24.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.837 0.351 . . . . 0.0 110.279 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -139.68 142.57 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.554 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 20.6 t30 -160.94 72.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.96 -50.56 4.42 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -118.22 152.49 50.68 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 122.586 2.191 . . . . 0.0 111.043 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.919 ' HB3' HG21 ' A' ' 13' ' ' THR . 13.2 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.09 45.76 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.668 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -148.06 139.0 23.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 110.656 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.473 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.0 p -113.63 130.72 56.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 25.0 p -90.92 0.01 57.62 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.359 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.764 HG22 ' HB3' ' A' ' 23' ' ' ARG . 17.6 t -37.15 -48.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.929 0.768 . . . . 0.0 112.832 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -100.99 -23.23 14.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -159.1 149.48 15.58 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 120.412 0.149 . . . . 0.0 111.38 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.48 150.0 71.3 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.019 2.479 . . . . 0.0 112.75 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -54.11 137.12 41.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.069 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.2 m -116.22 -70.27 0.8 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.21 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.65 -53.39 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.678 0.751 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.919 HG21 ' HB3' ' A' ' 1' ' ' CYS . 33.0 p -69.15 -7.19 33.92 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.778 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.55 -33.98 75.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.14 -26.14 65.63 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.552 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.58 -20.61 42.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.84 35.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.737 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.95 128.29 35.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.308 0.575 . . . . 0.0 111.353 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 26.2 p -97.64 158.17 15.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.82 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.8 t -76.58 67.36 2.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 m -94.91 123.0 38.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.796 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m120 57.27 36.33 27.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.417 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.764 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.73 17.68 9.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.497 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.96 141.15 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.218 0.533 . . . . 0.0 109.895 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 35.3 m -74.71 113.67 12.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.268 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.93 147.62 52.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.11 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.737 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 41.7 t30 -160.89 68.56 0.34 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.64 3.71 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.8 pt -117.95 153.44 51.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.672 2.248 . . . . 0.0 111.925 -179.588 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.712 ' HB3' HG21 ' A' ' 13' ' ' THR . 24.5 m . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.47 45.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.26 140.49 22.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.369 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.672 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -111.95 122.18 47.06 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.726 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -83.87 3.17 34.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.915 HG22 ' HB3' ' A' ' 23' ' ' ARG . 6.6 t -38.38 -43.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.038 0.836 . . . . 0.0 112.964 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 8' ' ' ILE . 16.4 m-85 -114.98 -14.61 11.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.6 pt -160.48 143.63 9.97 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-O 120.547 0.213 . . . . 0.0 111.348 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.26 151.38 74.08 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.649 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 6.4 m -50.89 130.77 25.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.757 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -109.22 -69.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.84 -53.6 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 122.118 0.961 . . . . 0.0 109.792 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.895 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 26.0 p -64.69 -8.26 13.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.88 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -69.01 -30.08 68.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.62 -23.19 61.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.923 0.868 . . . . 0.0 108.908 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.1 mm? -86.49 -12.3 49.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.001 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.47 22.39 37.45 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.395 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.895 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 69.6 m -70.57 124.39 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.934 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -102.67 147.4 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.613 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -74.49 122.64 23.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.574 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.3 m -144.09 121.07 11.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 3.1 m120 57.77 33.4 23.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.779 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.915 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.39 13.72 6.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.716 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.38 138.34 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 84.4 m -76.51 127.37 32.69 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.157 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -138.83 143.76 38.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.785 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.66 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.9 t30 -160.34 70.43 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.26 -47.77 3.66 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.9 pt -121.26 155.63 58.39 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.463 -0.298 0 C-N-CA 122.455 2.104 . . . . 0.0 111.324 -179.644 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HB3' HG21 ' A' ' 13' ' ' THR . 18.4 m . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.39 43.43 1.07 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.67 135.99 19.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.61 ' HB2' HG23 ' A' ' 6' ' ' VAL . 5.6 p -106.05 128.93 54.19 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.0 p -86.27 -1.09 57.17 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 23' ' ' ARG . 18.8 t -37.56 -46.31 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 8' ' ' ILE . 29.6 m-85 -105.46 -21.52 13.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.7 pt -161.69 150.05 12.61 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 120.529 0.204 . . . . 0.0 111.195 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.85 155.17 39.53 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.068 2.512 . . . . 0.0 112.702 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -52.16 135.34 31.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.038 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -115.12 -71.03 0.76 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.875 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.31 -50.67 77.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.769 0.795 . . . . 0.0 109.823 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.928 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.1 p -67.55 -11.4 57.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.486 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.18 79.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -68.65 -25.84 65.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.382 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.22 -8.02 59.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.773 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.24 30.51 25.03 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.413 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.928 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 88.9 m -81.4 138.86 35.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.5 t -113.09 147.55 37.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.348 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.1 t -75.97 116.4 16.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.1 m -144.91 127.18 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.49 33.43 20.57 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.211 0.529 . . . . 0.0 110.343 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.839 ' HB3' HG22 ' A' ' 6' ' ' VAL . 2.6 mmp_? 68.53 11.83 8.49 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.636 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.58 145.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 63.6 m -78.84 124.31 28.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.038 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.09 150.05 42.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 26.1 p-10 -160.11 58.67 0.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.347 1.07 . . . . 0.0 109.455 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.67 -42.49 2.9 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -118.24 153.52 51.57 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.458 -0.571 0 C-N-CA 122.381 2.054 . . . . 0.0 111.581 -179.455 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.739 ' HB3' HG21 ' A' ' 13' ' ' THR . 24.0 m . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.28 45.6 1.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -150.41 136.59 18.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.53 124.89 50.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.3 p -86.21 -2.27 58.21 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' A' ' 23' ' ' ARG . 21.6 t -36.53 -44.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -113.29 -16.52 12.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.7 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.0 pt -158.03 145.45 13.51 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.666 0.27 . . . . 0.0 111.475 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.3 153.2 71.87 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.305 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 4.8 m -53.67 131.92 39.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.796 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.9 m -109.42 -69.92 0.84 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.09 -53.41 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 122.057 0.932 . . . . 0.0 109.834 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.89 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 28.6 p -64.44 -8.9 15.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.904 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -68.76 -31.15 69.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.37 -23.79 61.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.841 0.829 . . . . 0.0 108.893 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.2 mm? -84.68 -14.4 48.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.978 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 24.37 26.49 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.426 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.89 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.0 m -74.12 127.34 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 111.048 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.0 t -107.64 147.4 30.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.049 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -71.39 121.62 18.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.272 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -150.15 124.38 9.48 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.98 37.68 21.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.855 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.943 ' HB3' HG22 ' A' ' 6' ' ' VAL . 35.2 mtp85 71.5 1.56 3.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.677 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.03 147.33 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 72.8 m -75.23 128.34 35.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.75 147.06 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 111.145 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.626 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 44.8 t30 -160.67 68.16 0.34 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.79 -49.88 4.0 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.56 155.92 48.18 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.459 -0.509 0 C-N-CA 122.191 1.927 . . . . 0.0 111.64 -179.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.696 ' HB3' HG21 ' A' ' 13' ' ' THR . 11.3 m . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.589 0.233 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 44.2 1.1 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -148.18 140.62 24.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.785 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -110.99 125.46 53.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -87.49 12.86 11.27 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 4' ' ' SER . 30.8 t -33.34 -50.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.396 1.06 . . . . 0.0 113.138 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.674 ' HD1' HG12 ' A' ' 6' ' ' VAL . 4.9 m-85 -125.68 -0.09 7.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -157.09 142.78 12.7 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 21.8 Cg_exo -64.43 152.83 80.01 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.911 2.407 . . . . 0.0 112.319 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -51.64 130.32 27.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.49 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -106.83 -69.18 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 t -63.69 -53.67 41.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.172 0.986 . . . . 0.0 109.77 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 1.021 ' HA ' HD13 ' A' ' 16' ' ' LEU . 31.1 p -65.58 -3.17 4.17 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.98 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -32.33 72.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.14 -26.17 63.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.806 0.812 . . . . 0.0 108.915 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.021 HD13 ' HA ' ' A' ' 13' ' ' THR . 7.1 mp -81.7 -10.83 59.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.375 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.63 26.21 39.56 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.032 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.955 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 64.0 m -72.89 131.73 42.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.843 0.354 . . . . 0.0 111.241 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -109.74 148.15 31.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.591 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.5 123.2 24.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -146.17 121.02 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 m120 58.02 35.52 25.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.941 0.4 . . . . 0.0 110.911 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.676 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 69.11 15.01 8.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.044 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.45 140.87 46.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 71.6 m -78.14 126.49 30.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.974 0.416 . . . . 0.0 110.155 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -148.67 142.51 25.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 21.3 p-10 -156.37 58.83 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.184 0.992 . . . . 0.0 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 -44.07 2.85 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.0 pt -115.75 150.04 44.17 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.416 2.077 . . . . 0.0 111.611 -179.203 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.937 ' HB3' HG21 ' A' ' 13' ' ' THR . 12.9 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.45 44.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.689 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.02 143.08 26.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.981 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.79 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -120.57 129.6 53.85 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.5 p -88.97 8.52 29.14 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' ' 4' ' ' SER . 30.7 t -33.14 -49.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.319 1.012 . . . . 0.0 112.825 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.629 ' HD1' HG12 ' A' ' 6' ' ' VAL . 4.9 m-85 -125.83 -1.28 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.759 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.67 142.03 12.52 Favored Pre-proline 0 N--CA 1.473 0.69 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.04 148.24 93.55 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.915 2.41 . . . . 0.0 112.512 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -56.31 137.94 51.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 29.9 m -117.79 -67.95 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.335 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.5 t -61.44 -56.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.79 0.805 . . . . 0.0 110.556 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.937 HG21 ' HB3' ' A' ' 1' ' ' CYS . 30.2 p -67.47 -5.66 15.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -68.02 -35.75 78.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -70.27 -21.3 62.98 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.89 -20.63 41.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.886 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.86 4.15 48.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.475 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.87 120.49 13.65 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.549 0.69 . . . . 0.0 111.466 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -97.95 153.72 18.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.815 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.05 118.12 16.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -150.67 131.4 14.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.65 28.54 17.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.73 0.776 . . . . 0.0 109.639 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.655 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 36.4 mmt180 68.06 16.95 9.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.214 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.43 151.83 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 39.7 m -82.6 121.24 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -138.74 140.83 38.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.459 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.1 t30 -160.56 74.36 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.15 -51.84 4.64 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -119.74 155.12 55.07 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 122.52 2.146 . . . . 0.0 110.877 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.735 ' HB3' HG21 ' A' ' 13' ' ' THR . 18.5 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.626 0.251 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.71 42.46 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.21 135.65 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.493 . . . . 0.0 110.826 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.805 ' HB2' HG23 ' A' ' 6' ' ' VAL . 3.6 p -105.94 128.62 53.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -91.62 10.25 28.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.852 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.805 HG23 ' HB2' ' A' ' 4' ' ' SER . 15.1 t -33.85 -45.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.291 0.994 . . . . 0.0 113.217 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.471 ' HD1' HG12 ' A' ' 6' ' ' VAL . 11.7 m-85 -131.77 1.2 3.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.0 pt -154.82 139.39 11.68 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.94 151.87 78.6 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.957 2.438 . . . . 0.0 112.648 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 m -52.55 132.92 36.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -114.26 -70.71 0.79 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.28 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.91 -51.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.644 0.735 . . . . 0.0 110.04 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.919 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.4 p -67.08 -7.6 24.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.692 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -30.99 69.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.94 -23.56 61.48 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.903 0.858 . . . . 0.0 108.903 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.5 mm? -84.8 -9.82 57.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.066 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.78 32.37 27.17 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.057 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.919 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 90.0 m -80.8 134.4 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.908 0.385 . . . . 0.0 111.589 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 p -107.82 144.72 34.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.92 124.51 27.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.1 m -150.17 127.04 11.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.7 m120 58.15 35.84 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.258 0.552 . . . . 0.0 110.762 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 24.5 mmt85 65.39 20.03 11.71 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.593 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 10.4 p -141.34 143.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 61.9 m -78.93 123.7 27.52 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.009 0.433 . . . . 0.0 111.295 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.97 149.31 39.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.6 p-10 -159.8 59.09 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.274 1.035 . . . . 0.0 109.317 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.83 -42.02 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.99 153.44 52.77 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.05 -1.075 . . . . 0.0 108.121 177.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.598 0 C-N-CA 122.329 2.019 . . . . 0.0 111.416 -179.477 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.851 ' HB3' HG21 ' A' ' 13' ' ' THR . 8.4 m . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.09 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 111.237 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -145.22 138.44 26.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.132 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.815 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -114.67 128.1 56.12 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.761 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -88.71 8.53 28.27 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.844 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.9 t -30.82 -50.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 124.541 1.15 . . . . 0.0 113.15 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.776 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.9 m-85 -132.83 4.68 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.5 pt -154.42 137.64 10.43 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 120.595 0.236 . . . . 0.0 111.454 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.77 150.59 85.25 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.763 2.309 . . . . 0.0 112.903 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.0 m -58.17 138.5 56.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.348 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.0 m -117.09 -71.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.234 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.39 -49.08 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.728 0.775 . . . . 0.0 109.883 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.851 HG21 ' HB3' ' A' ' 1' ' ' CYS . 30.9 p -68.33 -13.55 62.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.625 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.27 78.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.84 -27.07 66.39 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.46 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.96 -20.11 46.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.124 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.82 10.38 40.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.466 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -72.62 121.8 20.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.37 0.605 . . . . 0.0 111.217 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -96.61 155.38 16.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.035 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.4 t -72.49 118.8 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.498 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 m -142.85 120.0 11.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.53 35.73 26.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 110.558 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.698 ' HD3' HG13 ' A' ' 6' ' ' VAL . 89.8 mtt180 67.35 19.66 10.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.929 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.35 139.05 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 47.6 m -78.22 119.93 22.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.955 0.407 . . . . 0.0 109.961 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.33 142.67 43.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.708 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.9 t30 -160.38 73.74 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.59 -49.56 3.89 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.8 pt -118.57 152.62 51.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.456 -0.73 0 C-N-CA 122.183 1.922 . . . . 0.0 111.519 -179.493 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.893 ' HB3' HG21 ' A' ' 13' ' ' THR . 12.3 m . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.21 45.96 1.31 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.726 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -147.21 140.74 25.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.264 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.759 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -117.28 126.17 52.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -87.31 5.39 38.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.854 HG22 ' HB3' ' A' ' 23' ' ' ARG . 12.2 t -35.49 -44.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.157 0.91 . . . . 0.0 113.229 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.68 -5.83 7.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.3 pt -158.37 141.05 10.53 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.24 148.61 89.28 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.89 2.393 . . . . 0.0 112.548 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 m -55.2 138.58 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.827 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -120.33 -66.02 1.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.321 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.35 -54.56 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.634 0.73 . . . . 0.0 110.508 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.893 HG21 ' HB3' ' A' ' 1' ' ' CYS . 32.4 p -70.1 -5.41 26.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.679 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -28.54 64.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.87 -25.3 62.74 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.953 0.882 . . . . 0.0 108.839 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.807 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -82.05 -21.02 37.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.64 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.48 12.91 39.96 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.668 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -71.9 123.52 22.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 111.252 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 p -98.37 153.98 18.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.695 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.19 121.68 21.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -150.0 124.08 9.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 58.03 36.33 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.178 0.513 . . . . 0.0 111.011 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.854 ' HB3' HG22 ' A' ' 6' ' ' VAL . 8.3 mpt_? 69.59 9.37 7.19 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.742 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.91 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.661 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 43.3 m -82.67 124.4 30.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -137.98 142.2 40.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.587 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.7 t30 -160.85 73.07 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.896 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -50.4 4.4 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.51 155.13 59.69 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.459 -0.508 0 C-N-CA 122.584 2.189 . . . . 0.0 111.004 -179.716 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.873 ' HB3' HG21 ' A' ' 13' ' ' THR . 4.3 m . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.63 0.252 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.24 44.0 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.034 0.445 . . . . 0.0 111.131 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -147.18 137.03 23.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.707 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.8 p -114.27 128.02 56.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -86.71 2.86 47.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.826 HG22 ' HB3' ' A' ' 23' ' ' ARG . 12.6 t -36.94 -44.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.96 0.788 . . . . 0.0 113.079 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' ILE . 32.7 m-85 -115.14 -15.05 11.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.4 pt -159.47 145.71 12.2 Favored Pre-proline 0 N--CA 1.47 0.558 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.48 150.07 77.83 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.085 2.523 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 m -53.69 138.51 34.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -118.39 -71.13 0.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.1 t -63.12 -49.9 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.439 0.638 . . . . 0.0 110.201 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.873 HG21 ' HB3' ' A' ' 1' ' ' CYS . 34.8 p -67.79 -9.39 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.808 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.27 68.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.92 -24.89 62.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.784 0.802 . . . . 0.0 108.872 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.621 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -81.49 -21.13 38.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.594 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.12 13.92 37.84 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.17 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.744 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.98 122.93 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 0.0 111.112 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -98.88 154.35 18.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.18 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 t -74.27 120.77 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.384 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.5 m -148.82 124.73 10.61 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.4 34.08 23.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 110.562 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.826 ' HB3' HG22 ' A' ' 6' ' ' VAL . 84.3 mtt-85 68.4 15.33 9.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.639 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.48 143.9 34.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.4 m -81.94 119.01 23.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.971 0.415 . . . . 0.0 111.343 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.75 149.35 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.395 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.744 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.9 t30 -160.75 69.03 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.72 -47.44 3.66 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.0 pt -120.11 154.57 55.87 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.461 -0.42 0 C-N-CA 122.612 2.208 . . . . 0.0 111.741 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.891 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.5 m . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.1 42.59 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.512 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -148.66 150.07 32.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.994 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.542 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.8 p -130.07 130.21 44.59 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.816 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -82.79 -3.09 56.18 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.814 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.6 t -37.51 -45.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 124.104 0.877 . . . . 0.0 112.475 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' ILE . 33.7 m-85 -105.9 -22.77 12.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.0 pt -162.6 143.64 7.75 Favored Pre-proline 0 N--CA 1.471 0.585 0 O-C-N 123.162 0.289 . . . . 0.0 110.738 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.87 147.98 39.61 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 123.258 2.639 . . . . 0.0 113.192 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.0 m -53.62 135.15 41.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.017 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.1 m -117.07 -70.65 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.208 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.86 -51.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.83 0.824 . . . . 0.0 110.293 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 1' ' ' CYS . 43.7 p -68.64 -9.54 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.846 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.64 79.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.41 -25.63 65.13 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.659 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.07 -20.06 46.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.221 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.24 12.78 35.19 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.8 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.6 m -75.28 128.35 35.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 0.0 111.466 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 m -98.2 162.3 13.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.797 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.16 66.26 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.695 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.2 m -89.82 121.99 32.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.72 32.31 20.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.22 0.533 . . . . 0.0 110.756 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 69.2 mtp180 67.44 18.72 10.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.244 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' SER . 8.3 p -131.36 142.61 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 49.4 m -72.8 113.15 9.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -142.75 145.56 33.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.452 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.7 p-10 -156.33 55.64 0.57 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.254 1.026 . . . . 0.0 109.265 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 -46.22 2.77 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.4 pt -110.37 150.81 42.12 Favored Pre-proline 0 N--CA 1.442 -0.846 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 C-N-CA 122.488 2.125 . . . . 0.0 112.317 -178.741 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.804 ' HB3' HG21 ' A' ' 13' ' ' THR . 7.3 m . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.765 0.317 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.01 45.42 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.9 0.381 . . . . 0.0 111.414 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -146.39 134.12 21.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.724 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.4 p -109.48 126.35 53.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.1 p -89.24 8.04 32.36 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.727 HG12 ' HD1' ' A' ' 7' ' ' TYR . 38.8 t -31.78 -48.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 124.422 1.076 . . . . 0.0 113.122 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.727 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.5 m-85 -134.73 7.19 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.539 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 7.9 pt -152.51 136.41 10.09 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.75 149.18 87.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.503 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.3 132.83 55.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.247 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -111.21 -72.52 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.24 -50.09 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 122.018 0.913 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.804 HG21 ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.11 -15.97 62.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.724 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.86 83.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.26 -25.89 65.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.614 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.2 mt -80.24 -18.37 49.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.071 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.65 3.11 49.93 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.52 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -67.97 120.47 14.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.507 0.67 . . . . 0.0 111.256 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.4 m -98.14 149.16 22.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.552 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.84 120.8 16.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.388 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 m -150.13 125.7 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.34 36.62 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.927 0.394 . . . . 0.0 111.204 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HB3' HG22 ' A' ' 6' ' ' VAL . 61.3 mtp180 68.76 17.55 8.81 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.707 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 11.8 p -143.57 145.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.226 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 24.3 m -82.59 119.37 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.943 0.402 . . . . 0.0 111.363 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.09 149.41 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.451 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.5 t30 -161.0 69.29 0.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.2 -48.68 3.84 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 pt -116.28 153.41 48.64 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.459 -0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 111.72 -179.544 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.896 ' HB3' HG21 ' A' ' 13' ' ' THR . 7.8 m . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.21 45.6 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.779 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -146.8 133.61 20.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.066 0.46 . . . . 0.0 110.504 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.68 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.7 p -109.89 127.71 54.89 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -90.38 4.94 49.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 23' ' ' ARG . 15.9 t -34.5 -45.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.325 1.016 . . . . 0.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.529 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.6 m-85 -130.77 2.27 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.756 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.8 pt -153.82 138.85 11.63 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.35 146.32 89.7 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 m -56.5 136.28 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.554 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.7 m -124.07 -66.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.488 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.85 -55.48 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.573 0.702 . . . . 0.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.896 HG21 ' HB3' ' A' ' 1' ' ' CYS . 32.0 p -70.19 -5.93 30.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.629 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -28.72 64.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.8 -25.29 62.8 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.873 0.844 . . . . 0.0 108.733 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.759 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -82.42 -21.56 35.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.567 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.18 33.44 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.635 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.749 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -74.42 122.33 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.363 0.601 . . . . 0.0 111.202 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 t -98.44 153.21 18.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.269 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.3 t -71.95 122.88 21.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -150.39 126.79 10.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 56.9 32.83 22.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 111.094 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 6' ' ' VAL . 81.2 mtm180 71.46 18.62 5.43 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.491 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 9.1 p -143.24 142.74 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.868 0.366 . . . . 0.0 110.06 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.5 m -78.67 121.11 24.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.14 147.94 51.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.398 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.749 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.7 t30 -160.96 70.29 0.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.463 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.07 -46.47 3.51 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.89 156.15 62.65 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.46 -0.489 0 C-N-CA 122.653 2.235 . . . . 0.0 111.717 -179.74 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.835 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.8 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.852 0.358 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.7 47.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.595 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -146.24 137.14 24.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.001 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.719 ' HB2' HG23 ' A' ' 6' ' ' VAL . 4.3 p -109.78 123.32 49.34 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.769 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.6 p -86.71 3.01 46.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.273 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' A' ' 23' ' ' ARG . 10.2 t -34.54 -45.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 124.224 0.952 . . . . 0.0 113.163 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -125.77 -3.92 7.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.15 138.32 10.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 120.664 0.269 . . . . 0.0 111.615 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 150.7 86.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.637 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 m -56.95 133.22 54.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.437 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -111.52 -69.83 0.85 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 t -62.68 -53.08 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 122.05 0.929 . . . . 0.0 110.042 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.835 HG21 ' HB3' ' A' ' 1' ' ' CYS . 67.9 p -65.91 -8.42 22.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.995 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -29.74 66.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.74 -24.89 62.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.82 0.819 . . . . 0.0 108.823 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -80.79 -21.2 41.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.678 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.55 7.93 50.31 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.431 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -67.22 120.19 13.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.471 0.653 . . . . 0.0 111.192 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 m -98.45 152.31 19.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.462 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.49 121.56 18.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.456 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 m -149.51 122.41 8.75 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.55 35.92 22.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 110.918 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.908 ' HB3' HG22 ' A' ' 6' ' ' VAL . 8.9 mpt_? 69.08 11.55 8.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -133.01 147.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.88 0.371 . . . . 0.0 110.151 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 60.4 m -80.6 122.36 26.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.33 . . . . 0.0 110.356 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -137.93 142.95 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 111.503 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 16.9 t30 -160.96 72.44 0.44 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.34 -48.97 3.72 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 pt -118.57 151.58 49.99 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.27 1.98 . . . . 0.0 111.805 -179.503 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.929 ' HB3' HG21 ' A' ' 13' ' ' THR . 14.2 m . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.55 46.06 1.27 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.737 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -145.95 139.49 26.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.415 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.679 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.3 p -115.67 123.71 49.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 3.3 p -84.38 0.85 47.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.259 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 23' ' ' ARG . 6.7 t -38.12 -43.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 124.09 0.869 . . . . 0.0 113.046 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 8' ' ' ILE . 10.5 m-85 -115.78 -13.59 11.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.777 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.3 pt -160.93 142.33 8.89 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.446 0.165 . . . . 0.0 111.062 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.45 150.02 62.3 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.903 2.402 . . . . 0.0 112.65 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.3 m -54.39 138.03 40.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.778 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 m -118.56 -68.13 0.94 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.159 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.58 -53.33 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.72 0.771 . . . . 0.0 110.376 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.929 HG21 ' HB3' ' A' ' 1' ' ' CYS . 29.9 p -70.04 -8.35 48.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.686 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.19 73.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.01 -27.53 66.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.228 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.43 -19.94 45.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.088 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.68 8.07 46.7 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.693 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -69.04 120.81 15.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.545 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 m -97.56 149.67 21.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.462 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.57 104.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.603 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 m -121.67 110.73 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 23.7 m-20 56.96 43.78 24.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.412 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.937 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.19 6.59 5.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.337 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.2 135.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m -72.17 120.89 18.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -137.78 142.08 40.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 111.612 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 19.0 t30 -160.59 74.18 0.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.78 -48.28 3.84 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.37 153.87 62.21 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.554 0 C-N-CA 122.595 2.196 . . . . 0.0 111.247 -179.431 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.845 ' HB3' HG21 ' A' ' 13' ' ' THR . 8.5 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.42 45.62 1.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.536 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -147.59 136.41 22.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.886 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.72 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.2 p -109.79 125.77 53.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.7 p -88.95 6.56 38.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 23' ' ' ARG . 20.6 t -32.38 -48.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 124.446 1.091 . . . . 0.0 113.039 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.63 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.3 m-85 -133.66 6.76 3.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.7 pt -151.85 139.76 12.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 12.7 Cg_exo -68.59 144.05 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.777 2.318 . . . . 0.0 111.947 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 m -56.65 132.83 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -112.24 -70.51 0.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.3 -52.93 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.953 0.882 . . . . 0.0 110.18 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.845 HG21 ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.4 -10.56 34.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.953 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.66 -30.38 68.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.8 -24.8 62.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.808 0.814 . . . . 0.0 108.953 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -80.76 -21.12 41.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.599 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.86 49.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.472 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.721 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -68.13 119.55 12.89 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.474 0.654 . . . . 0.0 111.115 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -97.8 151.16 20.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.485 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.5 t -71.03 120.86 17.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.482 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.5 m -150.21 126.45 10.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 56.86 34.79 25.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 0.0 111.034 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.75 ' HB3' HG22 ' A' ' 6' ' ' VAL . 1.6 mpt_? 68.74 16.55 8.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.693 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.19 143.95 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.946 0.403 . . . . 0.0 109.94 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.624 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 55.2 m -77.72 118.35 20.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -131.69 144.39 50.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 0.0 111.785 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.721 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 18.8 t30 -161.22 71.66 0.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.778 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.17 -52.68 4.67 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -117.44 156.02 49.56 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 61.5 Cg_endo . . . . . 0 N--CA 1.456 -0.733 0 C-N-CA 122.195 1.93 . . . . 0.0 111.738 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.64 ' HB3' HG21 ' A' ' 13' ' ' THR . 32.1 m . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.62 43.37 1.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -150.77 132.92 15.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.073 0.463 . . . . 0.0 111.177 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.697 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -105.88 128.41 53.75 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -88.9 3.04 52.74 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -178.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 23' ' ' ARG . 7.1 t -36.47 -44.85 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.039 0.837 . . . . 0.0 113.162 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -120.58 -8.68 9.51 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.753 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.6 pt -158.04 141.48 11.07 Favored Pre-proline 0 N--CA 1.469 0.511 0 CA-C-O 120.549 0.214 . . . . 0.0 111.559 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 29.6 Cg_exo -60.96 152.52 70.27 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.926 2.418 . . . . 0.0 112.425 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.401 ' HB3' ' OG1' ' A' ' 13' ' ' THR . 6.9 m -51.53 135.82 27.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.937 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.5 m -114.61 -73.81 0.64 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.98 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.0 t -64.48 -48.48 84.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.698 0.761 . . . . 0.0 109.55 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.881 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 56.2 p -66.57 -14.75 62.77 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.252 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.96 -36.19 82.64 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.7 mp -68.63 -25.34 64.79 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 115.602 -0.727 . . . . 0.0 109.524 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.9 mt -83.66 -8.87 59.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.532 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.53 24.27 36.81 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.353 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.881 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.4 m -77.32 129.94 36.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.959 0.409 . . . . 0.0 111.153 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.6 t -105.27 144.61 31.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.32 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.1 t -72.59 122.99 22.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.539 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -150.58 126.28 10.3 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.24 36.33 25.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 122.082 0.944 . . . . 0.0 110.438 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 6' ' ' VAL . 29.5 mtm-85 67.68 16.47 9.8 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.207 -1.36 . . . . 0.0 112.757 179.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.15 141.11 34.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-O 120.949 0.404 . . . . 0.0 110.157 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 56.2 m -78.47 127.03 31.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.962 0.411 . . . . 0.0 110.898 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -134.91 150.49 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.611 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.632 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 45.6 t30 -160.02 68.41 0.39 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.86 -46.44 3.61 Favored Glycine 0 N--CA 1.451 -0.324 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 pt -121.99 156.98 58.98 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.461 -0.411 0 C-N-CA 122.25 1.967 . . . . 0.0 111.579 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.739 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.0 m . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 120.731 0.3 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.87 42.07 0.95 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -149.19 139.51 22.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.019 0.438 . . . . 0.0 110.512 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.744 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.5 p -110.47 126.32 54.22 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.771 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.3 p -87.0 4.64 41.04 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.744 HG23 ' HB2' ' A' ' 4' ' ' SER . 15.9 t -34.59 -46.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.188 0.93 . . . . 0.0 113.175 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.516 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.1 m-85 -126.47 -2.09 6.83 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.771 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.03 137.84 9.84 Favored Pre-proline 0 N--CA 1.468 0.468 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 34.6 Cg_exo -60.76 150.0 85.01 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 122.827 2.351 . . . . 0.0 112.279 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -51.55 131.56 29.53 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.487 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.4 m -113.36 -70.26 0.82 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.564 0.221 . . . . 0.0 111.433 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 t -63.26 -50.16 80.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-O 121.791 0.805 . . . . 0.0 109.766 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.944 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 68.9 p -67.62 -11.22 57.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.484 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.5 -34.58 78.25 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.31 -25.85 65.33 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.358 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.25 -6.9 59.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.718 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.49 29.05 33.96 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.954 -0.566 . . . . 0.0 112.399 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.944 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 81.0 m -77.67 136.18 38.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.943 0.401 . . . . 0.0 111.375 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -110.01 145.96 36.12 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.304 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.84 123.02 22.56 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.748 0.309 . . . . 0.0 110.535 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.0 m -144.07 120.19 10.77 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.73 33.85 23.74 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HB3' HG22 ' A' ' 6' ' ' VAL . 78.9 mtm180 73.31 13.59 4.63 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.769 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.1 t -131.7 137.87 54.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 65.3 m -75.25 126.36 30.85 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -147.26 143.01 27.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.336 -178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.523 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 24.1 p-10 -156.49 59.67 0.56 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 122.18 0.99 . . . . 0.0 109.603 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.68 -44.04 2.88 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -116.52 149.96 44.68 Favored Pre-proline 0 N--CA 1.443 -0.792 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo . . . . . 0 N--CA 1.461 -0.402 0 C-N-CA 122.468 2.112 . . . . 0.0 111.254 -179.459 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.751 ' HB3' HG21 ' A' ' 13' ' ' THR . 31.0 m . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.667 0.27 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.44 42.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -151.59 138.07 18.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.018 0.437 . . . . 0.0 110.52 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.776 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -110.28 127.52 55.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.754 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 5.9 p -88.79 7.05 35.99 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.776 HG23 ' HB2' ' A' ' 4' ' ' SER . 20.4 t -33.01 -48.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 124.344 1.028 . . . . 0.0 113.208 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.613 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.4 m-85 -128.99 1.59 5.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.754 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.37 137.93 10.26 Favored Pre-proline 0 N--CA 1.469 0.491 0 CA-C-O 120.677 0.275 . . . . 0.0 111.717 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 26.0 Cg_exo -61.91 150.17 87.26 Favored 'Trans proline' 0 C--O 1.233 0.264 0 C-N-CA 122.82 2.347 . . . . 0.0 112.351 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -52.51 133.2 35.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.476 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 32.4 m -114.79 -68.65 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.076 -0.249 . . . . 0.0 111.41 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.614 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.9 t -63.05 -54.28 35.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.756 0.788 . . . . 0.0 109.886 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.891 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 58.2 p -66.43 -7.68 21.04 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.513 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -67.02 -36.04 81.23 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -71.45 -19.88 62.17 Favored 'General case' 0 N--CA 1.46 0.058 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.7 mt -85.42 -10.21 56.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.191 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.72 24.14 36.74 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.317 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.891 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 85.7 m -74.96 128.4 35.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.031 0.443 . . . . 0.0 111.392 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 m -104.49 144.39 31.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.506 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.0 t -71.64 125.97 28.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.705 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.5 t -148.07 120.51 8.48 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 56.21 40.54 29.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.521 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.727 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 68.56 13.62 8.96 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.143 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 51.4 t -133.73 138.44 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 62.0 m -77.07 128.09 33.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -136.76 144.25 43.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.913 -178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.667 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 42.5 t30 -160.03 70.58 0.44 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.51 -47.48 3.64 Favored Glycine 0 N--CA 1.452 -0.235 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 pt -122.59 156.8 60.85 Favored Pre-proline 0 N--CA 1.443 -0.825 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 N--CA 1.461 -0.405 0 C-N-CA 122.353 2.036 . . . . 0.0 111.084 -179.823 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.86 ' HB3' HG21 ' A' ' 13' ' ' THR . 14.1 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 120.928 0.394 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.43 46.5 1.34 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.493 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -147.18 139.63 24.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.703 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.763 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -114.49 122.64 47.2 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -85.45 8.05 20.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.141 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.763 HG23 ' HB2' ' A' ' 4' ' ' SER . 25.4 t -32.74 -48.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 O-C-N 124.385 1.053 . . . . 0.0 113.119 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.651 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.6 m-85 -129.49 1.17 5.03 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.6 pt -155.18 138.24 10.6 Favored Pre-proline 0 N--CA 1.47 0.528 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -62.84 149.87 90.06 Favored 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.733 2.288 . . . . 0.0 112.807 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 6.6 m -57.15 133.9 55.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.409 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -110.15 -70.77 0.79 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 t -63.37 -51.03 75.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 122.16 0.981 . . . . 0.0 109.833 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.86 HG21 ' HB3' ' A' ' 1' ' ' CYS . 71.3 p -65.98 -11.85 50.74 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.912 -1.495 . . . . 0.0 111.833 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -67.74 -34.81 77.57 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.5 tp -67.93 -26.76 66.12 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.36 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.72 -19.41 48.91 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.991 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.97 4.49 51.22 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.606 -0.724 . . . . 0.0 112.468 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.29 119.64 11.88 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.491 0.662 . . . . 0.0 111.322 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.1 m -98.06 154.36 17.77 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.416 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.5 t -71.17 120.16 16.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.407 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.7 m -144.86 118.4 9.12 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 59.54 35.8 22.75 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.335 0.588 . . . . 0.0 110.262 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.637 ' HD3' HG13 ' A' ' 6' ' ' VAL . 87.1 mtt-85 67.15 16.94 10.33 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.833 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.4 t -131.68 140.0 49.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.639 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 59.8 m -78.81 121.16 24.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.837 0.351 . . . . 0.0 110.279 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -139.68 142.57 36.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.554 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 20.6 t30 -160.94 72.7 0.45 Allowed 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.96 -50.56 4.42 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -176.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -118.22 152.49 50.68 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.457 -0.62 0 C-N-CA 122.586 2.191 . . . . 0.0 111.043 -179.614 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.919 ' HB3' HG21 ' A' ' 13' ' ' THR . 13.2 m . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.09 45.76 1.27 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.668 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -148.06 139.0 23.21 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.083 0.468 . . . . 0.0 110.656 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.473 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.0 p -113.63 130.72 56.34 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 25.0 p -90.92 0.01 57.62 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.359 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.764 HG22 ' HB3' ' A' ' 23' ' ' ARG . 17.6 t -37.15 -48.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 123.929 0.768 . . . . 0.0 112.832 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -100.99 -23.23 14.56 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -159.1 149.48 15.58 Favored Pre-proline 0 N--CA 1.47 0.547 0 CA-C-O 120.412 0.149 . . . . 0.0 111.38 -178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.48 150.0 71.3 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 123.019 2.479 . . . . 0.0 112.75 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 23.0 m -54.11 137.12 41.03 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.069 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.2 m -116.22 -70.27 0.8 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.967 -0.293 . . . . 0.0 111.21 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 20.1 t -61.65 -53.39 48.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.678 0.751 . . . . 0.0 110.564 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.919 HG21 ' HB3' ' A' ' 1' ' ' CYS . 33.0 p -69.15 -7.19 33.92 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.778 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.55 -33.98 75.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.6 mp -68.14 -26.14 65.63 Favored 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.552 178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.4 mt -80.58 -20.61 42.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.17 13.84 35.14 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.534 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.737 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.95 128.29 35.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.308 0.575 . . . . 0.0 111.353 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 26.2 p -97.64 158.17 15.64 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.82 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.8 t -76.58 67.36 2.71 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.514 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.5 m -94.91 123.0 38.13 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.796 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m120 57.27 36.33 27.19 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.417 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.764 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.0 OUTLIER 67.73 17.68 9.8 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.497 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.9 p -140.96 141.15 31.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.218 0.533 . . . . 0.0 109.895 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.689 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 35.3 m -74.71 113.67 12.25 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.268 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -131.93 147.62 52.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.11 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.737 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 41.7 t30 -160.89 68.56 0.34 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.84 -47.64 3.71 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.8 pt -117.95 153.44 51.07 Favored Pre-proline 0 N--CA 1.444 -0.761 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.672 2.248 . . . . 0.0 111.925 -179.588 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.712 ' HB3' HG21 ' A' ' 13' ' ' THR . 24.5 m . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.47 45.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -150.26 140.49 22.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.156 0.503 . . . . 0.0 111.369 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.672 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -111.95 122.18 47.06 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.726 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -83.87 3.17 34.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.915 HG22 ' HB3' ' A' ' 23' ' ' ARG . 6.6 t -38.38 -43.24 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 124.038 0.836 . . . . 0.0 112.964 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.416 ' O ' HG23 ' A' ' 8' ' ' ILE . 16.4 m-85 -114.98 -14.61 11.85 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.726 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.6 pt -160.48 143.63 9.97 Favored Pre-proline 0 N--CA 1.47 0.532 0 CA-C-O 120.547 0.213 . . . . 0.0 111.348 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.26 151.38 74.08 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.649 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 6.4 m -50.89 130.77 25.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.757 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.2 m -109.22 -69.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.84 -53.6 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 122.118 0.961 . . . . 0.0 109.792 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.895 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 26.0 p -64.69 -8.26 13.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.99 -1.459 . . . . 0.0 111.88 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -69.01 -30.08 68.39 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.3 mt -71.62 -23.19 61.66 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.923 0.868 . . . . 0.0 108.908 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.1 mm? -86.49 -12.3 49.32 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.001 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.47 22.39 37.45 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.702 -0.681 . . . . 0.0 112.395 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.895 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 69.6 m -70.57 124.39 24.12 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.951 0.405 . . . . 0.0 110.934 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.7 m -102.67 147.4 26.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.613 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.2 t -74.49 122.64 23.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.574 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.3 m -144.09 121.07 11.37 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 3.1 m120 57.77 33.4 23.17 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.779 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.915 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.39 13.72 6.51 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.716 -179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.8 t -129.38 138.34 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.558 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 84.4 m -76.51 127.37 32.69 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.157 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -138.83 143.76 38.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.785 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.66 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.9 t30 -160.34 70.43 0.42 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.26 -47.77 3.66 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.9 pt -121.26 155.63 58.39 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 N--CA 1.463 -0.298 0 C-N-CA 122.455 2.104 . . . . 0.0 111.324 -179.644 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HB3' HG21 ' A' ' 13' ' ' THR . 18.4 m . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.717 0.294 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.39 43.43 1.07 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -149.67 135.99 19.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.053 0.454 . . . . 0.0 111.148 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.61 ' HB2' HG23 ' A' ' 6' ' ' VAL . 5.6 p -106.05 128.93 54.19 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.723 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.0 p -86.27 -1.09 57.17 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.839 HG22 ' HB3' ' A' ' 23' ' ' ARG . 18.8 t -37.56 -46.31 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 8' ' ' ILE . 29.6 m-85 -105.46 -21.52 13.2 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.67 0.618 . . . . 0.0 112.67 -178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.723 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.7 pt -161.69 150.05 12.61 Favored Pre-proline 0 N--CA 1.47 0.53 0 CA-C-O 120.529 0.204 . . . . 0.0 111.195 -178.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.85 155.17 39.53 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.068 2.512 . . . . 0.0 112.702 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 8.4 m -52.16 135.34 31.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.038 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.5 m -115.12 -71.03 0.76 Allowed 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.875 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.31 -50.67 77.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.769 0.795 . . . . 0.0 109.823 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.928 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.1 p -67.55 -11.4 57.96 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.486 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.2 -35.18 79.76 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -68.65 -25.84 65.03 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.382 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 86.1 mt -84.22 -8.02 59.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.773 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.24 30.51 25.03 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.413 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.928 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 88.9 m -81.4 138.86 35.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.895 0.379 . . . . 0.0 111.375 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.5 t -113.09 147.55 37.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.348 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.1 t -75.97 116.4 16.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.462 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.1 m -144.91 127.18 15.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.2 m120 60.49 33.43 20.57 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.211 0.529 . . . . 0.0 110.343 -178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.839 ' HB3' HG22 ' A' ' 6' ' ' VAL . 2.6 mmp_? 68.53 11.83 8.49 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.636 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.1 p -134.58 145.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 63.6 m -78.84 124.31 28.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.865 0.364 . . . . 0.0 111.038 -178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -141.09 150.05 42.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.111 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 26.1 p-10 -160.11 58.67 0.35 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.347 1.07 . . . . 0.0 109.455 179.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.67 -42.49 2.9 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.7 pt -118.24 153.52 51.57 Favored Pre-proline 0 N--CA 1.444 -0.755 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 177.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.458 -0.571 0 C-N-CA 122.381 2.054 . . . . 0.0 111.581 -179.455 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.739 ' HB3' HG21 ' A' ' 13' ' ' THR . 24.0 m . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.28 45.6 1.13 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -150.41 136.59 18.63 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.53 124.89 50.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.3 p -86.21 -2.27 58.21 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' A' ' 23' ' ' ARG . 21.6 t -36.53 -44.48 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -113.29 -16.52 12.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.7 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.0 pt -158.03 145.45 13.51 Favored Pre-proline 0 N--CA 1.467 0.416 0 CA-C-O 120.666 0.27 . . . . 0.0 111.475 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.3 153.2 71.87 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.753 2.302 . . . . 0.0 112.305 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 4.8 m -53.67 131.92 39.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.796 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.9 m -109.42 -69.92 0.84 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.7 t -63.09 -53.41 46.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 122.057 0.932 . . . . 0.0 109.834 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.89 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 28.6 p -64.44 -8.9 15.18 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.042 -1.435 . . . . 0.0 111.904 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 10' ' ' CYS . . . -68.76 -31.15 69.97 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.37 -23.79 61.96 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.841 0.829 . . . . 0.0 108.893 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.2 mm? -84.68 -14.4 48.58 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.978 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 24.37 26.49 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.426 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.89 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 92.0 m -74.12 127.34 32.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 0.0 111.048 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.0 t -107.64 147.4 30.73 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.049 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 52.1 t -71.39 121.62 18.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.272 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -150.15 124.38 9.48 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.98 37.68 21.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.855 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.943 ' HB3' HG22 ' A' ' 6' ' ' VAL . 35.2 mtp85 71.5 1.56 3.91 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.677 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.5 p -128.03 147.33 32.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.941 0.4 . . . . 0.0 110.539 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 72.8 m -75.23 128.34 35.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -136.75 147.06 46.48 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.014 0.435 . . . . 0.0 111.145 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.626 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 44.8 t30 -160.67 68.16 0.34 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.79 -49.88 4.0 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.56 155.92 48.18 Favored Pre-proline 0 N--CA 1.444 -0.771 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo . . . . . 0 N--CA 1.459 -0.509 0 C-N-CA 122.191 1.927 . . . . 0.0 111.64 -179.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.696 ' HB3' HG21 ' A' ' 13' ' ' THR . 11.3 m . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 120.589 0.233 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.76 44.2 1.1 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -148.18 140.62 24.37 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.12 0.486 . . . . 0.0 111.213 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.785 ' HB2' HG23 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -110.99 125.46 53.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -87.49 12.86 11.27 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.785 HG23 ' HB2' ' A' ' 4' ' ' SER . 30.8 t -33.34 -50.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.396 1.06 . . . . 0.0 113.138 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.674 ' HD1' HG12 ' A' ' 6' ' ' VAL . 4.9 m-85 -125.68 -0.09 7.44 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.695 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.9 pt -157.09 142.78 12.7 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 21.8 Cg_exo -64.43 152.83 80.01 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 122.911 2.407 . . . . 0.0 112.319 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -51.64 130.32 27.96 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.49 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.8 m -106.83 -69.18 0.85 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.5 t -63.69 -53.67 41.89 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 122.172 0.986 . . . . 0.0 109.77 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 1.021 ' HA ' HD13 ' A' ' 16' ' ' LEU . 31.1 p -65.58 -3.17 4.17 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.98 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.19 -32.33 72.49 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.4 tp -70.14 -26.17 63.82 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.806 0.812 . . . . 0.0 108.915 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.021 HD13 ' HA ' ' A' ' 13' ' ' THR . 7.1 mp -81.7 -10.83 59.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.375 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 84.63 26.21 39.56 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.032 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.955 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 64.0 m -72.89 131.73 42.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.843 0.354 . . . . 0.0 111.241 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -109.74 148.15 31.94 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.591 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.5 t -74.5 123.2 24.3 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.68 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.5 m -146.17 121.02 9.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.9 m120 58.02 35.52 25.29 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.941 0.4 . . . . 0.0 110.911 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.676 ' HG3' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER 69.11 15.01 8.76 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.54 -0.754 . . . . 0.0 112.044 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.0 t -132.45 140.87 46.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 1' ' ' CYS . 71.6 m -78.14 126.49 30.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.974 0.416 . . . . 0.0 110.155 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -148.67 142.51 25.7 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.337 -178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 21.3 p-10 -156.37 58.83 0.57 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.184 0.992 . . . . 0.0 109.298 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.93 -44.07 2.85 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 108.343 -1.903 . . . . 0.0 108.343 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.0 pt -115.75 150.04 44.17 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.46 -0.47 0 C-N-CA 122.416 2.077 . . . . 0.0 111.611 -179.203 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.937 ' HB3' HG21 ' A' ' 13' ' ' THR . 12.9 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 121.045 0.45 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.45 44.06 1.18 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.689 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.02 143.08 26.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.981 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.79 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -120.57 129.6 53.85 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.5 p -88.97 8.52 29.14 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -178.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.79 HG23 ' HB2' ' A' ' 4' ' ' SER . 30.7 t -33.14 -49.66 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 O-C-N 124.319 1.012 . . . . 0.0 112.825 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.629 ' HD1' HG12 ' A' ' 6' ' ' VAL . 4.9 m-85 -125.83 -1.28 7.28 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.759 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.67 142.03 12.52 Favored Pre-proline 0 N--CA 1.473 0.69 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.04 148.24 93.55 Favored 'Trans proline' 0 CA--C 1.529 0.267 0 C-N-CA 122.915 2.41 . . . . 0.0 112.512 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.5 m -56.31 137.94 51.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.72 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 29.9 m -117.79 -67.95 0.95 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.335 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.589 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.5 t -61.44 -56.1 20.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.79 0.805 . . . . 0.0 110.556 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.937 HG21 ' HB3' ' A' ' 1' ' ' CYS . 30.2 p -67.47 -5.66 15.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.909 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 11' ' ' THR . . . -68.02 -35.75 78.81 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 12' ' ' VAL . 4.2 pp -70.27 -21.3 62.98 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.3 mt -80.89 -20.63 41.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.886 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.86 4.15 48.66 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.542 -0.753 . . . . 0.0 112.475 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -66.87 120.49 13.65 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.549 0.69 . . . . 0.0 111.466 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.8 m -97.95 153.72 18.16 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.815 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.0 t -74.05 118.12 16.64 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.763 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -150.67 131.4 14.04 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.65 28.54 17.98 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.73 0.776 . . . . 0.0 109.639 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.655 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 36.4 mmt180 68.06 16.95 9.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.214 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.2 m -134.43 151.83 32.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 39.7 m -82.6 121.24 26.56 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -138.74 140.83 38.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.459 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.1 t30 -160.56 74.36 0.53 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.15 -51.84 4.64 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -119.74 155.12 55.07 Favored Pre-proline 0 C--O 1.243 0.711 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 176.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.586 0 C-N-CA 122.52 2.146 . . . . 0.0 110.877 -179.954 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.735 ' HB3' HG21 ' A' ' 13' ' ' THR . 18.5 m . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 120.626 0.251 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.71 42.46 0.97 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -149.21 135.65 19.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.134 0.493 . . . . 0.0 110.826 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.805 ' HB2' HG23 ' A' ' 6' ' ' VAL . 3.6 p -105.94 128.62 53.92 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.733 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -91.62 10.25 28.87 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.852 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.805 HG23 ' HB2' ' A' ' 4' ' ' SER . 15.1 t -33.85 -45.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.291 0.994 . . . . 0.0 113.217 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.471 ' HD1' HG12 ' A' ' 6' ' ' VAL . 11.7 m-85 -131.77 1.2 3.98 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.733 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.0 pt -154.82 139.39 11.68 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -61.94 151.87 78.6 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.957 2.438 . . . . 0.0 112.648 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.3 m -52.55 132.92 36.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.717 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 m -114.26 -70.71 0.79 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.28 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.91 -51.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.644 0.735 . . . . 0.0 110.04 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.919 ' HB ' ' SG ' ' A' ' 18' ' ' CYS . 70.4 p -67.08 -7.6 24.19 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.692 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -30.99 69.82 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -71.94 -23.56 61.48 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.903 0.858 . . . . 0.0 108.903 178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.5 mm? -84.8 -9.82 57.8 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.066 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 82.78 32.37 27.17 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.057 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.919 ' SG ' ' HB ' ' A' ' 13' ' ' THR . 90.0 m -80.8 134.4 35.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.908 0.385 . . . . 0.0 111.589 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 p -107.82 144.72 34.62 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.671 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.92 124.51 27.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 51.1 m -150.17 127.04 11.07 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.7 m120 58.15 35.84 25.39 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.258 0.552 . . . . 0.0 110.762 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HD2' ' HA ' ' A' ' 6' ' ' VAL . 24.5 mmt85 65.39 20.03 11.71 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.593 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 10.4 p -141.34 143.19 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 178.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 61.9 m -78.93 123.7 27.52 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.009 0.433 . . . . 0.0 111.295 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.97 149.31 39.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.678 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.552 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.6 p-10 -159.8 59.09 0.37 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.274 1.035 . . . . 0.0 109.317 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.83 -42.02 2.9 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 108.596 -1.802 . . . . 0.0 108.596 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 pt -118.99 153.44 52.77 Favored Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.05 -1.075 . . . . 0.0 108.121 177.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.458 -0.598 0 C-N-CA 122.329 2.019 . . . . 0.0 111.416 -179.477 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.851 ' HB3' HG21 ' A' ' 13' ' ' THR . 8.4 m . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.825 0.345 . . . . 0.0 111.024 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.09 42.68 1.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.081 0.467 . . . . 0.0 111.237 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -145.22 138.44 26.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.132 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.815 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.2 p -114.67 128.1 56.12 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.761 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.9 p -88.71 8.53 28.27 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.844 -178.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.815 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.9 t -30.82 -50.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 O-C-N 124.541 1.15 . . . . 0.0 113.15 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.776 ' HD1' HG12 ' A' ' 6' ' ' VAL . 5.9 m-85 -132.83 4.68 3.87 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.761 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.5 pt -154.42 137.64 10.43 Favored Pre-proline 0 N--CA 1.469 0.521 0 CA-C-O 120.595 0.236 . . . . 0.0 111.454 -179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.77 150.59 85.25 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 122.763 2.309 . . . . 0.0 112.903 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.0 m -58.17 138.5 56.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.348 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.0 m -117.09 -71.87 0.72 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.644 0.259 . . . . 0.0 111.234 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 38.2 t -63.39 -49.08 84.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.728 0.775 . . . . 0.0 109.883 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.851 HG21 ' HB3' ' A' ' 1' ' ' CYS . 30.9 p -68.33 -13.55 62.35 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.625 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.42 -35.27 78.92 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.7 tp -67.84 -27.07 66.39 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.46 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.9 mt -79.96 -20.11 46.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.124 179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.82 10.38 40.5 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.466 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -72.62 121.8 20.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.37 0.605 . . . . 0.0 111.217 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -96.61 155.38 16.79 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.035 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.4 t -72.49 118.8 15.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.498 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.8 m -142.85 120.0 11.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 57.53 35.73 26.11 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.169 0.509 . . . . 0.0 110.558 -178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.698 ' HD3' HG13 ' A' ' 6' ' ' VAL . 89.8 mtt180 67.35 19.66 10.11 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.929 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.35 139.05 48.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 47.6 m -78.22 119.93 22.29 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.955 0.407 . . . . 0.0 109.961 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -136.33 142.67 43.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.708 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.706 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.9 t30 -160.38 73.74 0.52 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.59 -49.56 3.89 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -176.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 37.8 pt -118.57 152.62 51.41 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo . . . . . 0 N--CA 1.456 -0.73 0 C-N-CA 122.183 1.922 . . . . 0.0 111.519 -179.493 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.893 ' HB3' HG21 ' A' ' 13' ' ' THR . 12.3 m . . . . . 0 N--CA 1.452 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.21 45.96 1.31 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.726 -179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -147.21 140.74 25.53 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.264 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.759 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.6 p -117.28 126.17 52.29 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.6 p -87.31 5.39 38.69 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.854 HG22 ' HB3' ' A' ' 23' ' ' ARG . 12.2 t -35.49 -44.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 124.157 0.91 . . . . 0.0 113.229 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -124.68 -5.83 7.52 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.75 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.3 pt -158.37 141.05 10.53 Favored Pre-proline 0 N--CA 1.47 0.563 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -60.24 148.61 89.28 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.89 2.393 . . . . 0.0 112.548 179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.3 m -55.2 138.58 44.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.827 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -120.33 -66.02 1.1 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.321 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.35 -54.56 33.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.634 0.73 . . . . 0.0 110.508 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.893 HG21 ' HB3' ' A' ' 1' ' ' CYS . 32.4 p -70.1 -5.41 26.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.679 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.93 -28.54 64.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.87 -25.3 62.74 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.953 0.882 . . . . 0.0 108.839 178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.807 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -82.05 -21.02 37.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.64 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.48 12.91 39.96 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-N 115.327 -0.852 . . . . 0.0 112.668 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.704 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -71.9 123.52 22.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.469 0.652 . . . . 0.0 111.252 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 6.9 p -98.37 153.98 18.17 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.695 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.6 t -74.19 121.68 21.6 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.642 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 t -150.0 124.08 9.42 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 58.03 36.33 25.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.178 0.513 . . . . 0.0 111.011 -179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.854 ' HB3' HG22 ' A' ' 6' ' ' VAL . 8.3 mpt_? 69.59 9.37 7.19 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.742 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.91 148.39 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.381 178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.661 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 43.3 m -82.67 124.4 30.17 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -137.98 142.2 40.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.587 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.704 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 17.7 t30 -160.85 73.07 0.47 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.896 179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.2 -50.4 4.4 Favored Glycine 0 N--CA 1.45 -0.391 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.51 155.13 59.69 Favored Pre-proline 0 C--O 1.243 0.752 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo . . . . . 0 N--CA 1.459 -0.508 0 C-N-CA 122.584 2.189 . . . . 0.0 111.004 -179.716 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.873 ' HB3' HG21 ' A' ' 13' ' ' THR . 4.3 m . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.63 0.252 . . . . 0.0 110.391 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -95.24 44.0 1.09 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.034 0.445 . . . . 0.0 111.131 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -147.18 137.03 23.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.846 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.707 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.8 p -114.27 128.02 56.16 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.739 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.1 p -86.71 2.86 47.16 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.162 0.431 . . . . 0.0 112.162 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.826 HG22 ' HB3' ' A' ' 23' ' ' ARG . 12.6 t -36.94 -44.52 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 O-C-N 123.96 0.788 . . . . 0.0 113.079 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.404 ' O ' HG23 ' A' ' 8' ' ' ILE . 32.7 m-85 -115.14 -15.05 11.73 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.739 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 4.4 pt -159.47 145.71 12.2 Favored Pre-proline 0 N--CA 1.47 0.558 0 N-CA-C 111.519 0.192 . . . . 0.0 111.519 -178.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.48 150.07 77.83 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.085 2.523 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 m -53.69 138.51 34.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.122 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.8 m -118.39 -71.13 0.75 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.353 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 29.1 t -63.12 -49.9 81.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.439 0.638 . . . . 0.0 110.201 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.873 HG21 ' HB3' ' A' ' 1' ' ' CYS . 34.8 p -67.79 -9.39 43.84 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.808 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.55 -30.27 68.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mp -70.92 -24.89 62.55 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.784 0.802 . . . . 0.0 108.872 178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.621 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -81.49 -21.13 38.9 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.594 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.12 13.92 37.84 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.17 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.744 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -73.98 122.93 23.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.352 0.596 . . . . 0.0 111.112 179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -98.88 154.35 18.1 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.18 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.9 t -74.27 120.77 20.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.384 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.5 m -148.82 124.73 10.61 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.4 34.08 23.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.266 0.555 . . . . 0.0 110.562 -178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.826 ' HB3' HG22 ' A' ' 6' ' ' VAL . 84.3 mtt-85 68.4 15.33 9.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.639 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.2 p -136.48 143.9 34.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.642 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 36.4 m -81.94 119.01 23.41 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.971 0.415 . . . . 0.0 111.343 -178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -130.75 149.35 52.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.395 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.744 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 27.9 t30 -160.75 69.03 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.72 -47.44 3.66 Favored Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.0 pt -120.11 154.57 55.87 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 N--CA 1.461 -0.42 0 C-N-CA 122.612 2.208 . . . . 0.0 111.741 -179.637 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.891 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.5 m . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.914 0.387 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.1 42.59 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.512 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -148.66 150.07 32.59 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.994 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.542 ' HB2' HG23 ' A' ' 6' ' ' VAL . 2.8 p -130.07 130.21 44.59 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.816 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 4.2 p -82.79 -3.09 56.18 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.814 -178.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.542 HG23 ' HB2' ' A' ' 4' ' ' SER . 42.6 t -37.51 -45.44 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 O-C-N 124.104 0.877 . . . . 0.0 112.475 179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' O ' HG23 ' A' ' 8' ' ' ILE . 33.7 m-85 -105.9 -22.77 12.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.816 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.0 pt -162.6 143.64 7.75 Favored Pre-proline 0 N--CA 1.471 0.585 0 O-C-N 123.162 0.289 . . . . 0.0 110.738 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -53.87 147.98 39.61 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 123.258 2.639 . . . . 0.0 113.192 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 48.0 m -53.62 135.15 41.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.017 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.1 m -117.07 -70.65 0.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.208 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.0 t -61.86 -51.83 67.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.83 0.824 . . . . 0.0 110.293 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 1' ' ' CYS . 43.7 p -68.64 -9.54 50.55 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.846 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.64 79.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 177.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -68.41 -25.63 65.13 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.659 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.07 -20.06 46.07 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.221 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.24 12.78 35.19 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.8 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 1.6 m -75.28 128.35 35.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 0.0 111.466 179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.2 m -98.2 162.3 13.27 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.797 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.7 t -78.16 66.26 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.695 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.449 ' O ' HG12 ' A' ' 24' ' ' VAL . 17.2 m -89.82 121.99 32.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.8 m120 56.72 32.31 20.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.22 0.533 . . . . 0.0 110.756 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.487 ' HA ' ' SG ' ' A' ' 5' ' ' CYS . 69.2 mtp180 67.44 18.72 10.1 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.244 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 21' ' ' SER . 8.3 p -131.36 142.61 42.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 49.4 m -72.8 113.15 9.52 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -142.75 145.56 33.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.452 -177.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.585 ' HB3' ' HA ' ' A' ' 18' ' ' CYS . 25.7 p-10 -156.33 55.64 0.57 Allowed 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 122.254 1.026 . . . . 0.0 109.265 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 -46.22 2.77 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 108.111 -1.995 . . . . 0.0 108.111 -176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 33.4 pt -110.37 150.81 42.12 Favored Pre-proline 0 N--CA 1.442 -0.846 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.457 -0.644 0 C-N-CA 122.488 2.125 . . . . 0.0 112.317 -178.741 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.804 ' HB3' HG21 ' A' ' 13' ' ' THR . 7.3 m . . . . . 0 N--CA 1.453 -0.275 0 CA-C-O 120.765 0.317 . . . . 0.0 110.48 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.01 45.42 1.21 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.9 0.381 . . . . 0.0 111.414 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -146.39 134.12 21.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.986 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.724 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.4 p -109.48 126.35 53.42 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 177.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.1 p -89.24 8.04 32.36 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -177.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.727 HG12 ' HD1' ' A' ' 7' ' ' TYR . 38.8 t -31.78 -48.87 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 124.422 1.076 . . . . 0.0 113.122 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.727 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.5 m-85 -134.73 7.19 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.539 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 7.9 pt -152.51 136.41 10.09 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -65.75 149.18 87.13 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.502 2.135 . . . . 0.0 112.503 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 m -59.3 132.83 55.17 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.247 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.7 m -111.21 -72.52 0.71 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -63.24 -50.09 80.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 122.018 0.913 . . . . 0.0 109.811 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.804 HG21 ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.11 -15.97 62.97 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 114.118 -1.401 . . . . 0.0 111.724 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.86 83.51 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.1 mt -68.26 -25.89 65.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.614 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 65.2 mt -80.24 -18.37 49.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.071 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.65 3.11 49.93 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.52 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -67.97 120.47 14.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.507 0.67 . . . . 0.0 111.256 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.4 m -98.14 149.16 22.82 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.552 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.0 t -70.84 120.8 16.96 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.388 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 48.2 m -150.13 125.7 10.28 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.6 m120 58.34 36.62 25.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.927 0.394 . . . . 0.0 111.204 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HB3' HG22 ' A' ' 6' ' ' VAL . 61.3 mtp180 68.76 17.55 8.81 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.707 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 11.8 p -143.57 145.02 22.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.852 0.358 . . . . 0.0 110.226 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 24.3 m -82.59 119.37 24.17 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.943 0.402 . . . . 0.0 111.363 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -131.09 149.41 52.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.451 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.745 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.5 t30 -161.0 69.29 0.35 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.2 -48.68 3.84 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.1 pt -116.28 153.41 48.64 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.459 -0.52 0 C-N-CA 122.695 2.263 . . . . 0.0 111.72 -179.544 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.896 ' HB3' HG21 ' A' ' 13' ' ' THR . 7.8 m . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.858 0.361 . . . . 0.0 110.774 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.21 45.6 1.25 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.779 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -146.8 133.61 20.08 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.066 0.46 . . . . 0.0 110.504 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.68 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.7 p -109.89 127.71 54.89 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 7.5 p -90.38 4.94 49.43 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 23' ' ' ARG . 15.9 t -34.5 -45.98 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 124.325 1.016 . . . . 0.0 112.909 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.529 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.6 m-85 -130.77 2.27 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.756 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 6.8 pt -153.82 138.85 11.63 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -64.35 146.32 89.7 Favored 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.685 2.257 . . . . 0.0 112.109 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 15.0 m -56.5 136.28 54.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.554 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.7 m -124.07 -66.19 1.01 Allowed 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.488 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 t -60.85 -55.48 24.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.573 0.702 . . . . 0.0 110.61 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.896 HG21 ' HB3' ' A' ' 1' ' ' CYS . 32.0 p -70.19 -5.93 30.84 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.629 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.73 -28.72 64.92 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.8 -25.29 62.8 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.873 0.844 . . . . 0.0 108.733 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.759 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -82.42 -21.56 35.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.259 -1.337 . . . . 0.0 109.567 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.44 14.18 33.44 Favored Glycine 0 N--CA 1.446 -0.668 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.635 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.749 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -74.42 122.33 22.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.363 0.601 . . . . 0.0 111.202 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.6 t -98.44 153.21 18.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.269 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 47.3 t -71.95 122.88 21.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.016 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 t -150.39 126.79 10.75 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.8 m120 56.9 32.83 22.17 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.98 0.419 . . . . 0.0 111.094 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.756 ' HB3' HG22 ' A' ' 6' ' ' VAL . 81.2 mtm180 71.46 18.62 5.43 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.491 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 9.1 p -143.24 142.74 25.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.868 0.366 . . . . 0.0 110.06 178.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.5 m -78.67 121.11 24.28 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.928 0.394 . . . . 0.0 111.265 -178.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -130.14 147.94 51.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.398 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.749 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 25.7 t30 -160.96 70.29 0.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.463 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.07 -46.47 3.51 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.89 156.15 62.65 Favored Pre-proline 0 N--CA 1.443 -0.787 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo . . . . . 0 N--CA 1.46 -0.489 0 C-N-CA 122.653 2.235 . . . . 0.0 111.717 -179.74 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.835 ' HB3' HG21 ' A' ' 13' ' ' THR . 17.8 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.852 0.358 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.7 47.8 1.46 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.595 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -146.24 137.14 24.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.001 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.719 ' HB2' HG23 ' A' ' 6' ' ' VAL . 4.3 p -109.78 123.32 49.34 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.769 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.6 p -86.71 3.01 46.64 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.273 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' A' ' 23' ' ' ARG . 10.2 t -34.54 -45.8 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 O-C-N 124.224 0.952 . . . . 0.0 113.163 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -125.77 -3.92 7.1 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.769 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 5.5 pt -156.15 138.32 10.14 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-O 120.664 0.269 . . . . 0.0 111.615 -178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -62.52 150.7 86.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.742 2.295 . . . . 0.0 112.637 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.4 m -56.95 133.22 54.58 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.437 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.5 m -111.52 -69.83 0.85 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 t -62.68 -53.08 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 122.05 0.929 . . . . 0.0 110.042 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.835 HG21 ' HB3' ' A' ' 1' ' ' CYS . 67.9 p -65.91 -8.42 22.19 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.995 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.13 -29.74 66.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.74 -24.89 62.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.82 0.819 . . . . 0.0 108.823 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.749 HD23 ' HA ' ' A' ' 13' ' ' THR . 2.9 mm? -80.79 -21.2 41.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.678 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.55 7.93 50.31 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.431 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -67.22 120.19 13.37 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.471 0.653 . . . . 0.0 111.192 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 m -98.45 152.31 19.66 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.462 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.7 t -71.49 121.56 18.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.456 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.9 m -149.51 122.41 8.75 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 59.55 35.92 22.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 110.918 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.908 ' HB3' HG22 ' A' ' 6' ' ' VAL . 8.9 mpt_? 69.08 11.55 8.31 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.749 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.8 m -133.01 147.39 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.88 0.371 . . . . 0.0 110.151 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 60.4 m -80.6 122.36 26.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.792 0.33 . . . . 0.0 110.356 -179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -137.93 142.95 40.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.081 0.467 . . . . 0.0 111.503 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 16.9 t30 -160.96 72.44 0.44 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.34 -48.97 3.72 Favored Glycine 0 N--CA 1.453 -0.214 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 pt -118.57 151.58 49.99 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.27 1.98 . . . . 0.0 111.805 -179.503 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.929 ' HB3' HG21 ' A' ' 13' ' ' THR . 14.2 m . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 120.901 0.382 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.55 46.06 1.27 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.737 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -145.95 139.49 26.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.415 179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.679 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.3 p -115.67 123.71 49.03 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 3.3 p -84.38 0.85 47.77 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.259 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' A' ' 23' ' ' ARG . 6.7 t -38.12 -43.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 O-C-N 124.09 0.869 . . . . 0.0 113.046 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.426 ' O ' HG23 ' A' ' 8' ' ' ILE . 10.5 m-85 -115.78 -13.59 11.39 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.777 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 3.3 pt -160.93 142.33 8.89 Favored Pre-proline 0 N--CA 1.47 0.54 0 CA-C-O 120.446 0.165 . . . . 0.0 111.062 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -57.45 150.02 62.3 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.903 2.402 . . . . 0.0 112.65 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.3 m -54.39 138.03 40.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.778 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 m -118.56 -68.13 0.94 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.159 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.6 t -61.58 -53.33 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.72 0.771 . . . . 0.0 110.376 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.929 HG21 ' HB3' ' A' ' 1' ' ' CYS . 29.9 p -70.04 -8.35 48.53 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.076 -0.966 . . . . 0.0 111.686 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.64 -33.19 73.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.4 tp -68.01 -27.53 66.63 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.228 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 mt -80.43 -19.94 45.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.021 -0.991 . . . . 0.0 110.088 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.68 8.07 46.7 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.693 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.714 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.6 m -69.04 120.81 15.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.507 0.67 . . . . 0.0 111.545 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.0 m -97.56 149.67 21.96 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.462 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.6 t -65.57 104.92 1.09 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.603 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.9 m -121.67 110.73 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.411 ' O ' ' HB2' ' A' ' 23' ' ' ARG . 23.7 m-20 56.96 43.78 24.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.412 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.937 ' HB3' HG22 ' A' ' 6' ' ' VAL . 0.3 OUTLIER 71.19 6.59 5.87 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.337 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.2 135.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.632 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 57.7 m -72.17 120.89 18.41 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.882 0.372 . . . . 0.0 110.053 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -137.78 142.08 40.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.019 0.438 . . . . 0.0 111.612 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 19.0 t30 -160.59 74.18 0.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.78 -48.28 3.84 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -122.37 153.87 62.21 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.554 0 C-N-CA 122.595 2.196 . . . . 0.0 111.247 -179.431 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.845 ' HB3' HG21 ' A' ' 13' ' ' THR . 8.5 m . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.42 45.62 1.3 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.536 -179.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -147.59 136.41 22.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.886 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.72 ' HB2' HG23 ' A' ' 6' ' ' VAL . 1.2 p -109.79 125.77 53.07 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.73 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 19.7 p -88.95 6.56 38.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.75 HG22 ' HB3' ' A' ' 23' ' ' ARG . 20.6 t -32.38 -48.65 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 124.446 1.091 . . . . 0.0 113.039 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.63 ' HD1' HG12 ' A' ' 6' ' ' VAL . 6.3 m-85 -133.66 6.76 3.77 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.7 pt -151.85 139.76 12.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 8' ' ' ILE . 12.7 Cg_exo -68.59 144.05 59.07 Favored 'Trans proline' 0 N--CA 1.464 -0.217 0 C-N-CA 122.777 2.318 . . . . 0.0 111.947 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.9 m -56.65 132.83 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.374 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 23.5 m -112.24 -70.51 0.8 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.6 t -62.3 -52.93 54.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 CA-C-O 121.953 0.882 . . . . 0.0 110.18 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.845 HG21 ' HB3' ' A' ' 1' ' ' CYS . 76.2 p -65.4 -10.56 34.55 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 114.158 -1.383 . . . . 0.0 111.953 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.66 -30.38 68.06 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.5 mt -70.8 -24.8 62.64 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.808 0.814 . . . . 0.0 108.953 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 13' ' ' THR . 3.0 mm? -80.76 -21.12 41.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.599 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.86 49.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.472 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.721 ' HA ' ' HB2' ' A' ' 27' ' ' ASN . 1.7 m -68.13 119.55 12.89 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.474 0.654 . . . . 0.0 111.115 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 m -97.8 151.16 20.48 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.485 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.5 t -71.03 120.86 17.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.482 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 46.5 m -150.21 126.45 10.68 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.5 m120 56.86 34.79 25.35 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.015 0.436 . . . . 0.0 111.034 -179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.75 ' HB3' HG22 ' A' ' 6' ' ' VAL . 1.6 mpt_? 68.74 16.55 8.94 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.693 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.19 143.95 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.946 0.403 . . . . 0.0 109.94 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.624 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 55.2 m -77.72 118.35 20.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -131.69 144.39 50.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.172 0.511 . . . . 0.0 111.785 -177.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.721 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 18.8 t30 -161.22 71.66 0.4 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.12 -0.945 . . . . 0.0 108.778 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.17 -52.68 4.67 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -176.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -117.44 156.02 49.56 Favored Pre-proline 0 C--O 1.244 0.804 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.761 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 61.5 Cg_endo . . . . . 0 N--CA 1.456 -0.733 0 C-N-CA 122.195 1.93 . . . . 0.0 111.738 -179.478 . . . . . . . . 1 1 . 1 stop_ save_